KR20070017416A - Pharmaceutical product tracking - Google Patents

Abstract

A business terminal for executing business processes related to the pharmaceutical, wherein the pharmaceutical is associated with a packaging in which coded data comprising a plurality of coded data portions is placed on or in the respective coded data portions. Indicates an identifier of the pharmaceutical preparation, and the terminal for processing a business;

A radiation source for exposing at least one coded data portion;

A sensor for sensing at least one exposed coded data portion; and

Using at least one sensed coded data portion to determine a detected identifier,

And a processor for executing the business process using the sensed identifier.

Tracking device, Reed-Solomon data

Description

Pharmaceutical Tracking {PHARMACEUTICAL PRODUCT TRACKING}

The present invention relates explicitly to a method and apparatus for the protection of products and security documents using machine-readable tags placed on or in the surface of the product or security document.

At the same time pending applications

The following applications were submitted by the applicant at the same time as this application.

The disclosure of these concurrent applications is incorporated herein by reference. The applications are identified by their filing number, which can be replaced by the corresponding application number when designated.

[Cross Reference]

Various methods, systems and apparatus related to the present invention are disclosed in the following US concurrently pending applications and licensed patents filed by the applicant or assignee of the present invention.

Several applications are listed by filing number, which are replaceable at the time of application number notice.

[Drug Counterfeiting]

The pharmaceutical industry is large and has grown steadily on a global scale of $ 400 billion in 2002. About 20% of total sales revenue was spent on research and development (R & D). The pharmaceutical industry is also global, and its security structure is primarily a result of the need to protect large R & D investments. Many governments are huge buyers of constraints in the state-funded health care system.

Pharmaceutical costs currently represent about 15% of total health expenses in OECD countries.

Trade and manufacturing activities are carried out at an international level, while national authorities consider their country's location in a global perspective when planning their national policy. There is a need to balance global industrial interests with concerns for public health and safety.

In this environment,

Global trade regulations through international trade agreements (ITAs);

● protection of research and development costs through patent activities;

● There is a need to improve the security of pharmaceutical supply chains through public health and safety concerns.

World trade includes numerous public bodies regulated through ITAs and pursuing various objectives related to public health, industry and trade regulations and security policies. Thus, the World Trade Organization (WTO) is therefore one of a number of organizations that provide agreements on specific concerns of the pharmaceutical industry.

The following conventions highlight some of the key trade requirements of the WTO that are affecting how the pharmaceutical industry is organized.

Convention on Origin Regulations: Origin regulations are a necessary criterion for determining the national origin of a product, which is essential because the goods can be treated as a means of producing different characteristics depending on their origin. Origin rules are the criteria for determining:

● which imported products are eligible for preferential treatment or preferential treatment (under international law);

• when the instruments and instruments of trade policy, such as anti-dumping obligations and safeguard measures, are implemented;

Trade statistics,

Labeling and ticketing requirements, and

● Procedures for Government Procurement.

Agreement on Import Authorization Procedures: The Agreement on Import Authorization Procedures requires the Government to publish sufficient information to enable traders to know how and why licenses are granted. They should also explain how countries should inform the WTO when they introduce new import procedures or change existing procedures.

Agreement on Preshipment Inspections: The obligations applicable to governments using preshipment inspections are:

Non-discrimination,

Transparency,

Protection of confidential business information;

Avoid unreasonable delays

● the use of specific guidelines for conducting quote verification,

● avoiding conflicts of interest by inspection bodies.

Agreement on the Trade of Intellectual Property Rights, Including Trade in Counterfeit Goods: The Agreement recognizes widely variable standards in the protection and implementation of intellectual property rights. The lack of a framework of countries in which the rules and regulations involved in the international trade of counterfeit goods was a growing source of tension in international economic relations.

The above WTO rules are arguably some of the broader statutory and statutory requirements that currently govern the international and domestic trade activities of the pharmaceutical industry. They also underline the imminent legislative and statutory pressures that would mandate the use of unique item identification.

An additional area that has always been of particular interest in the International Counterfeit Countermeasures (IACC) is the increased availability of counterfeit products, which pose and represent a threat to public health and safety. By providing increased awareness over the past two years, the IACC's interest in public health and safety risks has only increased.

WHO says counterfeit drugs account for 10% of all pharmaceuticals, 16% of which contain erroneous ingredients, and 60% of which contain no active ingredients. The proportion of these counterfeits amounts to 60% in developing countries.

In addition to using the pharmaceutical industry as a means of raising funds, there is the possibility that terrorists can use their duties as a means of attack, for example by shipping counterfeit products containing deadly biotoxins. .

The US Congress recognizes the growing share of organized crime and terrorist activity in intellectual property infringement through trademark abuse and pharmaceutical counterfeiting, and acknowledges that they are a threat that puts public health and safety at bay.

Revenue is often used to invest in more intense activities.

The IACC has been tracking the terrorist organization's influx through crime and forgery, and there is ample evidence to provide an indication that a connection will exist.

It should also be noted that there is a significant overlap between security concerns and problems raised by the need to enhance trademark protection.

In order to improve pharmaceutical certification and to actively monitor the physical flow of pharmaceuticals from raw materials to consumers, the pharmaceutical industry has not adopted automated process for identifying unique items, and the pharmaceutical industry has It is simply impossible to deal with things effectively.

In view of the pressure on the pharmaceutical industry to address security and trademark protection issues, it is necessary to consider the adoption of new technologies. The two keys to improving overall efficiency and protecting the supply chain are cargo tracking and product certification.

There may be some overwhelming debate in supporting the introduction of cargo tracking, but there is also complexity that needs to be addressed.

The two basic goals of the pharmaceutical industry are consumer care and public safety. To achieve these goals in the United States,

The FDA and each state government control the industry through laws and administrative orders designed to protect the integrity of drugs throughout the pharmaceutical supply chain.

In this law, the absolute is the administrative requirement for pharmaceutical certification and the ability to track cargo.

Cargo Tracking provides manufacturers, distributors, and pharmacies with an organizational way to detect and manage counterfeiting, drug use, and mishandling.

Create a foundation for improved patient safety.

The introduction of cargo tracking functions also introduces the concept of genealogy.

Florida recently gained national attention by introducing bills enacted by legislatures to establish lineages for the sale of each drug in the United States.

Although this bill is not yet legal, its intent can prove its authenticity and reduce the risk of consolation items coming into the supply chain. In particular, this bill requires the following lineage information accompanying each drug through all stages of the supply chain;

● Drug Name,

● dosage,

● container size,

● number of containers,

Drug lot and control number,

● the name of the task and the addresses of all persons involved in each preceding task, starting with the manufacturer, and

● the date of each pre-processing,

Other countries have also proposed genealogy rules. Most notably

Financially sponsored by E.U., the Italian government began to enforce the cargo tracking of pharmaceuticals under the Bollini Act in 2000. This law requires the use of special stickers that include the serial numbers and traces of all parties in the supply chain. However, this creates a huge difficulty for manufacturers and distributors. As a result, the full implementation of the law could not be done until June 2004, due to the lack of technology to handle the recording and archiving of serial numbers. A further problem is that the design specifications for the database structure needed to maintain cargo tracking have not yet been determined.

Although the physical form of the products may change through manufacturing and distribution, there are still links to all the raw materials and work processes used to make the finished products. This type of link indicates that a particular attribute is inherited.

Each medication used by the patient has a special lot number and expiration date printed on the container.

The drug is loaded onto an identifiable truck for a certain period of time, at a certain temperature.

The effectiveness of pharmaceuticals ultimately depends on the quality of the manufacturing process and the environmental conditions of transport and storage. These are hereditary properties that all line up.

The organization of the majority of information links for all pharmaceutical items in the supply chain is complex.

To simplify product data management, two additional concepts are needed. These are data sets and data inheritance.

Data inheritance is the history of parent data.

This is a logical synonym for item set or assembly. Cargo tracking may be possible if data are considered to be considered within the supply chain as a series of parent-child relationships. To rebuild the history of an item,

Each change in form must be transferred from parent to child.

The data set is coupled with or combined with the data to reduce the number of readings at the critical point in the supply chain, thus capturing the necessary information links for large scale pharmaceutical authentication and more feasible cargo tracking.

If a data set is not available, the identifiers for each product need to be read on a pallet, resulting in a number of additional readings, especially when dealing with pallet level shipments.

In order to overcome the problems associated with large amounts of product data, there is considerable interest in expanding or replacing barcodes currently in use with universal product code (UPC). In North America, products are typically identified by 12-digit upc (universal product code), and in Europe and elsewhere, the 13-digit European Article Number (EAN), a machine-readable product code in the form of printed 2D barcodes. Is identified by.

ucc (uniform code council) and EAN (European Article Number) are a subset of upc and 14-digit Global Trade Item Numbers (GTINs) that define and process related codes.

The Auto-ID Center has defined standards for surveying GTINs with 96-bit Electronic Product Codes (EPC) to ensure compatibility between EPC and current practices. The MIT Auto-ID Center has developed standards for 96-bit EPC paired with Internet-based object naming services (ONS) and product makeup language (PML).

Once the EPC is scanned, it is used to prove, via ONS, the matched product information encoded in the PML. EPC consists of an 8-bit header, a 28-bit object class, and a 30-bit serial number. Although EPCs can be encoded in many physical forms and can be carried over a range of interfaces, the Auto-ID Center strongly claims the benefits of using low cost passive RFID tags to transport EPCs for discrete item identification. do.

The attraction of the Auto-ID solution lies in its ability to use EPC as a pointer to prove information about drugs contained in remote databases. The EPC serves as a persistent link to verify that the item was duly obtained. This will serve as a strong deterrent to fraud in many ways along the supply chain.

If the consumer decides to return the item or there is a questionable problem with the contents, there is a persistent link to identify the product details.

This prevents illegal returns, protects consumers from medical problems resulting from product use or misuse, makes them traceable, and can be used by bad people or result in medical problems. Tracked products. Inventory control and reordering are much more reliable.

The item's EPC acts like a key in a distributed PML database that records the item's evolutionary history and item properties that originate through the pharmaceutical supply chain.

The PML is located at each node of the supply chain, acting as a secure Internet-based communication combine to provide important handling structures and devices.

Tracking of higher level units (eg pallets or shippers, shipments, order numbers and transport routes) in the supply chain is essential. Readers installed at all aisle entry and exit points can be used to automatically track movement at all points in the supply chain and to automatically update the logs. The Internet or any of the provided computer networks may provide a communication link.

The hardware components for the Auto-ID solution have been technically significant over the past few years. Many manufacturers can manufacture infrastructure components that are key to meeting the particular needs of the pharmaceutical industry.

In cargo tracking and pharmaceutical certification improvements, in addition to the proposed applications, the Auto-ID infrastructure also serves as the basis for future applications of importance to the health care industry.

For example, the human genome project creates greater opportunities for manufacturing pharmaceuticals for treating minority individuals suffering from certain diseases.

These "designer drugs" can be made into small lot sizes to make based on the order. In such an environment, detailed plans and coordination take new forms, with thousands of biotech pharmaceuticals flooding the pharmaceutical supply chain.

The distribution of these new drugs to the right group of people has a problem that current detailed plans do not deal effectively with.

However, these new possibilities also have drawbacks:

The task of handling flow information for each of the six billion estimated pharmaceutical items sold in the United States last year only taxes the capacity of the Internet or provided computer networks even when datasets and succession concepts are used.

An additional complexity is that the Auto-ID approach can be fine-tuned by information concurrency among a number of different supply chain partners to ensure a high level of reliability for genealogy and pharmaceutical authentication information. If a single supply chain partner did not handle the information properly, the lineage might show gaps that could cause counterfeit problems. The Auto-ID approach also speculates that different entities in the pharmaceutical supply chain can achieve the usual level of collaboration in maintaining this information infrastructure.

Another challenge to overcome is that the Auto-ID approach requires that all pharmaceutical manufacturers, carriers, wholesalers and pharmacies have the hardware and computer capabilities needed to read and store EPC information. Thus, it is unrealistic to believe that this ability will occur immediately.

Thus, the pharmaceutical industry will continue to adopt an evolutionary approach to the standardization of unique item identification technologies through manufacturing and supply chains. In addition, the area of technologies will need to be adopted and integrated to introduce incremental improvements in security and supply chain efficiency.

Recently, two mainstream technologies offer alternatives to unique product item identification, such as EPCs, namely

● With 2D optical barcode

• Radio Frequency Identification List (RFID).

2D optical barcodes consist of a composite image that can store approximately 2,000 bytes of data along two dimensions. Uniform code council (UCC) and European Article Numbering (EAN) International have standardized the range of 2D barcodes and have standardized everything with significantly larger data capacities than existing EPCs.

2D optical barcodes are now widely used in the global pharmaceutical industry. In the United States, the Food and Drug Administration (FDA) regulates their use for all pharmaceutical products manufactured within FDA's jurisdiction to identify production lines. The main advantage driving their acceptance is that they are cheap to produce.

The major disadvantage of 2D optical barcodes is that they are difficult to read because of label damage and that a direct "line of sight" is required for scanning.

In addition to this, 2D optical barcodes are unsightly and therefore disadvantageous to the packaging of the product. This problem is often exacerbated by constraints that use small packaging, but requires large barcodes that are largely capable of overshadowing much of the packaging.

RFID tags are a technique that inserts the use of electromagnetic or electrostatic coupling to uniquely identify an object. It consists of three parts: an antenna, a transceiver, and a transponder.

In the case of constraints, RFID tags provide a unique product item identification encoded in the form of an EPC. The pharmaceutical industry recognizes a number of benefits of introducing unique and accurate product identification technologies. Expected benefits include:

● Eliminates inventory losses and deletions due to “collapse”,

• improve the efficiency of shipment and receipt of products,

• If necessary, substantially reducing the time required to identify the location of products for recall,

• provide an efficient basis for meeting regulatory requirements,

● reduction in consumer complaints due to increased shipment accuracy guarantees; and

• Provides lot and expiration date tracking capabilities.

RFID tracking can be automated to help improve the integrity of the pharmaceutical supply chain. By identifying and tracking products within the supply chain, companies can maintain significantly tighter control over legitimate shipments, ensuring that they are not robbed and stolen. This may prevent products from falling into the hands of counterfeiters who may dilute or alter pharmaceuticals and thus distribute them to unsuspecting pharmacies and consumers.

For this reason, a number of major pharmaceutical companies, such as Johnson & Johnson and Eli Lilly and company, are now exploring the availability of RFID tags on all drug shipments.

There are also regulatory requirements that drive the adoption of RFID technologies. FDA plays a leading role in providing forums and guidance for the adoption of new technologies and actively promotes the implementation of methods for authenticating prescription pharmaceuticals through the supply chain to ensure compliance and patient safety.

In working with pharmaceutical companies and manufacturers of anti-counterfeiting security systems, the FDA identifies technologies that can protect the industry against various threats to consumers and trademark protection. Although it does not say which technologies can respond to the identified threats, it can mention the security features that need to be used for product packaging and shipping materials. The Healthcare Distribution Management Association (HDMA) also recommended that pharmaceutical manufacturers and wholesalers use product identifiers in some cases by 2005, and that RFID tags at the item level must be deployed by 2007.

Recently, the FDA published a proposed rule identified as “Bar code label Requirement for Human Drug products and Blood FDA proposed Rule (14 March, 2003). (14, March, 2003) Barcode Label Requirement for Human Drug products and blood , Federal Register (vol. 68. NO. 50) pp. 12499-12534.

The proposed rule would require pharmaceutical companies to identify each drug and would require doses using linear barcodes. The need to include the lot number and expiration date is still under consideration. The benefits of using unique item identification are still under consideration, but this will probably be for some time as there is currently no suitable solution available.

However, in addition to anticipating benefits and regulatory pressures for the use of RFID, there are also some disadvantageous situations that make RFID tags unsuitable for some pharmaceutical products.

The first is that RFID tags are expensive to manufacture. Recent production costs for RFID are about 30-50 cents. This cost can be significantly reduced when high yields and widespread acceptance are achieved, while in the near future it is unlikely to drop below 5 cents per RFID tag.

There may be some additional costs associated with integrating RFID tags in packaging and labeling.

Another serious problem is that metals, liquids, and other electromagnetic frequency (EMF) signals can interfere with RFID tag scanners, thereby seriously jeopardizing the reliability and integrity of RFID systems. In the pharmaceutical industry, numerous radiopaque materials are used in the contents and containers of products. In order to overcome these problems of RFID systems, it is necessary to separate boxes of separate goods, so they can pass through RFID tag readers and migrate from dock to dock over time.

These restrictions will apply at the item level in point of sale (POS). This alone can make them into a large, unsuitable arrangement.

A third disadvantage of RFID tags is related to consumer privacy. For example, if terminally ill patients have collected their RFID-labeled morphine sulphate prescriptions, there is a potential for illegal use of a scanning device to detect the nature of the contents by reading the RFID tag without the owner's knowledge. Knowing the contents, the person can decide whether to steal the products.

However, once the item is passed to the consumer, the risk can be reduced by ensuring that access to the information over the network is changed dramatically and protection of personal information or product details is secured. This can be done by using practical consumer records that follow emerging standards for handling and protecting PIFs (Patient Information Folders) for health care systems.

Collectively, these drawbacks are that RFID tags will always be suitable for all constraints or treatments, and such treatment can be deployed as an alternative technique and adopted with it as a somewhat different form of product identification system. have.

[Surface coding background]

Netpage surface coding consists of dense planar tiling of tags. Each tag encodes its own location in the plane.

Each tag also encodes an identifier of the region containing the tag, along with adjacent tags. This zone ID is unique among all zones.

In a netpage system, the area corresponds to the total size of the tagged surface, such as one side of a sheet of paper.

Surface coding is designed so that a capture field of a size large enough to ensure the capture of the entire tag is large enough to ensure the capture of the ID of the area containing the tag.

The tag's own capture, like other tag specific data, guarantees the capture of the two-dimensional location of the tag within the region. Thus, surface coding allows the sensing device to obtain zone IDs and tag locations during purely local interaction with the coding surface, for example during "clicks" or while tapping lightly on the coding surface with a pen.

The use of netpage surface coding is described in more detail in the following co-pending patent applications: USSN 10 / 815,647 filed on April 2, 2004 entitled “Obtaining Product Assistance” (registration number HYG001US); And US Ser. No. 10 / 815,609, filed April 2, 2004, entitled " Laser Scanner Device for Printed Product Identification Cod. &Quot;

[Basic Knowledge of Encryption]

Cryptographic systems are used to protect sensitive information when it is stored and transported, and also to authenticate transactions to parties. Two classes of popular cryptography systems are secret key cryptography systems and public key cryptography systems.

Secret key cryptographic systems are also referred to as symmetric cryptographic systems, which use the same key to encrypt and decrypt a message. Two parties wishing to exchange messages must first securely exchange secret keys.

Public key cryptography systems, also referred to as asymmetric key cryptography, use two cryptographic keys. The two keys are mathematically related in such a way that a message encrypted using one key can only be decrypted using the other key. One of these keys is public while the other is private. These are referred to as the public key and private key, respectively. The public key is used to encrypt any message for the private key holder. Once encrypted using the public key, the message can only be decrypted using the private key. Thus, two parties can exchange messages securely without first exchanging a secret key. To ensure that the private key is secure, it is common for the private key holder to generate a public-private key pair.

The public key cryptography system can be used to generate digital signatures. If a holder of a private key generates a message with a known hash and then encrypts that hash with the private key, the encrypted hash constitutes the “signature” of the holder of the private key for that particular message. Anyone can simply prove it by using a public key, proving the hash for the message, and decrypting the encrypted hash. If the signature is attached to the message, the recipient of the message can prove both whether the message is real and whether it has not changed during the move.

The secret key can also be used to generate a digital signature, but the disadvantage is that the signature verification can be performed by a party closely involved in the secret key.

For public key cryptography to work, there must be a way of distributing public keys that prevents spoofing. This is normally done using certificates and certificate auturorities. The certification body is a trusted third party that authenticates the association between the public key and the identity of an individual or other entity. The certification body verifies the identity by inspecting the identity document, and then generates and signs an electronic certificate containing the details of the identity and the public key. Anyone who trusts the certificate authority can use the public key in the certificate with a high degree of certainty that it is genuine. People only need to verify that the certificate is genuinely signed by a known certificate authority whose public key is known.

To achieve security comparable to a secret key cryptography system, public key cryptography uses key lengths of thousands of bits compared to several digits, or hundreds of bits.

Schneier B. ( Applied Cryptography , 2nd edition, John Wiley & Sons 1996) provides a detailed discussion of encryption technology.

A first broad form of the invention is a pharmaceutical product that combines a pharmaceutical terminal that combines a processing terminal that performs a business process related to a pharmaceutical product with a package located on coded data or datanet comprising a plurality of coded data portions. Each coded data portion indicating identity, and a radioactive material for exposing at least one or more coded data portions, a sensor for sensing at least one or more exposed coded data portions, at least one or more sensed coded data portions And a processor for determining a sensed identity and performing a process using the detected identity.

Optionally, the processor of the present invention comprises a certificate of pharmaceutical formulation; Approval of work processes; Provided is a terminal for business processing which uses identity by using at least one of determining business process details and updating information tracking related to pharmaceutical constraints.

Optionally the business processing terminal of the present invention includes a cash register; vending machine; Supermarket checkout; It provides a terminal for business processing, characterized in that at least one of the portable scanner attached to the computer system.

Optionally the identification of the business terminal of the present invention is formed at least in part from at least one of the following: a serial number of the pharmaceutical formulation; Identity of pharmaceutical preparations; EPC; The identity of the packaging and the identity of the packaging area.

Optionally, the coded data portion comprises at least a portion of the signature, wherein the signature is a digital signature comprising at least a portion of the identity, and at least one sensed coded data portion of at least one or more sensed signature portions. Determine a processor that causes authentication of the pharmaceutical formulation using the detected identity and the at least one detected signature portion.

Optionally, the processor of the business terminal of the present invention generates data indicative of at least partially indicated detected identity and at least one detected signature portion, and moves the displayed data to a computer system, the computer system Replies to determine using the indicated data, detected identity and at least one detected signature portion, and authenticates the pharmaceutical formulation using the detected identity and at least one detected signature portion.

Optionally, the pharmaceutical preparation of the processing terminal of the present invention is proved by at least one of the following: processor and computer system: using sensed identity, using a key Determining, using the detected identity and key, the determined signature, and comparing the determined signature with a portion of at least one detected signature to authenticate the pharmaceutical by them.

Optionally, the entire signature is encrypted within a plurality of coded data portions, and the processor determines from the plurality of sensed coded data portions, the sensed signature, wherein the constraint is the following: processor and computer system A processing terminal characterized by being proved by at least one of the following: determining the key using the detected identity, using the detected signature and the key to determine the determined identity, and authenticating the pharmaceutical by them This is to compare the determined identity with the sensed identity.

Optionally, the coded data includes a plurality of layouts, each layout clarifying a location of a plurality of first symbols that encodes the identity, and the plurality of second symbols are associated with the signature. A terminal for business processing, characterized by at least some clarity.

Optionally, the transaction processing terminal further comprises a communication system for communicating with a database, and a database stored data comprising at least one of the following with respect to a database relating to pharmaceuticals: wherein the signature is a digital signature that is at least part of identity; Attestation data comprising at least one key associated with the signature; Tracking data at least partially indicating tracking information including at least one of the following: owner of the pharmaceutical formulation; One or more tasks performed using pharmaceuticals; The location of the pharmaceutical preparation and the location of the sensing device.

Product data at least partially representing product information including at least one of the following: product cost; Patient identifier; User identifier; Owner identifier; Date of Manufacture; Batch number; Product manufacturer; Product distributor; Product supplier; Issuing country; Components; Storage conditions; Disposal conditions; Serial Number; Expiration date; effect; Side Effect; Conditions of use; Instructions for use; Link to more detailed information; Contraindications and dosage.

Optionally, the processing terminal includes a display for showing at least one of the following contents:

Verification results; Tracking information, and product information.

Optionally, the coded data is a business terminal, characterized in that it is substantially invisible to an unaided human.

Optionally, the coded data is printed on a surface using at least one of the following contents; Invisible ink and infrared absorption ink.

Optionally, the coded data is a business terminal, characterized in that it is provided in substantially coincident with human readable information.

Optionally, said encoding comprises a plurality of coded data portions, wherein at least some of the coded data portions encrypt at least one of the following: location; Location of each coded data portion on the surface; The size of the coded data portions; Signature part; The size of the signature; Identity of part of the signature; The unit of the indicated location, and at least part of the data object, and the entire data object, are encrypted at least once by the plurality of coded data portions.

Optionally, the data subject includes at least one of the following contents: Multipurpose Internet Mail Extensions (MIME) data; Text data; Image data; Audio data; Video data; Application data; contact data; Information data; Business card data.

Optionally, the coded data includes at least one of the following contents: redundant data; Data to enable error correction; Read-Solomon data; Cyclic redundancy data (CRC) data.

Optionally, the digital signature comprises at least one of the following contents, comprising: a random number combined with identity; A hash that fits at least the atmosphere of identity; Proving using a public key corresponding to a hash that is at least in the mood of identity generated using the private key; A cipher text generated by encrypting at least the sameness; You can at least prove that you use a public key that corresponds to a ciphertext generated using a ciphertext and a private key generated by encrypting identity and a random number.

Optionally, the coded data is arranged according to at least one layout with n-fold rotational symmetry, where n is at least 2, the layout being rotated n each with 1 / n rotation about the center of rotation. A sub-layout that is identical to the at least one secondary layout, wherein the at least one secondary layout includes rotation-display data that identifies the secondary layout directly from a different secondary layout. to be.

Optionally, said coded data is arranged in accordance with at least one layout having n-fold rotational symmetry, where n is at least 2, the layout comprising a sequence of integer multiples m of the n symbol. Encrypt the data, where m is one or more, and each cryptographic symbol is distributed n-toothwise around the center of the rotational symmetry of the layout, so that the ciphertext decryption of the symbol in each of the n-directions of the layout is n Create concepts, each concept comprising different periodic variations of the direction-indicating data, which is a terminal for processing, characterized by indicating the angle of rotation of the layout.

Optionally, the business processing terminal includes a printer for printing packaging, the printer comprising: a printer; A processing terminal for determining the visible information to be provided with respect to the packaging, determining the identity associated with the pharmaceutical formulation, generating coded data using the identity, and printing the packaging by printing the coded data and the visible information to be.

Optionally, the processing terminal is a processing terminal characterized by performing a method for allowing a user to further interact with a pharmaceutical agent, the method receiving a display data from a sensing device in a computer system. The sensing device immediately responds to the detection of the coded data to produce at least partially identical indication data and uses the indication data to determine at least one action; Perform an action associated with the pharmaceutical agent, the action comprising at least one of the following: providing information to the user; Update tracking information related to pharmaceutical formulations; Conduct business related to pharmaceutical formulations and verify pharmaceutical formulations; Receiving feedback from the user.

Optionally, the processing terminal further executes a pharmaceutical formulation authentication method, wherein each coded data portion further represents a signature, wherein the signature is at least some digital signature of identity, within a plurality of coded data portions. The encrypted terminal, the method comprising:

Within the sensing device, at least one coded data portion is sensed and generated using display data representing identity and at least one signature portion, the detected coded data portion,

Within the processor, the determined identity and at least one determined signature portion are determined from the indication data and the determined identity and at least one determined signature portion are used to prove the pharmaceutical formulation.

Optionally, the processing terminal further executes a pharmaceutical formulation authentication method, wherein each coded data portion further represents a signature, the signature is at least some digital signature of identity, and the method includes: A business terminal comprising: receiving indication data from a sensing device, said sensing device being adapted for the detection of data coded to produce display data at least partially representative of the identity of the pharmaceutical formulation and a portion of the signature. Answer, and use the determined identity and at least one determined signature portion to prove the pharmaceutical formulation.

Optionally, the processing terminal further executes a possible copying method of pharmaceutical packaging, the method comprising: in a computer system comprising: receiving display data from a sensing device; The sensing device immediately responds to the detection of the coded data to produce display data indicative of identity, and determines the determined identity from the indication data; Access using the determined identity, track data regarding the pharmaceutical formulation, the tracking data at least partially indicating the location of the pharmaceutical formulation; In addition, tracking data is used to determine if the pharmaceutical is replicable.

Optionally, the processing terminal further executes a pharmaceutical tracking method, the method receiving coded data from a sensing device in a computer system, the sensing device being coded to produce display data representing identity of a product item. Immediately responding to detection of the data, and updating using received indication data, at least in part tracking data representing the tracking information.

Optionally, said processing terminal further executes a pharmaceutical packaging manufacturing method, wherein said method is in a computer system; Determine the serial number associated with the pharmaceutical formulation, create it using the serial number, identity, create the identity, use the signature, and generate the coded data using the identity, the coded data comprising multiple coded data portions; Wherein each coded portion of data is encrypted with a signature, the signature being a digital signature of at least some identity, and printing at least one of identity and serial number with at least some coded data on the pharmaceutical package. It includes.

Optionally, the processing terminal further executes a pharmaceutical formulation dispensing method, which receives, in a computer system, indication data from a sensing device, the sensing device producing at least partially identical representation data. Immediately responding to detection of coded data, using indication data from a distribution database to determine at least one criterion for dispensing the pharmaceutical, and if the at least one criterion is met, dispensing the pharmaceutical. .

Optionally, said processing terminal further comprises a sensing device for use with a pharmaceutical formulation, said sensing device comprising: a housing adapted to be held by a user in use, a radiation source for exposing at least one coded data portion, A sensor for sensing at least one exposed coded data portion and a processor for determining sensed identity using at least one or more sensed, coded data portions. According to a second broad form provided by the present invention, the present invention provides a printer for printing a packaging associated with a pharmaceutical formulation, the printer determining the visible information to be provided on the packaging, determining the identity associated with the pharmaceutical formulation, and identifying the identity. Create coded data, the coded data comprising a plurality of coded data portions, each coded data portion indicating at least the identity of the pharmaceutical formulation and packaging by printing the coded data and the visible information. It is to print.

Optionally, each said coded data portion represents at least a portion of a signature, which signature is a digital signature that is at least part of identity, wherein the printer determines the signature and uses the signature to produce coded data. It provides a printer.

Optionally, the printer includes a processor for creating a signature using securely stored data storage data and data stored within the data store.

Optionally, the printer is to encrypt the complete signature in the plurality of coded data portions.

Optionally, the printer determines a layout, the layout being at least one document description indicating a location of each coded data portion on the packaging, or a location of visual information on the packaging, wherein the coded data and the visible information Print using at least one thing.

Optionally, the printer comprises a database associated with the pharmaceutical formulation, a communication system for communicating with database stored data, the database stored data comprising one of the following; Proof data comprising at least one key associated with a signature, the signature further comprising a digital signature representing at least part of the identity;

Owner of the pharmaceutical preparation; One or more business processes executed using pharmaceuticals; Location of pharmaceutical formulation; Display at least partly tracking information including at least one of the location of the sensing device, product cost, patient identifier, user identifier, owner identifier, date of production, batch number, product publisher, product distributor, product supplier, issuing country, contents Product information, including at least one of: inventory status, distribution status, serial number, expiration date, effects, side effects, status of use, instructions for use, links to more information, contraindications, and usage Product information for displaying at least one of the product information, such as to display.

Optionally, the printer is at least one or more of updated at least some of the data related to the pharmaceutical formulation, and generates coded data using at least some of the data related to the pharmaceutical formulation.

Optionally, the identity is the serial number of the pharmaceutical formulation; Identity of pharmaceutical preparations; EPC; At least in part from the identity of the packaging and the identity of the packaging region.

Optionally, the packaging includes at least one of a blister pack, a bottle, a cap, a label, a box, and a cut sheet.

Optionally, the printer receives the packaging and scans the packaging and uses the determined information to determine information represented by at least one of the source of the pharmaceutical, the pharmaceutical type, the identity of the pharmaceutical and the serial number of the pharmaceutical. Create at least part of the coded data.

Optionally, since the coded data is an indication of a plurality of reference points, the detection of the at least one coded data portion by the sensing device may be based on the identity, at least one signature part, the location of the sensing device related to packaging, and the sensing related to packaging. At least one of the movements of the device is made determinable.

Optionally, the coded data is substantially invisible to the human eye.

Optionally, the coded data is to print on a surface using at least one of an invisible ink and an infrared-absorbing ink.

Optionally, the coded data is provided in a substantially consistent manner with visible and human readable information.

Optionally, the coded data comprises a plurality of coded data portions, wherein at least some of the coded data portions are located in each coded data portion, location of each coded data portion on a surface, coding Encrypts at least one of the size of a portion of the data, the portion of the signature, the size of the signature, the identity of the portion of the signature, the unit of the indicated location, and at least one of the data subjects, wherein the overall data subject is encoded by a plurality of coded data portions. It is encrypted at least once.

Optionally, the data subject includes at least one of MIME (Multipurpose Internet Mail Extensions) data, text data, image data, audio data, video data, application data, contact data, information data, business card data, and a phone book. will be.

Optionally, the coded data includes at least one of redundant data, data enabling error correction, Reed-Solomon data, and cyclic redundancy check (CRC) data.

Optionally, the digital signature may be able to prove using a random number associated with identity, a hash that matches at least the same mood, a public key that corresponds to at least the hash that matches the mood of identity generated using a private key. At least one of at least one of a ciphertext generated by encrypting at least the same, at least one ciphertext generated by encrypting at least the sameness and a random number, and attestable ones using a public key corresponding to the ciphertext generated using the private key.

Optionally, said coded data is arranged in accordance with at least one layout having n-fold rotational symmetry, where n is at least 2, the layout being rotated n each with 1 / n rotations around the center of rotation. And a secondary layout, the at least one secondary layout comprising rotation-display data identifying the very secondary plan directly from the different secondary layouts.

Optionally, said coded data is arranged in accordance with at least one layout having n times rotational symmetry, wherein n is at least 2, said layout comprising a sequence of integer multiples m of the n symbol. Where m is one or more, and each cryptographic symbol is distributed at n locations around the center of the rotational symmetry of the layout, so that the ciphertext translation of the symbol in each of the n directions of the layout plan is n concepts of directional data. Each concept includes different periodic variations of the orientation data, which represent the angle of rotation of the layout.

Optionally, the printer comprises a processing terminal for executing the processing related to the pharmaceutical agent, the terminal comprising a radiation source for exposing the at least one coded data portion, the at least one exposed coded data portion. A sensor for sensing, a processor for determining and using at least one sensed coded data portion, sensed identity, and for performing business processes using sensed identity.

Optionally, the printer further executes a method by which a user can interact with the pharmaceutical agent, the method receiving display data from the sensing device, within the computer system, the sensing device presenting at least partially identical display data. Respond directly to the detection of data coded to produce, determine and use presentation data, at least one action, perform an action associated with a constraint, and provide the user with information, the tracking of information related to the constraint. It includes at least one of updating, performing a business process related to a pharmaceutical product, proving the pharmaceutical product, and receiving feedback from a user.

Optionally, the printer further experiments with pharmaceutical authentication, each coded data portion further representing a signature, the signature being at least some digital signature of identity, encrypted within multiple coded data portions, The method detects, within the sensing device, at least one coded data portion and creates the sameness, using the indication data representing the at least one signature portion, the sensed coded data portion, and, within the processor, the determined identity. And determining at least one determined signature portion from the indication data and using the determined identity and the at least one determined signature portion to verify the pharmaceutical formulation.

Optionally, the printer further executes pharmaceutical authentication, each coded data portion further representing a signature, the signature being a digital signature of at least some identity, the method displaying from a sensing device, within a computer system. Upon receipt of the data, the sensing device responds directly to the detection of the coded data to produce an indication data indicative of at least partly the identity of the pharmaceutical formulation and the signature portion, and returns the determined identity and at least one determined signature portion below the indication data. And verifying the pharmaceutical formulation using the determined identity and at least one determined signature portion.

Optionally, the printer further executes a method for determining possible duplication of packaging, the method receiving in the computer system indication data from a sensing device, the sensing device detecting the coded data to produce display data indicating identity. Respond directly to, determine the identity determined from the indication data, access using the determined identity, track the data regarding the pharmaceutical, and the trace data at least partially determine whether the pharmaceutical replica may be present, To make decisions.

Optionally, the printer further executes a pharmaceutical tracking method, which method receives, in a computer system, indication data from a sensing device, the sensing device coded to produce display data representing identity of a product item. And responding immediately to the detection of, and updating using the received indication data, the tracking data at least partially indicating the tracking information.

Optionally, the printer further executes a packaging recipe, the method determining, within a computer system, a serial number associated with the pharmaceutical formulation, created using serial number, identity, using identity, signature, and coding with identity. Resulting in the generation of the encoded data, the coded data comprising a plurality of coded data portions, each coded data portion encrypting a signature, which is a digital signature of identity and at least part of the same, and on the pharmaceutical packaging. Printing at least some coded data and at least one of identity and serial number.

Optionally, the printer further executes a pharmaceutical dispensing method, the method receiving display data from a sensing device in a computer system, the sensing device sensing the coded data to produce at least partially identical display data. Respond directly to and use the indication data from the distribution database to determine at least one criterion for dispensing the pharmaceutical, and if the at least one criterion is satisfied, including the causing the pharmaceutical to be dispensed.

Optionally, the printer further comprises a sensing device for use with a pharmaceutical formulation, the sensing device comprising a housing suitable for being held by the user in use, a radiation source for exposing at least one coded data portion, at least one exposure And a processor for detecting the coded coded data portion, at least one sensed coded data portion, and a processor for determining using sensed identity.

As a third broader aspect of the invention, the invention relates to a method of allowing a user to interact with a pharmaceutical formulation, the packaging in which the pharmaceutical formulation places coded data on or within the packaging, and at least some The coded data indicates at least identity and the method receives an indication data from a sensor in a computer system, the sensor responding directly to the detection of the coded data to produce at least partially indication data indicative of identity. And use the indication data to determine at least one action, perform an action associated with the pharmaceutical agent, which provides information to the user, update tracking related to the pharmaceutical agent, execute business processes related to the pharmaceutical agent, Authenticating the pharmaceutical formulation, and receiving at least one of receiving feedback from the user Include the statement.

Optionally, said identity is coded data portion identity; The identity of the pharmaceutical, the identity of the EPC, the packaging and the identity of the packaging area, which are associated with each action and are at least partially created from at least one of these contents.

Optionally, the method includes using the indication data in the computer system to determine the description and using the description to determine the action.

Optionally, the coded data represents a plurality of reference points, and the display data at least partially displays at least one of a location of a sensing device related to packaging and a movement of the sensing device related to packaging, wherein the method further comprises a computer. In the system, the indication data is used to determine at least one of a determined location and a determined movement, and to perform at least a partial action based on at least one of the determined location and the determined movement.

Optionally, said coded data comprises a plurality of coded data portions, each coded data portion representing at least part of a signature, the signature being at least a digital signature of part of the identity, wherein at least one coded In response to sensing of the data portion, the sensing device generates display data at least partially representing the at least one signature portion, and the method determines from the display data in the computer system the determined identity and the at least one determined signature portion. And verifying the pharmaceutical formulation using the determined identity and at least one determined signature portion.

Optionally, the entire signature is encrypted within a plurality of coded data portions, and the method includes sensing a plurality of coded data portions within the sensing device, thereby determining a full signature.

Optionally, the coded data includes a plurality of layouts, each layout evident a location of a plurality of first symbols that encrypt identity, and the plurality of second symbols clarifying at least part of the signature.

Optionally, the information may include product cost, patient identifier, user identifier, owner identifier, date of manufacture identifier, batch number, product manufacturer, product distributor, product supplier, issuer addition, ingredients, storage conditions, disposal conditions, serialization. Include at least one of a number, expiration date, effect, side effects, conditions of use, instructions for use, links to more detailed information, contraindications and dosage.

Optionally, the feedback includes at least one of signs of the effects of the pharmaceutical, marketing feedback, questions about the pharmaceutical and answers to customer surveys.

Optionally, the tracking information is indicative of at least one of the current owner of the pharmaceutical formulation, one or more business processes performed using the pharmaceutical formulation, the location of the pharmaceutical formulation and the location of the sensing device.

Optionally, the coded data is substantially invisible to the human eye.

Optionally, the coded data is printed on the surface using at least one of an invisible ink and an infrared absorbing ink.

Optionally, the coded data is provided in a substantially consistent manner with visible and human readable information.

Optionally, the encoding (data) herein comprises a plurality of coded data portions, wherein at least some coded data portions comprise a location of each coded data portion, a location of each coded data portion on the surface. Encrypt at least one of the size of the coded data portions, the portion of the signature, the size of the signature, the identity of the portion of the signature, the unit of the indicated location and the at least some data objects, wherein the entire data object is assigned to the plurality of coded data portions. Is encrypted at least once.

Optionally, the data subject here includes at least one of MIME (Multipurpose Internet Mail Extensions) data, text data, image data, audio data, video data, application data, contact data, information data, business card data and a phone book. It is.

Optionally, the coded data comprises: redundant data; Data to enable error correction; At least one of Reed-Solomon data and cyclic redundancy check (CRC) data.

Optionally, the digital signature here is a random key associated with the identity, a random number associated with the identity, at least a hash suitable for the atmosphere of identity, a hash corresponding to at least the atmosphere of identity generated using a private key and a public key corresponding to it. Attestable identity using at least one ciphertext generated by encrypting at least identity, and attestable using a public key corresponding to a ciphertext generated using at least one ciphertext and private key generated by encrypting identity and random numbers It includes at least one of them.

Optionally, the coded data is arranged according to at least one layout with n-fold rotational symmetry, where n is at least 2, the layout being rotated n each with 1 / n rotation about the center of rotation. And a secondary layout, the at least one secondary layout comprising rotation-display data that identifies the secondary layout directly from a different secondary layout.

Optionally, said coded data is arranged in accordance with at least one layout having n-fold rotational symmetry, wherein n is at least 2, said layout comprising a sequence of integer multiples n of n symbols. Where n is one or more, and each cryptographic symbol is distributed around the center of rotational symmetry of the layout by n-location selection, so it is distributed around the center of the layout by n-location, The ciphertext translation of the symbol in each yields an n-concept of direction data, each concept comprising different periodic variations of the direction-indication data, which represents the angle of rotation of the layout.

Optionally, the method comprises the use of a processing terminal for executing a processing related to a pharmaceutical formulation, the processing terminal comprising: a radiation source for exposing at least one coded data portion, at least one exposed coding And a processor for determining a sensed identity using a sensor for sensing the sensed data portion and at least one sensed coded data portion, and for executing a business process using the sensed identity.

Optionally, the method comprises the use of a printer for packaging printing, the printer determining the visible information provided on the packaging, determining the identity associated with the pharmaceutical formulation, using the identity to generate coded data, This coded data includes a plurality of coded data portions, each coded data portion being for at least indicating the identity of the pharmaceutical formulation and for printing the packaging by printing the coded data and the visible information.

Optionally, the method is further used for authenticating a pharmaceutical formulation, each coded data portion representing at least part of a signature, at least in part being a digital signature of identity, encrypted within multiple coded data portions, The method; Within the sensing device, at least one coded data portion is sensed and the sensed coded data portion is used to generate presentation data representing identity and at least one signature portion and, within the processor, from the presentation data, the determined identity And determining at least one determined signature portion and using the determined identity and at least one determined signature portion to verify the pharmaceutical formulation.

Optionally, the method is further used to verify a pharmaceutical formulation, wherein each coded data portion further represents at least a portion of the signature, the signature is a digital signature that is at least part of the identity, and the method comprises: Receiving the indication data, the sensor responds directly to the detection of the coded data to produce an indication of the identity of the pharmaceutical formulation and at least partly the signature portion, and displays the determined identity and the at least one determined signature portion. Determining from the data and using the determined identity and at least one determined signature portion to verify the pharmaceutical formulation.

Optionally, the method is further used to know if there is a copyability of the pharmaceutical packaging, the method receiving indication data from a sensing device in a computer system, the sensing device having the data of the coded code to produce the identification data indicating identity. Respond directly to the detection, from the indication data, determine the determined identity, access using the determined identity, track the data related to the pharmaceutical agent, the trace data being at least partly an indication of the pharmaceutical agent's location, and If the pharmaceutical product is likely to be replicated, then the decision includes using tracking data.

Optionally, the method is further used for pharmaceutical tracking, which method receives indication data from a sensing device in a computer system, the sensing device detecting the coded data to produce display data indicative of the identity of the product item. And immediately updating the collected data indicative of the collected information.

Optionally, the method is further used for pharmaceutical packaging, the method comprising: determining a serial number associated with the pharmaceutical product in a computer system; Using serial numbers, creating identity, using identity, creating signatures and using identity to generate coded data, the coded data contains a number of coded data portions, each coded data portion And causing the signature and digital signature to cause the signature to print at least one of identity, serial number, and at least some coded data on a digital pharmaceutical packaging of at least partial identity.

Optionally, the method is further used for dispensing a pharmaceutical formulation, which method receives indication data from a sensing device in a computer system, the sensing device having at least partially coded data to produce presentation data indicative of identity. Immediately responding to the sensing and using the indication data to determine at least one criterion for dispensing the pharmaceutical from the distribution database and causing the pharmaceutical to be dispensed if the at least one criterion is satisfied.

A fourth broad form of the invention is to provide a method for allowing a user to interact with a pharmaceutical formulation, the pharmaceutical formulation being combined with packaging in or on the coded data, at least some of the coded data being at least identical. Wherein the method detects, within the sensing device, at least some coded data, uses the sensed coded data to determine display data that at least partially represents identity, and transmits the display data to a computer system. The computer system immediately responds to the indication data for determining at least one action using the indication data, providing information to at least the user in combination with the pharmaceutical agent, updating the tracking information relating to the pharmaceutical agent, Conducting business related to pharmaceuticals, certifying pharmaceutical products To, and includes running the action comprises one of will receive feedback from the user.

Optionally, the sensing device is for use with a pharmaceutical formulation, the sensing device comprising a housing suitable for holding by the user in use, a radiation source for exposing at least one coded data portion, and at least one coded data portion. And a processor for determining sensed identity using the sensor for sensing and at least one sensed coded data portion.

The fifth broad form of the invention relates to pharmaceutical formulation authentication, wherein the pharmaceutical formulation is associated with packaging in which coded data comprising a plurality of coded data portions is placed on or within the packaging, each coded data portion. Denotes the identity of the pharmaceutical formulation and at least part of the signature, the signature is a digital signature that is at least part of the identity and is encrypted within the plurality of coded data portions, and the method detects at least one coded data portion within the sensing device. And use the sensed coded data portion to produce presentation data representing identity and at least one signature portion, determine identity and at least one determined signature portion from the presentation data in the processor, and determine the determined identity and at least one Is to include the pharmaceutical certification using some of the determined signatures. .

Optionally, the method obtains a key from a data store securely stored using identity within the processor, the store storing at least one secret key, and using the determined identity and key to generate a generated signature, Comparing the generated signature with a portion of the at least one determined signature to prove the pharmaceutical formulation by them.

Optionally, the securely stored data store here creates the processor's internal storage.

Optionally, the method detects a plurality of coded data portions within a sensor within the processor and uses the sensed coded data portions to produce presentation data representing a signature and from the presentation data within the processor, a determined signature. Determining the identity, using the identity, determining the key, using the determined signature and the key to create the generated identity, and comparing the generated identity with the determined identity to prove the constraint by them. It is.

Optionally, the method includes, within the processor, using the same to obtain a key from the local data store and, if the key cannot be obtained from the local data store, using the same to obtain the key from a remote data store. It is.

Optionally, the method obtains, within the processor, a key from a local data store using identity, and uses the same to obtain a key from distant data if the key cannot be obtained from the local data store. .

Optionally, the method determines whether at least one of the sensing device and the processor is capable of sufficiently sensing at least one coded data portion within the sensing device, and using the sensed coded data portion to identify the identity, at least Displaying data indicative of a portion of one signature, and determining, within the processor, the identity determined from the presentation data and at least one determined signature portion, and using the determined identity and at least one determined signature portion to verify the pharmaceutical formulation. do.

Optionally, the identity is generated at least in part from at least one of coded data partial identity, pharmaceutical pharmaceutical identity, EPC, identity of packaging and identity of packaging region.

Optionally, the coded data includes a plurality of layouts, each layout defining a location of a plurality of first symbols that encrypts identity, and the plurality of second symbols at least defining a signature portion.

Optionally, the method comprises, within the processor, communicating with a local database, database stored data relating to the pharmaceutical formulation, and including at least one of the following; Authentication data containing a minimum key combined with a signature that is at least part of the identity, which is a digital signature, trace data includes the owner of the pharmaceutical formulation, one or more business processes performed using the pharmaceutical formulation, the location of the pharmaceutical formulation, and the location of the sensing device. Product data representing at least partially tracking information including at least one of the above, the product data being product cost, patient identifier, user identifier, owner identifier, date of manufacture, product distributor, product supplier, issuing country, components At least partially indicate product information, including storage conditions, disposal conditions, serial numbers, expiration dates, effects, side effects, conditions of use, instructions for use, links to more detailed information, contraindications, and dosages .

Optionally, the method includes showing at least one of the verification results, the tracking information, and the product information.

Optionally, the packaging here includes at least one of a blister pack, a bottle, a cap, a label, a box, and a cut sheet.

Optionally the coded data is substantially invisible to the human eye.

Optionally, the coded data is printed on the surface using at least one of an invisible ink and an infrared absorption ink.

Optionally, the coded data is provided substantially with visible human readable information.

Optionally, said coded data comprises a plurality of coded data portions, wherein at least some of the coded data portions comprise a location of each coded data portion, a location of each coded data portion on a surface, coded The size of the data parts, the signature part, the size of the signature, the identity of the signature part, the unit of the indicated location and encrypting at least one of the at least parts of the data object, the entire data object is assigned to the plurality of coded data parts. Is encrypted at least once.

Optionally, the data subject here is at least one of MINE (Multipurpose Internet Mail Extensions) data, text data, image data, audio data, video data, application data, contact data, information data, business card data and phone book. It will include.

Optionally, the coded data includes at least one of redundant data, data enabling error correction, Reed-Solomon data, and cyclic redundancy check (CRC) data.

Optionally, the signature is provable here using a random key associated with the identity, a hash that matches at least the mood of the identity, a hash corresponding to the hash of at least the identity generated using the private key, At least one of a ciphertext generated by encrypting at least the same, at least one of which can be proved using a public key corresponding to a ciphertext generated using at least a ciphertext and a private key generated by encrypting identity and a random number.

Optionally, the coded data is arranged according to at least one layout having n-fold rotational symmetry, where n is at least 2, the layout being rotated with n each rotated by 1 / n rotation over the center of rotation. It includes the same secondary layout, and the at least one secondary layout includes rotation-display data that identifies that secondary layout directly from different secondary layouts.

Optionally, said coded data is arranged in accordance with at least one layout having n-fold rotational symmetry, where n is at least 2, said layout comprising a sequence of integer multiples m of n symbols. Where m is one or more, and each cryptographic symbol is distributed at n-location in the centralism of the rotational symmetry of the layout, so that the ciphertext translation of the symbol in each of the n-directions of the layout represents n concepts of direction data. Each concept involves different periodic variations of the direction-indicating data, which represent the angle of rotation of the layout.

Optionally, the method comprises the use of a processing terminal for executing a business process related to the pharmaceutical formulation, the business terminal comprising a radiation source for exposing at least one coded data portion, at least one exposure. And a processor for determining a sensed identity using at least one sensed coded data portion and a sensor for sensing the coded coded data portion and for performing business processing using the sensed identity.

Optionally, the method comprises the use of a printer to print the packaging, the printer determining the visible information provided on the package, determining the identity associated with the pharmaceutical formulation, using the identity to produce coded data, The coded data portion represents at least the identity of the pharmaceutical formulation and is for printing the packaging by printing the coded data and the visible information.

Optionally, the method is further used to allow a user to interact with the pharmaceutical agent, the method receiving indication data from a sensor within a computer system, the sensor coding at least to produce display data indicative of at least part of identity. Immediately respond to the detection of the collected data, and use the indication data to determine at least one action, and to perform an action associated with the constraint, which provides information to the user and tracks the constraint. Update information; Performing business processes related to the pharmaceutical formulation, including at least one of those demonstrating the pharmaceutical formulation, and including receiving feedback from the user.

Optionally, the method is further used to verify a pharmaceutical formulation, the method receiving indication data from a sensing device within a computer system, wherein the sensing device displays the presentation data indicative of at least partly the identity of the pharmaceutical formulation and a portion of the signature. Immediately respond to the detection of coded data to make, from this indication data, determine the determined identity and at least one determined signature portion, and include the pharmaceutical formulation authentication using the determined identity and at least one determined signature portion. .

Optionally, the method is further used to determine the possibility of duplicating the pharmaceutical packaging, the method responsive to the detection of coded data in order to make the indication data from the sensing device in the computer system, and from this indication data, Determine the determined identity, and use the determined identity to access the tracking data related to the pharmaceutical, the tracking data is at least partly an indication of the location of the pharmaceutical, and using the tracking data to determine if the pharmaceutical is replicable It involves doing.

Optionally, the method is further used for pharmaceutical tracking, which method receives, in a computer system, the indication data from the sensing device, the sensing device detecting the coded data to produce the indication data representing the identity of the product item. And immediately updating the tracking data representing the tracking information, at least in part, using the received indication data.

Optionally, the method is further used for pharmaceutical packaging, wherein the method determines, within a computer system, a serial number associated with the pharmaceutical formulation, using the serial number to make identity, using identity to create a signature, Using identity to result in generation of coded data, the coded data comprising a plurality of coded data portions, each coded data portion being encrypted, the signature being identical, and the signature being at least partially Digital signature, which causes the pharmaceutical packaging to cause the printing of at least one of identity and serial number with at least some coded data.

Optionally, the method is further used for pharmaceutical dispensing, wherein the method receives indication data from a sensing device in a computer system, the sensing device at least partially adapted to the detection of coded data to produce presentation data indicative of identity. Immediately responding, using the indication data, determining from the distribution database at least one criterion for dispensing the pharmaceutical, and whether the pharmaceutical to be dispensed satisfies the at least one criterion.

Optionally, the sensing device is for use with a pharmaceutical formulation, the sensing device being adapted to be held by the user in use, a radiation source for exposing at least one coded data portion, and at least one exposed coded data. And a processor for determining sensed identity using at least one sensed coded data portion, the radiation source for sensing the portion.

Optionally, the present invention relates to a pharmaceutical authentication scheme, wherein the pharmaceutical formulation is packaged with coded data comprising a number of coded data portions on or within the packaging, wherein each coded data portion is identical to the pharmaceutical formulation. And at least part of the signature, the signature being a digital signature that is at least part of the identity, the method receiving indication data from the sensing device within the computer system, the sensing device at least partly identifying the identity and signature of the pharmaceutical formulation. Respond immediately to detection of the coded data to produce an indication data representing a portion, and from the indication data, determine a determined identity and at least one determined signature portion and validate the pharmaceutical formulation using the determined identity and at least one determined signature portion. It is to include.

Optionally, the method may use the determined identity in the computer system to determine the key, use the determined identity and the key to create a generated signature, and apply at least one determined signature portion and the generated signature to the pharmaceutical agent. It includes comparing to prove by.

Optionally, wherein the full signature is encrypted within the plurality of coded data portions, and the sensing device responds directly by sensing the plurality of coded data to produce an indication data representing the full signature, the method comprising: Determine the signature determined using the indication data within the system, use the determined identity to determine the key, use the determined signature and the key to create the generated identity, and determine the identity and the generated identity to the pharmaceutical By comparison to prove it.

Optionally, the method further comprises determining, within the computer system, tracking data at least partially indicating the location of the pharmaceutical formulation, using the determined identity, and using the tracking data to determine whether the pharmaceutical formulation is a replicable replication. It is to include.

Optionally, the method may be used within a computer system and in response to a successful attestation, to permit processing of the pharmaceutical formulation, update tracking information associated with the pharmaceutical formulation, and the tracking information at least partially locates the pharmaceutical formulation. To indicate.

Optionally, the method further comprises at least one key in communication with a database in the computer system, the database storing data relating to the pharmaceutical formulation and comprising at least one of the following contents: The data, the signature is at least a digital signature that is part of the identity, the tracking data, the tracking data at least partially representing the tracking information including at least one of the following contents, the owner of the pharmaceutical formulation, as long as it is performed using the pharmaceutical formulation More than one business process, the location of the pharmaceutical and the location and product data of the sensing device, the product data at least partially representing product information including at least one of the following: product cost, patient identifier, user identifier, owner Identifier, date of manufacture, batch number, manufacturing I) product distributor, product supplier, issuing country, ingredients, storage conditions, disposal conditions, serial number, expiration date, effect, adverse effects, conditions of use, instructions for use, links to more detailed information, contraindications and dosage do.

Optionally, the method includes causing display of tracking results to show at least one of the following contents in the computer system, and results of proof, such as product information.

Optionally, said identity is generated at least partially from at least one of the following: coded data partial identity; Identity of pharmaceutical preparations; EPC; The identity of the packaging and the identity of the packaging area.

Optionally, the coded data comprises a plurality of layouts, each layout clarifying the location of the plurality of first symbols that encrypts identity, and the plurality of second symbols clarifying at least part of the signature.

Optionally, the packaging here includes at least one of blister packs, bottles, caps, labels, boxes and cutouts.

Optionally, the coded data is substantially invisible to the human eye.

Optionally, the coded data is printed on the surface using at least one of invisible ink and infrared absorbing ink.

Optionally, the coded data is provided in substantial correspondence with visible human readable information.

Optionally, the encoding herein comprises a plurality of coded data portions, wherein at least some coded data portions comprise a location of each coded data portion, a location of each coded data portion on the surface, coded data Encrypting the size of the portions, the portion of the signature, the size of the signature, the identity of the portion of the signature, the unit of the indicated location, and at least one of the at least portions of the data object, the entire data object being assigned to the plurality of coded data portions. Encrypted at least once.

Optionally, the data subject here is at least one of MIME (multipurpose Internet mail extension) data, text data, image data, audio data, video data, application data, contact data, information data, business card data and phone book. It will include.

Optionally, the coded data includes at least one of redundant data, data enabling error correction, Reed-Solomon data, and cyclic redundancy check (CRC).

Optionally, the digital signature here uses a random number associated with the identity, at least a hash that matches the mood of the identity, a hash generated at least using the mood of the identity generated using the private key, and a corresponding public key. At least one of attestable, at least one ciphertext generated by encrypting the identity, at least one ciphertext generated by encrypting the identity and the random number, and attestable using a public key corresponding to the ciphertext generated using the private key. It is.

Optionally, the coded data is arranged in accordance with at least one layout with n-fold rotation-symmetry, where n is at least 2, the layout being rotated each in 1 / n rotations around the center of rotation. and a secondary layout equal to n, wherein the at least one secondary layout includes rotation-display data that identifies that secondary layout directly from different secondary layouts.

Optionally, said coded data is arranged in accordance with at least one layout having n-fold rotational symmetry, where n is at least 2, said layout comprising a sequence of integers m of n symbols Encrypt the data, where m is one or more, and each cryptographic symbol is distributed at n-locations around the center of the layout, so that decryption of the symbol in each of the n directions of the layout results in different periodic variations of the directional data. And the rotation angle of the layout is indicative.

Optionally, the method comprises the use of a processing terminal for performing business processing related to the pharmaceutical formulation, the processing terminal comprising at least one radiation source for exposing a coded data portion. A sensor for detecting the exposed coded data portion, and a processor for determining detected identity using at least one sensed coded data portion, and for performing business processing using the sensed identity. It is to include.

Optionally, the method includes the use of a printer to print the packaging, which determines the visible information to be provided on the packaging, determines the identity associated with the pharmaceutical formulation, uses the identity to create coded data, and This coded data comprises a plurality of coded data portions, each coded data portion at least indicating identity of the pharmaceutical formulation and for printing the packaging by printing the coded data and the visible information.

Optionally, the method is further used to allow a user to interact with the pharmaceutical formulation, which method receives the indication data from the sensing device within the computer system, the sensing device at least partially producing the indication data indicative of identity. Respond immediately to the detection of coded data, and use the indication data to determine at least one action, perform an action associated with the pharmaceutical, which provides information to the user, update tracking of information related to the pharmaceutical Include at least one of the proofs of the pharmaceutical formulation, and perform receipt of feedback from the user.

Optionally, the method is further used for pharmaceutical authentication, wherein the method detects at least one coded data portion within the sensing device and uses the sensed coded data portion to identify identity and at least one signature portion. Create indication data indicative of, and determine, from the indication data in the processor, the determined identity and at least one determined signature portion and include the pharmaceutical formulation authentication using the determined identity and the at least one determined signature portion.

Optionally, the method is further used to determine a possible duplicate of the pharmaceutical packaging, the method receiving an indication data from a sensing device in a computer system, the sensing device receiving a representation of the coded data to produce identification data indicative of identity. Respond directly to the detection, determine, from the indication data, the determined identity and use the determined identity to access the tracking data related to the pharmaceutical, the tracking data being at least partly an indication of the location of the pharmaceutical and tracking This involves using the data to determine if the pharmaceutical is a replica.

Optionally, the method is further used for pharmaceutical tracking, wherein the method is coded to receive, in a computer system, the indication data from the sensing device, and to generate the marking data representing the identity of the product item. Immediately responding to the detection of and using the received indication data to update the tracking data indicative of the tracking information at least in part.

Optionally, the method is further used for pharmaceutical packaging, wherein the method determines a serial number associated with the pharmaceutical agent within a computer system, creates an identity using the serial number, creates a signature using the identity, and uses the same Results in the generation of coded data, the coded data comprising a plurality of coded data portions, each coded data portion encrypting a signature with an identity, the signature being at least a partial digital signature of identity, On pharmaceutical packaging, causing identity with at least some coded data and causing at least one of the serial numbers to print.

Optionally, the method is further used for pharmaceutical dispensing, which method receives, in a computer system, indication data from a sensing device, the sensing device at least partially sensing the coded data to produce indicative data indicative of identity. Respond directly to, using the indication data, determine at least one criterion for dispensing the pharmaceutical from the distribution database, and allow the pharmaceutical to be distributed if one or more conditions are met.

Optionally, the sensing device is for use with a pharmaceutical formulation, the sensing device being adapted to be held by the user in use, the radiation source for exposing the at least one coded data portion, the at least one exposed coded data portion. And a processor for determining a sensed identity using at least one sensed coded data portion.

Another broad form of the invention provides a method for authenticating a pharmaceutical formulation, the pharmaceutical formulation in combination with a packaging arranged inside and on top of the coded data comprising a plurality of coded data regions, each of The coded data area represents the identity of the pharmaceutical agent and at least a portion of the signature, wherein the signature is at least part of the digital signature of the identity, and the method detects at least one or more coded data areas within the sensing device, A display data is generated using a coded data area, the display data at least partially indicating the identity and at least one signature, and transmitting the display data to a computer system, the computer system determined from the display data. Identity, determining at least one determined signature , And immediately respond to the display data to authenticate the pharmaceutical formulation.

The sixth broad form of the present invention provides a possible replication decision method for pharmaceutical packaging. The packaging is arranged with coded data comprising a plurality of coded data portions on or within the packaging, each coded data portion exhibiting at least the identity of the pharmaceutical formulation, the method comprising displaying from a sensing device within a computer system. Upon receipt of the data, the sensing device immediately responds to the detection of the coded data to produce an indication data indicative of identity, from the indication data, determine the determined identity, and use the determined identity to track data related to the pharmaceutical formulation. Approaching, the tracking data at least partially includes indicating the location of the pharmaceutical formulation, and using the tracking data to determine whether the pharmaceutical formulation is a replica capable.

The tracking data also represents tracking information for each of a plurality of existing pharmaceuticals, and the method includes determining, within the computer system, whether the pharmaceutical is a replica of one of the existing pharmaceuticals.

The method also uses indication data in a computer system to determine the current location of the pharmaceutical formulation, to compare the current location with the tracking information, and that the current location is inconsistent with the tracking information, resulting in the possibility of duplicating the pharmaceutical formulation. It includes the decision of whether or not there is.

Optionally, the method includes determining, within the computer system, whether the current location is inconsistent with the tracking information using predetermined rules.

Optionally, wherein each coded data portion is at least a partial representation of a signature, the signature is a digital signature of at least a partial signature, wherein the presentation data at least partially represents a portion of at least one signature, and the method includes Determining, from the indication data, at least one determined signature portion within the computer system and including the pharmaceutical formulation authentication using the determined identity and the at least one determined signature portion.

Optionally, the method includes authorizing the processing related to the pharmaceutical formulation and updating the tracking information related to the pharmaceutical formulation within the computer system and in response to successful authentication.

Optionally, the method further comprises, within a computer system, a communication with a database, the database storing data relating to the pharmaceutical formulation, the database comprising at least one of the following contents, the at least one key associated with the signature: Usage data, wherein the signature is a digital signature that is at least part of an identity, the tracking data, the tracking data at least partially indicating tracking information including at least one of the following contents, the owner of the pharmaceutical formulation; One or more business processes performed using the pharmaceutical preparation, the location of the pharmaceutical preparation, the location of the sensing device, the product data, the product data at least partially representing product information including at least one of the following: Cost, Patient Identifier, User Identifier, Owner Identifier, Date of Manufacture, Batch Number, Product Manufacturer, Product Distributor, Product Supplier, Country of Origin, Ingredient, Storage Conditions, Disposal Conditions, Serial Number, Expiry Date, Effect, Side Effects , Conditions of use, instructions for use, links to more detailed information, contraindications and dosages.

Optionally, the method comprises in the computer system causing display to show at least one of the results of authentication, tracking information, and product information.

Optionally, said identity is the identity of the coded data portion; At least in part from at least one of the identity of the pharmaceutical formulation, the identity of the EPC, the packaging, and the identity of the packaging region.

Optionally, the packaging here includes at least one of a blister pack, a bottle, a cap, a label, a box, and a single sheet.

Optionally, the coded data is substantially invisible to the human eye.

Optionally, the coded data is printed on the surface using at least one of invisible ink and infrared absorbing ink.

Optionally, the coded data is provided to be substantially consistent with visible human readable information.

Optionally, the encoding herein comprises a plurality of coded data portions, wherein at least some of the coded data portions encode at least one of the following contents, the location of each coded data portion, on the surface The location of each coded data portion, the size of the coded data portions, the signature portion, the size of the signature, the identity of the portion of the signature, the unit of indicated location selection, and the data object of at least a portion of the data object in total are coded. It is encrypted at least once by the data parts.

Optionally, the data subject here includes at least one of MIME (multipurpose Internet mail extension) data, text data, image data, audio data, video data, application data, contact data, information, business card data, and a phone book. It is.

Optionally, the coded data comprises at least one of excessive data, data enabling error correction, Reed-Solomon data, and cyclic redundancy check.

Optionally, the digital signature here uses a random number associated with the identity, at least a hash that matches the mood of the identity, a hash generated at least using the mood of the identity generated using the private key, and a corresponding public key. At least one of attestable, at least one ciphertext generated by encrypting the identity, at least one ciphertext generated by encrypting the identity and the random number, and attestable using a public key corresponding to the ciphertext generated using the private key.

Optionally, the coded data is arranged according to at least one layout having n-fold rotational symmetry, where n is at least 2, the layouts each rotated in 1 / n rotations around the center of rotation, A secondary layout equal to n, wherein at least one secondary layout includes rotation-display data that identifies the secondary layout directly from a different secondary layout.

Optionally, said coded data is arranged in accordance with at least one layout having n-fold rotational symmetry, where n is at least 2, said layout comprising a sequence of integer multiples m of the n symbol. Where m is one or more, and each cryptographic symbol is distributed at n-locations around the center of the layout, so that the ciphertext translation of the symbol in each of the n directions of the layout results in n concepts of direction data, Each concept involves different periodic variations of the direction indication data, which indicates the angle of rotation of the layout.

Optionally, the method comprises the use of a processing terminal for performing a business process related to the pharmaceutical formulation, the business terminal comprising a radiation source for exposing at least one coded data portion, the at least one exposed A sensor for sensing a coded data portion, a processor for determining sensed identity using at least one sensed coded data portion, and executing a business process using the sensed identity. .

Optionally, the method includes the use of a printer to print the packaging, which determines the visible information provided on the packaging, determines the identity associated with the pharmaceutical formulation, uses the identity to create coded data, and The coded data comprises a plurality of coded data portions, each coded data portion representing at least the identity of the pharmaceutical formulation and for printing the packaging by printing the coded data and the visible information.

Optionally, the method is further used to allow a user to interact with the pharmaceutical agent, the method receiving indication data from a sensor in a computer system, the sensor coding at least to produce display data indicative of at least part of identity. Immediately respond to the detection of the collected data, perform an action associated with the pharmaceutical agent, which action provides information to the user; Update tracking of information related to the pharmaceutical product, perform business processes related to the pharmaceutical product, and receive pharmaceutical feedback from the user.

Optionally, the method is further used to authenticate a pharmaceutical, wherein each coded data portion represents at least part of a signature, the signature is a digital signature that is at least part of identity, and is encrypted within multiple coded data portions. And the method detects at least one coded data portion in the sensing device, and uses the sensed coded data portion to produce display data indicative of identity and at least one signature portion and from the display data in the processor. Determine the identity and at least one determined signature portion and include the pharmaceutical formulation authentication using the determined identity and at least one determined signature portion.

Optionally, the method is further used to verify the pharmaceutical formulation, wherein each coded data portion further represents at least a portion of the signature, the signature is a digital signature that is at least part of the identity, and the method comprises: Receiving the indication data, the sensing device immediately responds to the detection of the coded data in order to produce the indication data representing at least partly the signature of the pharmaceutical agent, and from the indication data, the identity determined, and at least one determined Determine a portion of the signature and include the pharmaceutical formulation authentication using the determined identity and at least one determined portion of the signature.

Optionally, the method is further used for drug product tracking, where the method receives indication data from a sensing device within a computer system, the sensing device being configured to detect the coded data to produce an indication data indicating identity of the product item. Immediately responding, using the received indication data, to at least partially update tracking data representing the tracking information.

Optionally, the method is further used for pharmaceutical packaging, wherein the method determines a serial number associated with the pharmaceutical product in a computer system, uses the serial number to make identity, uses identity to make a signature, and identifies identity Resulting in the generation of coded data, the coded data comprising a plurality of coded data portions, each coded data portion encrypting a signature with the identity, the signature being at least part of the identity It is a digital signature and includes, on a pharmaceutical package, causing identity to be printed with at least some coded data and at least one of a serial number.

Optionally, the method is further used for pharmaceutical dispensing, which method receives indication data from a sensing device in a computer system, wherein the sensing device is at least partially sensitive to the detection of coded data to produce presentation data indicative of identity. Immediately responding, using the indication data, from the distribution database, determining at least one criterion for dispensing the pharmaceutical, and whether the pharmaceutical to be dispensed satisfies the at least one criterion.

Optionally, the sensing device is for use with a pharmaceutical formulation, the sensing device being adapted to be held by the user in use, a radiation source for exposing at least one coded data portion, and at least one exposed coded data. A sensor for sensing the portion and a processor for determining sensed identity using at least one sensed coded data portion.

A broad form of the invention provides a method for replicating pharmaceutical packaging, wherein the packaging is arranged with coded data comprising a plurality of coded data portions on or within the packaging, each coded data portion being at least of the pharmaceutical formulation. Wherein the sensing device senses at least some of the coded data, uses the sensed coded data to determine display data at least partially indicating the identity, and transmits the display data to a computer system; The computer system determines, from the indication data in the indication data, the determined identity and uses the determined identity to access tracking data relating to the pharmaceutical formulation, the tracking data at least partially indicating the location of the pharmaceutical product, Use the tracking data And to determine whether the medicinal product replica.

A seventh broad form of the present invention provides a method for tracking a drug product, the drug product being combined with a packaging disposed on or within the coding data comprising a plurality of coded data portions, each coding The data portion indicates the identity of the pharmaceutical product, the method receives indication data from the sensing device within the computer system, and the sensing device immediately responds to the coded data for generating the indication data indicating the identity of the production item. And using the received display data, update the tracking data indicating the tracking information at least partially.

Optionally, here, the at least one tracking information and indication data, the identity of the sensing device, the patient's identity, the identity of the modern owner of the pharmaceutical preparation, one or more business processes carried out using the pharmaceutical preparation, the location of the pharmaceutical preparation, It represents at least one of the locations of the sensing device.

Optionally, wherein each coded data portion represents at least part of a signature, and the signature is a digital signature that is at least part of identity, wherein the presentation data at least partially represents at least one signature portion and the method comprises a computer. Within the system; Determine at least one determined signature portion from the indication data, and include the pharmaceutical formulation authentication using the determined identity and the at least one determined signature portion.

Optionally, the method includes acknowledging the processing of the pharmaceutical formulation and updating the tracking information in the computer system and in response to a successful proof.

Optionally, the entire signature is encrypted within a plurality of coded data portions, wherein the system thereby comprises a sensing device arranged to sense the plurality of coded data portions to determine the total signature.

Optionally, the method further comprises, within a computer system, communicating with a database, the database storing data relating to the pharmaceutical agent, comprising at least one of the following contents, and including at least one key associated with the signature. The data, the signature is a digital signature that is at least part of the identity, the product data, the product data at least partially represents product information including at least one of the following: product cost, patient identifier, user identifier, owner identifier, Date of manufacture, batch number, product manufacturer, product distributor, product supplier, country of origin, ingredients, storage conditions, disposal conditions, serial number, expiration date, effects, adverse effects, conditions of use, instructions, more detailed information Link, contraindications, and dosage.

Optionally, the method comprises causing the computer system to cause display of at least one of the results of authentication, tracking information, and product information.

Optionally, the coded data comprises a plurality of layouts, each layout clarifying a location of a plurality of first symbols that encrypts identity, and the plurality of second symbols clarifying at least part of the signature.

Optionally, said identity is generated at least partially from at least one of coded data partial identity, identity of pharmaceutical formulation, EPC, identity of packaging, and identity of packaging region.

Optionally, the packaging herein includes at least one of a blister pack, a bottle, a cap, a label, a box, and a sheet of paper.

Optionally, the coded data is substantially invisible to the human eye.

Optionally, the coded data is printed on the surface using at least one of an invisible ink and an infrared absorbing ink.

Optionally, the coded data is provided in substantial correspondence with visible human readable information.

Optionally, the encoding herein comprises a plurality of coded data portions, wherein at least some of the coded data portions comprise a location of each coded data portion; Location of each coded data portion on the surface; The size of the coded data portions; Signature part; The size of the signature; Identity of part of the signature; By encrypting the unit of the indicated location and at least one of the data objects, the entire data object is encrypted at least once by the plurality of coded data portions.

Optionally, wherein the data subject is; It includes MIME (multipurpose Internet mail extension) data, text data, image data, audio data, video data, application data, contact data, information, business card data, and at least one of a phone book.

Optionally, the coded data includes at least one of redundant data, data enabling error correction, Reed-Solomon data, and cyclic redundancy checks.

Optionally, the digital signature here is provable using a public key corresponding to a random number associated with the identity, a hash suitable for the atmosphere of the identity, at least a hash suitable for the atmosphere of the identity generated using the private key. At least one of at least one of a ciphertext generated by encrypting at least the same, at least one ciphertext generated by encrypting at least the sameness and a random number, and attestable using a public key corresponding to the ciphertext generated using the private key.

Optionally, the coded data is arranged according to at least one layout with n-fold rotational symmetry, where n is at least 2, the layout being rotated n each with 1 / n rotations around the center of rotation. At least one secondary layout, wherein the at least one secondary layout is to identify rotation-display data that identifies the secondary layout directly from a different secondary layout.

Optionally, said coded data is arranged in accordance with at least one layout having n-fold rotational symmetry, wherein n is at least 2, said layout comprising a sequence of integer multiples m of the n symbol. Encrypt the data, where m is one or more, and each cryptographic symbol is distributed at n-locations around the center of the rotational symmetry of the layout, so that the ciphertext translation of the symbol in each of the n directions of the layout is n Consists of concepts, each concept comprising different periodic variations of the direction-indicating data, which is indicative of the angle of rotation of the layout.

Optionally, the method comprises the use of a processing terminal to execute a processing related to the pharmaceutical formulation, the processing terminal comprising: a radiation source for exposing at least one coded data portion; A sensor for detecting at least one exposed coded data portion, and a processor for determining sensed identity using at least one sensed coded data portion, and executing a business process using the sensed identity. It is to include.

Optionally, the method includes the use of a printer to print the packaging, which determines the visible information to be provided on the packaging, determines the identity associated with the pharmaceutical formulation, uses the identity to produce coded data, The coded data comprises a plurality of coded data portions, each coded data portion representing at least the identity of the pharmaceutical formulation, and for printing the packaging by printing the coded data and the visible information.

Optionally, the method is further used to allow a user to interact with the pharmaceutical agent, the method being within a computer system; Receiving display data from the sensor, the sensor responds directly to the detection of the coded data to produce at least partially identical display data, and uses the display data to determine at least one action, Execute the associated action, which provides information to the user; Update tracking of information related to pharmaceuticals; Conducting business processes related to pharmaceuticals; At least one of the pharmaceutical authorizations, and including receipt of feedback from the user.

Optionally, the method is further used to authenticate the pharmaceutical, wherein each coded data portion further represents at least a portion of the signature, which signature is at least a digital signature that is part of the identity and within the plurality of coded data portions. Encrypted, the method detects at least one coded data portion within the sensing device, and uses the sensed coded data portion to produce indication data indicative of identity and at least one signature portion, and, within the processor, Determining the identity and at least one determined signature portion from the indication data and including the pharmaceutical formulation authentication using the determined identity and at least one determined signature portion.

Optionally, the method is further used for authenticating a pharmaceutical formulation, each coded data portion further representing at least part of a signature, the signature being a digital signature that is at least part of identity, and wherein the method comprises a sensing device in a computer system. Receiving the indication data from the device, the sensing device responds directly to the detection of the coded data in order to at least partly identify the identity of the pharmaceutical formulation and the indication data indicative of the signature portion, and from the indication data, the identity determined, at least one Determining a part of the determined signature and including the pharmaceutical formulation authentication using the determined identity and the at least one determined part of the signature.

Optionally, the method is further used to determine a possible duplicate of the pharmaceutical packaging, the method receiving an indication data from a sensing device in a computer system, the sensing device receiving a representation of the coded data to produce identification data indicative of identity. Respond directly to the detection, determine, from the indication data, the determined identity, use the determined identity to access the tracking data related to the pharmaceutical, the tracking data is at least in part an indication of the location of the pharmaceutical, and Using the data, to determine if the pharmaceutical is a replica possible.

Optionally, the method is further used to make a pharmaceutical packaging, the method determines a serial number associated with the pharmaceutical formulation within a computer system, uses the serial number to make identity, uses identity to make a signature, Using identity, results in the generation of coded data, the coded data comprising a plurality of coded data portions, each coded data portion encrypting a signature with the identity, and the signature being at least part of the identity It is a signature and includes, on the pharmaceutical package, at least one of the same as at least some coded data and a serial number.

Optionally, the method is further used for pharmaceutical bonsai, wherein the method receives indication data from a sensing device in a computer system, the sensing device at least partially adapted to the sensing of coded data to produce indicative data indicative of identity. Immediately responding, using the indication data to determine at least one criterion for dispensing the pharmaceutical from the distribution database and causing the pharmaceutical to be produced if the pharmaceutical to be dispensed meets at least one criterion. .

Optionally, the sensing device is for use with a pharmaceutical formulation, the sensing device being adapted to be held by the user in use, a radiation source for exposing at least one coded data portion, and at least one exposed coded data. A sensor for sensing the portion and a processor for determining sensed identity using at least one sensed coded data portion.

In another broad form of the invention, a pharmaceutical tracking method, a pharmaceutical formulation, is associated with a packaging in which coded data comprising a plurality of coded data portions on or within the packaging is disposed, each coded data portion Denotes the identity of the pharmaceutical formulation, the method receives indication data from a sensing device in a computer system, the sensing device responds directly to the detection of the coded data to produce an indication data indicating identity of the product item, and Using the displayed display data, the tracking data update indicating at least partly the tracking information.

In an eighth broad aspect of the present invention, the invention provides a method of producing a pharmaceutical product packaging. In a computer system, the method includes determining a serial number associated with a pharmaceutical product, generating an identifier using the serial number, generating a signature using the identifier, and causing generation of coded data using the identifier. Step, said coded data comprises a plurality of coded data portions, each coded data portion encodes an identifier and at least some signatures, the signature is a digital signature of at least some identifiers, and at least some on pharmaceutical product packaging Causing to print the coded data and at least one of the identifier and the serial number. 2. The method according to paragraph 1, wherein the identifier is at least partially formed from at least one of a serial number of a pharmaceutical product, an identifier of the pharmaceutical product, an EPC, an identifier of a packaging, and an identifier of a range of packaging.

Optionally, the method comprises encoding a complete signature within the plurality of coded data portions.

Optionally, the method determines visual information related to the pharmaceutical formulation and determines a description, the description describing the layout of the visible information; Recording the association between identity and layout, and using the layout to cause the packaging to print.

Optionally, the description herein represents at least one action associated with the pharmaceutical formulation, the action comprising: providing information to a user; Update tracking information related to the pharmaceutical formulation; Conducting business processes related to pharmaceuticals; To demonstrate pharmaceutical preparations; And at least one of the feedback receipts from the user.

Optionally, the method communicates with a database within a computer system, the database storing data associated with the pharmaceutical agent, the attestation data comprising at least one key associated with the signature, the signature being a digital signature that is at least part of the identity. , The tracking data, the tracking data at least partially representing tracking information including at least one of the following, the owner of the pharmaceutical formulation, one or more tasks performed using the pharmaceutical formulation, the location and detection device of the pharmaceutical formulation Product cost, patient identifier, user identifier, owner identifier, date of manufacture, batch number, product manufacturer, product distributor, product supplier, issuing country, ingredients, storage conditions, disposal Conditions, Serial Numbers, Expiration Dates, Effects, Side Effects, Terms of Use, Further Information Product information at least partially indicating product information including at least one of a link, contraindications, dosage, and the like.

Optionally, the method comprises updating the at least some data related to the pharmaceutical within the computer system, making the coded data using at least some data related to the pharmaceutical.

Optionally, the method further comprises information from the scanning system within the computer system in response to a scan of the packaging, the information indicating the raw material of the pharmaceutical formulation, the type of pharmaceutical formulation, the identity of the pharmaceutical formulation, and at least one of the serial numbers of the pharmaceutical formulation, Include receipt.

Optionally, since the coded data represents a plurality of reference points, the sensing of at least one coded data portion by the sensing device is characterized by the identity, at least one signature part, the location of the sensing device relating to packaging, and the sensing relating to packaging. At least one of the movements of the device is made determinable.

Optionally, said identity is generated at least in part from at least one of coded data partial identity, identity of pharmaceutical formulation, identity of EPC packaging, and identity of packaging region.

Optionally, the packaging herein is a blister pack; bottle; Bottle cap; label; It contains at least one of a box and a sheet of paper.

Optionally, the coded data is substantially invisible to the human eye.

Optionally, the coded data is printed on the surface using at least one of invisible ink and infrared-absorbing ink.

Optionally, the coded data is provided in substantial correspondence with visible human readable information.

Optionally, the encoding herein comprises a plurality of coded data portions, wherein at least some coded data portions comprise a location of each coded data portion, a location of each coded data portion on the surface, coded data Encrypting at least one of the size of the portions, the portion of the signature, the size of the signature, the identity of the portion of the signature, the units of the indicated location, and at least some of the data object. The entire data object is encrypted at least once by the plurality of coded data portions.

Optionally, the data subject here includes at least one of MIME (Multipurpose Internet Mail Extensions) data, image data, audio data, video data, application data, contact data, information, business card data, and a phone book. .

Optionally, the coded data includes at least one of redundant data, data enabling error correction, Reed-Solomon data, and cyclic redundancy check data.

Optionally, the digital signature may comprise a random number associated with the identity, a hash at least for the atmosphere of identity, a hash at least for the atmosphere of identity generated using a private key, and a proof using the corresponding public key. At least one of the possible, at least one ciphertext generated by encrypting the identity, and at least one capable of proving the public key corresponding to the ciphertext generated using the ciphertext and the private key generated by encrypting the identity and the random number.

Optionally, the coded data is arranged according to at least one layout having n-fold rotational symmetry, where n is at least 2, the layouts each rotated in 1 / n rotations around the center of rotation, a secondary layout equal to n, wherein at least one secondary layout includes rotation-display data that identifies the secondary layout directly from a different secondary layout.

Optionally, said coded data is arranged in accordance with at least one layout having n-fold rotational symmetry, wherein n is at least 2, said layout comprising a sequence of integer multiples m of the n symbol. Encrypt the data, where m is one or more, and each cryptographic symbol is distributed at n-locations around the center of the layout, so that the ciphertext decryption of the symbol in each of the n directions of the layout results in n concepts of directional data. Each concept includes different periodic variations of the direction indication data, which represent the angle of rotation of the layout.

Optionally, the method comprises the use of a processing terminal for performing a business process related to the pharmaceutical formulation, the business terminal comprising a radiation source for exposing at least one coded data portion, the at least one exposed A sensor for sensing a coded data portion, and a processor for determining sensed identity using at least one sensed coded data portion and executing business processing using the sensed identity.

Optionally, the method includes the use of a printer to print the packaging, which determines the visible information to be provided on the package, determines the identity associated with the pharmaceutical formulation, uses the identity to create coded data, and The coded data comprises a plurality of coded data portions, each coded data portion representing at least the identity of the pharmaceutical formulation and for printing the packaging by printing the coded data and the visible information.

Optionally, the method is further used to allow a user to interact with the pharmaceutical formulation, the method receiving the indication data from the sensing device within the computer system, the sensing device at least partially producing the indication data indicative of identity. Respond immediately to the detection of coded data, and use the indication data to determine at least one action, perform an action associated with the pharmaceutical, which provides information to the user, update tracking of information related to the pharmaceutical Include, at least one of, pharmaceutical authorizations, and receive feedback from the user.

Optionally, the method is further used for pharmaceutical authentication, each coded data portion further representing at least a portion of a signature, the signature being a digital signature that is at least part of identity, and encryption within multiple coded data portions. Wherein the method detects, within the sensing device, at least one coded data portion, and uses the sensed coded data portion to produce display data indicative of identity and at least one signature portion and in the processor Determining, from the indication data, the determined identity and at least one determined signature portion and including the pharmaceutical formulation authentication using the determined identity and the at least one determined signature portion.

Optionally, the method is further used for pharmaceutical authentication, each coded data portion further representing at least part of a signature, the signature being a digital signature that is at least part of identity, and wherein the method comprises, within a computer system, a sensing device Receiving the indication data from the at least one sensor, the sensing device responds at least in part to the identity of the pharmaceutical formulation and to the detection of the coded data in order to produce the indication data indicative of the signature portion, the identity determined from the indication data, and at least one Determining a part of the determined signature and including the pharmaceutical formulation authentication using the determined identity and the at least one determined part of the signature.

Optionally, the method is further used to know if there is a possibility of replication of the pharmaceutical packaging, the method receiving indication data from a sensing device in a computer system, the sensing device receiving the coded data to produce identification data indicating identity. Respond directly to the detection, determine, from the indication data, the determined identity, and use the determined identity to access the tracking data related to the pharmaceutical, the tracking data being at least partially an indication of the location of the pharmaceutical, and the tracking data To determine if a pharmaceutical is likely to be replicated.

Optionally, the method is further used for pharmaceutical tracking, which method receives, in a computer system, indication data from a sensing device, wherein the sensing device detects coded data to produce indication data representing identity of a product item. Directly responding to, and using the received indication data, updating the tracking data at least partially indicating the tracking information.

Optionally, the method is further used for pharmaceutical dispensing, the method receiving, in a computer system, indication data from a sensing device, wherein the sensing device senses coded data to produce at least partially identical presentation data. Directly responding to, using the indication data, from the distribution database, determining at least one criterion for dispensing the pharmaceutical, and whether the pharmaceutical to be dispensed satisfies the at least one criterion.

Optionally, the sensing device is for use with a pharmaceutical formulation, the sensing device comprising: a housing suitable for maintenance by the user in use, a radiation source for exposing at least one coded data portion, at least one exposed coded And a processor for determining sensed identity using a sensor for sensing the data portion and at least one sensed coded data portion.

A ninth broad aspect of the present invention provides a pharmaceutical dispensing method, wherein the pharmaceutical formulation is associated with a packaging in which coded data is placed on or in a package, wherein at least some coded data is present at least in the pharmaceutical formulation. Indicative of identity, the method receives indication data from a sensing device within a computer system, the sensing device responding directly to the detection of coded data to produce display data at least partially indicating identity, and using the display data. Determining, from the distribution database, at least one criterion for dispensing the pharmaceutical and whether the pharmaceutical to be dispensed satisfies the at least one criterion.

Optionally, wherein at least one criterion indicates an intended recipient of the pharmaceutical formulation, the method determines identity data indicative of identity of each individual requesting the pharmaceutical formulation within a computer system, and identity for at least one criterion Comparing the data and determining whether at least one criterion can be met if the identity of each individual is identical to the identity of the intended recipient.

Optionally, the sensing device comprises a data store for storing the identity data, and the method comprises determining the identity data from the data store.

Optionally, the at least one criterion herein is indicative of at least one of an intended time for dispensing the pharmaceutical, an intended date for dispensing the pharmaceutical, and at least one of the intended locations for dispensing the pharmaceutical.

Optionally, the coded data comprises a plurality of coded data portions, each coded data portion representing at least part of a signature, wherein the signature is a digital signature that is at least part of identity, wherein at least one coding In response to detecting the detected portion of data, the sensing device generates at least partially presentation data representing at least one signature portion, and the method determines, from the presentation data in the computer system, the determined identity and the at least one determined signature portion. And authenticate the pharmaceutical formulation using the determined identity and at least one determined signature portion, and include the pharmaceutical formulation distribution in response to successful authentication.

Optionally, the full signature is here encrypted within the plurality of coded data portions, the method comprising sensing in the sensing device a number of coded data portions thereby to determine the complete signature. .

Optionally, the method further comprises, within a computer system, communicating with a database, the database storing data relating to the pharmaceutical formulation, comprising at least one of the following contents, and comprising at least one key associated with the signature; The attestation data, the signature is a digital signature that is at least part of the identity, the tracking data, the tracking data at least partially indicating tracking information including at least one of the following contents, the owner of the pharmaceutical formulation; One or more business processes performed using the pharmaceutical product, the location of the pharmaceutical product and the location of the sensing device, the product data, the product data at least partially representing product information including at least one of the following: , Patient identifier, user identifier, owner identifier, date of manufacture, batch number, product manufacturer, product distributor, product supplier, country of origin, ingredients, storage conditions, disposal conditions, serial number, expiration date, effects, adverse effects, Conditions of use, links to further information, contraindications and dosage.

 Optionally, the method may include findings of the proof, tracking information, and

Causing the display of at least one of the product information.

Optionally, said identity is generated at least in part from coded data partial identity, pharmaceutical formulation identity, EPC, identity of packaging, and identity of packaging region.

Optionally, the packaging herein includes at least one of a blister pack, a bottle, a cap, a label, a box, and a single sheet of paper.

Optionally, the coded data is substantially invisible to the human eye.

Optionally, the coded data is printed on the surface using at least one of invisible ink and infrared absorbing ink.

Optionally, the coded data is provided to be substantially consistent with visible human readable information.

Optionally, the encoding herein comprises a plurality of coded data portions, wherein at least some of the coded data portions encode at least one of the following contents, the location of each coded data portion, on the surface The location of each coded data portion, the size of the coded data portions, the signature portion, the identity of the portion of the signature, the unit of the indicated location, at least a portion of the data object, the complete data object is at least by the plurality of coded data portions. It is encrypted once.

Optionally, the data subject here includes MIME (General Purpose Internet Mail Extensions) data; Text data, image data, audio data, video data, application data, contact data, contact information, business card data for business, and at least one of the phone books.

Optionally, the coded data includes at least one of redundant data, data enabling error correction, Reed-Solomon data and cyclic redundancy checks.

Optionally, the digital signature here uses a random number associated with the identity, at least a hash that matches the mood of the identity, a hash generated at least using the mood of the identity generated using the private key, and a corresponding public key. At least one of verifiable, at least one ciphertext generated by encrypting the identity, at least cryptographic text generated by encrypting the identity and the random number, and attestable ones using the public key corresponding to the ciphertext generated using the private key. will be.

Optionally, the coded data is arranged according to at least one layout with n-fold rotation-symmetry, where n is at least 2, the layouts each rotated in 1 / n rotations around the center of rotation. and a secondary layout equal to n and containing rotation-display data identifying at least one secondary layout.

Optionally, said coded data is arranged in accordance with at least one layout having n-fold rotational symmetry, where n is at least 2, the layout comprising a sequence of integer multiples m of the n symbol. Encrypt the data, where m is one or more, and each cryptographic symbol is distributed at n-locations around the center of the layout, so that the ciphertext translation of the symbol in each of the n directions of the layout results in n concepts of directional data. Each concept includes different periodic variations of the direction indication data, which indicates the degree of rotation of the layout.

Optionally, the method comprises the use of a processing terminal for performing a business process related to the pharmaceutical formulation, the business terminal comprising a radiation source for exposing at least one coded data portion, the at least one exposed A sensor for sensing a coded data portion, and a processor for determining sensed identity using at least one sensed coded data portion, and executing a business process using the sensed identity.

Optionally, the method includes the use of a printer to print the packaging, which determines the visible information provided on the packaging, determines the identity associated with the pharmaceutical formulation, and uses the identity to code the coded data. The created, coded data comprises a plurality of coded data portions, each coded data portion representing at least the identity of the pharmaceutical formulation and for printing the packaging by printing the coded data and the visible information.

Optionally, the method is further used to allow a user to interact with the pharmaceutical formulation, the method receiving the indication data from the sensing device within the computer system, the sensing device at least partially producing the indication data indicative of identity. Respond directly to the detection of coded data, and use the display data to determine at least one action, perform an action associated with a pharmaceutical agent, which provides information to the user, and provides tracking information related to the pharmaceutical agent. Update, perform a task related to pharmaceuticals, include at least one of pharmaceuticals certifications, and receive feedback from a user.

Optionally, the method is further used to authenticate the pharmaceutical, wherein each coded data portion further represents at least a portion of the signature, the signature is a digital signature that is at least part of the identity, and is encrypted within multiple coded data portions. The method; Within the sensing device; Detect at least one coded data portion, and use the sensed coded data portion to create an indication data representing identity and at least one signature portion and, within the processor, an identity determined from the indication data, at least one Determining a part of the determined signature and including the pharmaceutical formulation authentication using the determined identity and the at least one determined part of the signature.

Optionally, the method is further used for pharmaceutical authentication, each coded data portion further representing at least a portion of the signature, the signature being a digital signature that is at least part of the identity, and the method, within the computer system, from a sensing device Receiving the indication data, the sensing device responds at least in part to the identity of the pharmaceutical formulation and to the detection of the coded data to produce an indication data indicative of a portion of the signature, and from the indication data, at least one Determining a part of the determined signature and including the pharmaceutical formulation authentication using the determined identity and the at least one determined part of the signature.

Optionally, the method is further used to determine a possible duplicate of the pharmaceutical packaging, the method receiving the indication data from the sensing device in a computer system, the sensing device receiving the coded data to produce the indicating data indicating identity. Respond directly to the detection, determine, from the indication data, the determined identity and use the determined identity to access the tracking data related to the pharmaceutical, wherein the tracking data is at least partly an indication of the location of the pharmaceutical and track Using data, this includes determining whether a pharmaceutical is replicable.

Optionally, the method is further used to track a pharmaceutical formulation, which method receives indication data from a sensing device within a computer system, the sensing device detecting the coded data to produce display data indicative of the identity of a product item. Directly responding to, and using the received indication data, to update the tracking data at least partially indicating the tracking information.

Optionally, the method is further used for manufacturing pharmaceutical packaging, wherein the method determines a serial number associated with the pharmaceutical formulation in a computer system, uses the serial number to make identity, uses identity to make a signature, Using identity, results in the generation of coded data, the coded data comprising a plurality of coded data portions, each coded data portion encrypting a signature with identity, and the signature being at least part of identity. Digital signature, on pharmaceutical package; At least some of the coded data and the same, and printing at least one of the serial numbers.

Optionally, the sensing device is for use with a pharmaceutical formulation, the sensing device being adapted to be held by the user in use, a radiation source for exposing at least one coded data portion, and at least one exposed coded data. A sensor for sensing the portion and a processor for determining sensed identity using at least one sensed coded data portion.

Another broad form of the invention provides a pharmaceutical dispensing method, wherein the pharmaceutical agent is combined with a packaging in which coded data is placed on or in the package, wherein at least some of the coded data represents at least the identity of the pharmaceutical formulation. The method comprises detecting, within a sensing device, at least some coded data, using the sensed coded data to determine indication data at least partially indicating identity and moving the indication data to a computer system. And the computer system, using the indication data, determines, from the distribution database, at least one criterion for pharmaceutical distribution and causes the pharmaceutical to be dispensed if the pharmaceutical to be dispensed meets at least one criterion. .

Another broad form of the invention is a sensing device for use with a pharmaceutical formulation, wherein the pharmaceutical formulation is combined with a packaging in which coded data comprising a plurality of coded data portions is placed on or in a package, each coded The data portion represents the identity of the pharmaceutical formulation, and the sensing device is configured to detect a housing suitable for being held by the user in use, a radiation source for exposing at least one coded data portion, and at least one exposed coded data portion. And a processor for determining sensed identity using at least one sensed coded data portion.

Optionally, the sensing device comprises a communication system, wherein the processor produces indication data indicative of at least in part the sensed identity and moves the indication data to the computer system, the computer system authenticating the pharmaceutical formulation. Respond promptly to the presentation data in order to carry out an action involving at least one of approving the business process, determining the business process details, and updating tracking information related to the pharmaceutical constraint.

Optionally, the processor is here to use the sensed identity to perform at least one of authentication of the pharmaceutical formulation, approval of the processing of the transaction, determination of the processing details, and tracking information updates related to the pharmaceutical.

Optionally, the identity is at least partially generated from at least one of the serial number of the pharmaceutical formulation, the identity of the pharmaceutical formulation, the EPC, the identity of the packaging region, and the identity of the packaging region.

Optionally, said coded data portion represents at least part of a signature, said signature is a digital signature that is at least part of identity, and said processor uses at least one sensed coded data portion to detect at least one sensed signature. Determine a portion and use the detected identity and at least one portion of the detected signature to cause a pharmaceutical authentication.

Optionally, the pharmaceutical formulation is verified by at least one of a processor and a computer system, the computer system using the sensed identity to determine a key, and using the sensed identity and key to determine a determined signature. And thereby comparing the determined signature with a portion of at least one detected signature to authenticate the pharmaceutical.

Optionally, wherein the complete signature is encrypted within the plurality of coded data portions, and the processor determines, from the plurality of sensed coded data portions, the sensed signature, and the constraint uses the detected identity to key Is determined by at least one of the processor and the computer system, using the detected signature and key to determine the determined identity, thereby comparing the determined identity with the sensed identity to prove the constraint. .

Optionally, the coded data comprises a plurality of layouts, each layout clarifying a location of a plurality of first symbols that encrypts identity, and the plurality of second symbols clarifying at least part of the signature.

Optionally, the packaging includes at least one of a blister pack, a bottle, a cap, a label, a box, and a single sheet.

Optionally, the sensing device comprises a communication system for communicating with a database, the database storing data relating to the pharmaceutical formulation and comprising at least one of the following contents comprising at least one key associated with a signature The attestation data, the signature is a digital signature that is at least part of the identity, and the tracking data, the tracking data is the owner of the pharmaceutical formulation, one or more tasks performed using the pharmaceutical formulation, the location of the pharmaceutical formulation, and the detection Display at least partly tracking information including one of the location of the device, product cost, patient identifier, user identifier, owner identifier, date of manufacture, batch number, product manufacturer, product distributor, product supplier, issuing country , Ingredient, storage condition, disposal condition, serial number, expiration date, effect, side effect, use tank Includes product data at least partially indicating product information, including at least one of a case, instructions for use, a link to more details, contraindications and dosages.

Optionally, the sensing device comprises a display for showing at least one of the results of the attestation, the tracking information and the product information.

Optionally, the coded data is substantially invisible to the human eye.

Optionally, the coded data is printed on the surface using at least one of invisible ink and infrared-absorbing ink.

Optionally, the coded data is provided in substantial correspondence with visible human readable information.

Optionally, the encoding herein comprises a plurality of coded data portions, wherein at least some of the coded data portions are to encrypt at least one of the following contents. The location of each coded data portion on the surface, the location of each coded data portion, the size of the coded data portion, the signature portion, the size of the signature, the identity of the signature portion, the units of the indicated locations, and at least a portion of the data object. , The entire data object coded at least once by the plurality of coded data portions.

Optionally, the data object includes at least one of MIME data, text data, image data, audio data, video data, application data, contact data, information, business card data, and a phone book.

Optionally, the coded data comprises: redundant data; Data to enable error correction; It includes at least one of Reed-Solomon data and cyclic redundancy check (CRC) data.

Optionally, the digital signature here uses a random number associated with the identity, at least a hash that matches the mood of the identity, a hash generated at least using the mood of the identity generated using the private key, and a corresponding public key. At least one of attestable, at least one ciphertext generated by encrypting the identity, at least one ciphertext generated by encrypting the identity and the random number, and attestable using a public key corresponding to the ciphertext generated using the private key. .

Optionally, said coded data is arranged in accordance with at least one layout having n-fold rotational symmetry, where n is at least 2, each layout rotated in 1 / n rotation about the center of rotation, A secondary layout equal to n, wherein at least one secondary layout includes rotation-display data that identifies the secondary layout directly from a different secondary layout.

Optionally, wherein the coded data is arranged in accordance with at least one layout having n-fold rotational symmetry, where n is at least 2 and the layout comprises a sequence of integer multiples m of the n symbol. -Encrypt the presentation data, where m is one or more, and each cryptographic symbol is distributed at n-locations around the center of the layout, so that the ciphertext translation of the symbol in each of the n-directions of the layout is n Giving rise to concepts, each concept comprising a different periodic variation of the direction indication data, which represents the angle of rotation of the layout.

Optionally, the business terminal is coupled to perform a business process related to the pharmaceutical formulation, the business terminal is a radiation source for exposing at least one coded data portion, the at least one exposed coded data. A sensor for sensing a portion, and a processor for determining sensed identity using at least one sensed coded data portion, and using the sensed identity to execute a business process.

Optionally, the printer is coupled to the printer to print a packaging associated with the pharmaceutical agent, the printer; Determine the visible information provided on the package, determine the identity associated with the pharmaceutical constraint, create coded data using the identity, the coded data comprising a plurality of coded data portions, each coded data portion at least To print the packaging by displaying the identity of the pharmaceutical formulation and printing the coded data and the visible information.

Optionally, the sensing device is further used to allow a user to interact with the pharmaceutical formulation, the method receiving receipt data from the sensing device in a computer system, the sensing device producing at least partially identical display data. Directly respond to the detection of the coded data, and use the indication data to determine at least one action, perform an action associated with the pharmaceutical agent, which provides information to the user, and provides tracking information related to the pharmaceutical agent. Update, perform a task related to pharmaceuticals, include at least one of pharmaceuticals certifications, and receive feedback from a user.

Optionally, the sensing device is further used to implement pharmaceutical formulation authentication, where each coded data portion further represents at least part of a signature, the signature is a digital signature that is at least part of identity, and multiple coded data portions Encrypted within, the method detects at least one coded data portion within the sensing device, and uses the sensed coded data portion to produce indication data indicative of identity and at least one signature portion, and in the processor Determining the identity and at least one determined signature portion from this indication data and including the pharmaceutical formulation authentication using the determined identity and at least one determined signature portion.

Optionally, the sensing device is further used to perform pharmaceutical formulation authentication, wherein each coded data portion further represents at least a portion of the signature, the signature is a digital signature that is at least part of the identity, and the method comprises: Receiving indication data from the sensing device, the sensing device responds directly to the detection of the coded data at least in part to produce an indication data indicative of the identity of the pharmaceutical formulation and the signature portion, and from this indication data, Determining at least one determined signature portion and including the pharmaceutical formulation authentication using the determined identity and the at least one determined signature portion.

Optionally, the sensing device is further used to implement a possible duplicate determination method of pharmaceutical packaging, the method receiving coded data from the sensing device in a computer system, the sensing device being coded to produce identity data indicative of identity. Respond directly to the detection of the data, and from this indication data, determine the determined identity, and use the determined identity to access the tracking data related to the pharmaceutical formulation, the trace data at least partially indicating an indication of the location of the pharmaceutical formulation. And using the tracking data to determine if a pharmaceutical replication is possible.

Optionally, the sensing device is further used to perform a pharmaceutical tracking method, which method receives the indication data from the sensing device in a computer system, and the sensing device is coded to produce display data indicating identity of the product item. Immediately responding to detection of the received data, and using the received indication data, updating the tracking data at least partially representing the tracking information.

Optionally, the sensing device is further used to implement a pharmaceutical packaging manufacturing method, the method comprising: determining a serial number associated with a pharmaceutical formulation within a computer system; Using serial numbers, creating identity, using identity, creating signatures, using identity, resulting in the generation of coded data, the coded data comprising a number of coded data portions, each of The coded data portion encodes the identity and the signature, which signature is a digital signature that is at least part of the identity, resulting in the printing of at least one of the identity and serial number with at least some coded data on the pharmaceutical packaging. It involves doing.

Optionally, the sensing device is further used to implement a pharmaceutical formulation dispensing method, which method receives indicia data from the sensing device in a computer system, the sensing device being at least partially coded to produce presentation data indicative of identity. Respond directly to the detection of the data and use the indication data, determine from the distribution database at least one criterion for dispensing the pharmaceutical, and allow the pharmaceutical to be dispensed if the pharmaceutical to be dispensed meets at least one criterion It includes things.

An eleventh broad aspect of the present invention is to provide a method for identifying a subject, wherein the method includes, within a computer system, receipt of a request for verification, at least partially identity of the subject, at least one signature fragment, the identity At least part of the digital signature of the signature, comprising an application indicating the identity determined using the verification application, using the verified identity and determining, from a database, one or more criteria regarding at least one verification; At least one criterion is compared with the received confirmation application, and the subject is asked to confirm whether one or more criteria have been met.

The at least one criterion relates to a limit on at least one of a plurality of received confirmation applications, the percentage of confirmation applications, and the timing of the received confirmation applications.

Optionally, said limit is defined for at least one of said identity of said subject, said signature, said signature fragment, applicant for verification, and subject respectively.

Optionally, the limit is proportional to the size of the signature fragment.

Optionally, the method determines, within the computer system, the application history of a plurality of previously received confirmation applications, and corresponding limits, using the confirmation application, using the confirmation application and the application history. Determine the number and allow the subject to check whether the application number has exceeded the corresponding limit.

Optionally, the application history indicates a time setting of the received confirmation application.

Optionally, the application history is combined with the identity of the subject, the signature, the signature fragment, the applicant for verification, and the subject.

Optionally, the method identifies within the computer system at least one signature fragment with the subject by authenticating the subject using identity.

Optionally, the verification request partially indicates at least the identity of the signature fragment.

Optionally the subject engages with a surface arranged above and within the coded data comprising a plurality of coded data portions, each coded data portion representing at least identity and a signature fragment, the signature fragment being at least one In response to detecting the coded data portion, the sensing device generates the confirmation request.

Optionally, the verification request indicates at least partly the identity of the signature fragment, wherein the fragment identity is at least one of a number coded within at least one sensed coded data, a location of at least one sensed coded data portion on the surface. Based on one.

Optionally, the method only compares, within the computer system, the received confirmation application with at least one criterion after the confirmation failed.

Optionally, the method receives, within a computer system, a verification request and at least partially identifies the identity of the subject, linking a signature fragment, the signature fragment that is at least part of the digital signature of the identity, and the random signature, the verification request. Determine the identity determined using the linkage, determine the signature fragment using the linkage, and identify the subject using the determined identity and the signature fragment.

Optionally, the method determines, within a computer system, a key using the determined identity, creates a signature generated using the determined identity and the key, compares the generated signature with a connection, and generates the signature fragment. Identify and authenticate

Another broad form of the invention provides coded data arranged in or on a surface, the coded data comprising a plurality of coded data portions, each coded data portion being an identity, part of a signature. , The signature, which is at least part of a digital signature of the same, and also a random signature.

Another broad form of the invention provides coded data arranged in or on a surface, the coded data comprising a plurality of coded data portions, each coded data portion having at least some identity, At least a fragment of the signature, the signature which is a digital signature of at least part of the identity, and also the location of the coded data on the surface.

Optionally, each coded data portion at least partially represents data portion identity, data portion identity unique to each coded data portion, and data portion identity indicating the location.

Alternatively, the coded data is placed on or within the surface using the layout, which layout represents the location of the corresponding coded data portion for each data portion identity.

Optionally, the sign uses RSA encryption.

Embodiments of the present invention will now be described with reference to the accompanying drawings.

1 is a diagram illustrating an example of a document including Hyperlabel encoding;

2 illustrates an example of a system for interaction with the hyperlabel document of FIG. 1;

3 shows a further example of a system for interaction with the hyperlabel document of FIG. 1, FIG.

4 is a diagram illustrating a first example of a tag structure;

FIG. 5 is a diagram illustrating an example of a symbol unit cell of the tag structure of FIG. 4. FIG.

6 is a diagram illustrating an example of an array of symbol unit cells of FIG. 5;

7 is a diagram illustrating an example of symbol bit ordering in unit cells of FIG. 5;

8 shows an example of the tag structure of FIG. 4 with a set of each bit;

9 illustrates an example of tag types in a tag group for the tag structure of FIG. 4;

10 is a diagram illustrating an example of continuous tiling of tag groups of FIG. 9;

FIG. 11 is a diagram illustrating an example of a direction-indicating circular location codeword R for the tag group of FIG. 4;

12 is a diagram illustrating an example of a local codeword A for a tag group of FIG. 4;

13 is a diagram illustrating examples of distributed codewords B, C, D, and E for the tag group of FIG. 4;

14 shows an example of a layout of a complete tag group;

15 is a diagram illustrating an example of a codeword of a tag group of FIG. 4;

16 illustrates an example of an optional tag group for the tag group of FIG. 4;

17 is a diagram illustrating a second example of a tag structure;

18 is a diagram illustrating a third example of a tag structure;

19 is a view showing an example of an article signature subject model;

20 is an example of hyperlabel tags applied to a drug.

21 is a view showing an example of a drug distribution process,

FIG. 22 shows an example of scanning in a retail interaction;

23 illustrates an example of details of an online scanning interaction;

24 illustrates an example of details of an offline scanning interaction;

25 illustrates an example of a netpage pen scanning interaction;

FIG. 26 shows an example of details of a netpage pen scanning interaction;

27 is a diagram showing an example of a hyperlabel tag class diagram,

28 is a diagram illustrating an example of an item ID rating chart;

29 shows an example of a drug ID rating chart,

30 is a diagram showing an example of a target description, ownership, and a collective rating diagram;

31 is a diagram illustrating an example of a target scanning history grade chart;

32 is a diagram illustrating an example of a scanner rating diagram;

33 is a diagram showing a target ID hot list diagram;

34 is a diagram showing an example of an effective ID zone rating diagram;

35 shows an example of a public key list rating chart;

36 shows an example of a trusted authenticator rating diagram;

37 is a view showing an example of cargo tracking target management;

38 shows an example of a hyperlabel supermarket checkout counter,

39 shows an example of a cash register;

40 is a diagram illustrating an example of a portable validity scanner.

Detailed Description of the Drawings

Netpage surface coding consists of tiling on dense planes of tags. Each tag encrypts its own location in the plane. Each tag, along with its neighbors, also encrypts the identifier of the area that contains that tag. In a netpage system, a region typically covers the entire range of tagged surfaces, such as one side of a sheet of paper.

Hyperlabel is an adaptation of Netpage tags for use in specific item identification for a wide variety of applications, including secure document protection, object tracking, drug security, supermarket automation, interactive product labels, and printing. Web-browsing from the page, e-mail on the page, and the like.

Using Memjet digital printing technology (which is the subject of a number of pending US patent applications, including USSN 10 / 407,212), hyperlabel tags can be placed on a substantially entire surface, such as a security document, banknote, or pharmaceutical package, infra-red (IR). ) Is printed using ink. By printing the tags of the infrared-absorbing ink on any substrate that is infrared reflective, the near infrared wavelengths and thus the tags are easily detected by the solid state image sensor with an appropriate filter but invisible to the human eye. This allows machine readable information to be encrypted over a large portion of a bill or other surface, with no visible effect on the letters or pictures of the original bill above it. The scanning laser or image sensor may read tags placed on any portion of the surface to perform related actions, such as identifying individual bills or articles.

An example of such a hyperlabel encrypted document is shown in FIG. 1. In the present embodiment, the hyperlabel document consists of graphic data 2 printed using visible ink and coded data 3 formed from hyperlabel tags 4. This document contains the interaction elements 6 defined by the zones 7 corresponding to the spatial extents of the corresponding graphic 8. In use, the tags encrypt tag data, including the ID. By detecting at least one tag and determining and interpreting the encrypted ID using an appropriate system, this allows related actions to be performed.

In one embodiment, a tag map is used to define the layout of tags on a hyperlabel document based on an encrypted ID in the tag data. The ID can also be used to refer to a document description that describes the individual elements of the hyperlabel document, in particular the type and space range (zone) of interactive elements, such as a button or text area. have. Thus, in this embodiment, the element 6 has a zone 7 corresponding to the spatial range of the corresponding graphic 8. This allows the computer system to interpret the interaction with the hyperlabel document.

In the location presentation technique, the encoded ID in the tag data of each tag causes the exact location of the tag on the hyperlabel document to be determined from the tag map. This location is then used to determine from the document description whether the detected tag is located in the zone of the interactive element.

In the object display technique, the encoded ID in the tag data causes the presence of a tag in an area of the document to be determined from the tag map (relative location of the tag in the area may also be displayed). In this case, the document description can be used to determine whether the area corresponds to the zone of the interactive element.

An example of this process will now be described with reference to Figs. 2 and 3, these figures show how a sensing device in the form of a netpage or hyperlabel pen 101 is printed with hyperlabels such as security documents, labels, product packaging, etc. It shows if it interacts with the encrypted data on the document (1).

The hyperlabel pen 101 detects a tag using an area image sensor and detects tag data. The hyperlabel pen 101 uses sensed coded data to generate interaction data, which is a short-range radio link 9 forming part of the computer 75 or printer 601. Is passed through to the relay 44. The relay sends the interaction data via the network 19 to the document server 10 which uses the ID to access the document description and interprets the interaction. In the appropriate environment, the document server sends a corresponding message to the application server 13, which can then perform the corresponding action.

In alternative implementations, a PC, web terminal, netpage printer or relay device may communicate directly with local or remote application software including a local or remote application web server. In this regard, the output is not limited to being printed by a netpage printer. It may be displayed on a PC or web terminal, and further interaction may be on screen-based, or mixtures thereof, rather than paper-based.

Typically, hyperlabel pen users register with registration server 11, which associates the user with an identifier stored in a separate hyperlabel pen. By providing the sensing device identifier as part of the interaction data, this allows users to identify and conduct transactions and the like.

Hyperlabel documents are created by having an ID server generate an ID, which is transferred to the document server 10. After determining the document description, the document server 10 records the association between the document description and its ID, and allows subsequent verification of the document description using that ID.

This ID is then used to generate tag data, using the page description and tag map, before the document is printed by the hyperlabel printer 601, which will be described in more detail below.

Each tag is represented by a pattern that contains two kinds of elements. The first kind of element is a target. Targets allow the tag to be located in the image of the coded surface and allow perspective distortion of the tag to be estimated. The second kind of element is a macrodot. Each macrodot encrypts the value of a bit by its presence or absence.

The pattern is displayed on the coded surface in such a way that it can be obtained by an optical imaging system, in particular by an optical system having a narrowband response in the near infrared. The pattern is typically printed on the surface, using narrowband near infrared ink.

In a hyperlabel system, the zone typically corresponds to the surface of the entire product, or security document, and the zone ID corresponds to a specific item ID. For clarity the inventors in the following discussion refer to articles and item IDs (or simply IDs), where the item ID corresponds to the zone ID.

Surface coding is designed such that the acquisition of a watch wide enough to guarantee the acquisition of the entire tag is large enough to guarantee the acquisition of the ID of the area containing the tag. The acquisition of the tag itself ensures the acquisition of the two-dimensional location of the tag within the area and the acquisition of other tag-specific data. Thus, surface coding allows the sensing device to obtain a zone ID and tag location during pure local interaction with the coded surface, eg, while "clicking" or tapping on a pen-coded surface.

A wide variety of different tag structures can be used and some examples will now be described.

[First example of tag structure]

4 shows the structure of a complete tag. Each of the four test circles is a target. The tag and the overall pattern have quadruple rotational symmetry at the physical level.

Each rectangular area represents a symbol, and each symbol represents four bits of information.

5 shows the structure of a symbol. It contains four macrodots, each of which represents a value of one bit by its presence (1) or absence (0).

Spacing of macrodots is specified by parameter s throughout this document. It has a nominal value of 143 m, based on nine dots printed at a pitch of 1600 dots per inch. However, it varies by ± 10% depending on the capacity of the device used to generate the pattern.

6 shows an array of nine adjacent symbols. Macrodot spacing is uniform in and between symbols.

7 shows an ordering of the bits in a symbol. Bit 0 is the least significant in the symbol and bit 3 is the most important. Note that this ordering is correlated to the direction of the symbol. The direction of a particular symbol in a tag is identified by the direction of the label of the symbol in the tag diagrams. In general, the directions of all symbols in a particular section of the tag have the same direction and coincide with the bottom of the symbol closest to the center of the tag.

Only macrodots are the display part of a symbol within a pattern. The square outline of the symbol is used in this document to explain the structure of the tag more clearly. 8 shows, as an example means, the actual pattern of a tag with each bit set. In practice, each bit of a tag can never be set.

Macrodots are nominal circulation with a nominal diameter of (5/9) s . However, depending on the capacity of the device used to generate the pattern, the size varies with ± 10%.

The target is a nominal circulation with a nominal diameter of (17/9) s . However, depending on the capacity of the device used to generate the pattern, the size varies with ± 10%.

Tag patterns vary in size by ± 10%, depending on the capacity of the device used to generate the pattern. Any deviation from the nominal size is recorded in the tag data to produce accurate location samples.

Each symbol shown in the tag structure of FIG. 4 has a unique label. Each label consists of an alpha prefix and a numeric suffix.

[Tag group]

Tags are arranged in tag groups. Each tag group contains four tags arranged in a rectangle. Thus, each tag has one of four possible tag types, depending on its location within the tag group rectangle. Tag types are labeled 00, 10, 01, and 11, as shown in FIG.

Each tag in the tag group is rotated as represented by the number, that is, tag type 00 rotates 0 degrees, tag type 10 rotates 90 degrees, tag type 11 rotates 180 degrees, and tag type 01 rotates 270 degrees. do.

10 shows how tag groups are repeated in successive tiling of tags. The tiling ensures that any set of four adjacent tags includes one tag of each type.

[Direction-marking circular location code]

The tag includes a 24-ary (4, 1) cyclic location codeword, which can be decoded in one of four possible directions of the tag to determine the actual direction of the tag. Symbols that are part of a cyclic location codeword have a prefix of "R" and are numbered from 0 to 3 in increasing order of significance.

The cyclic location codeword is (0, 7, 9, E16). Note that although a 4-bit symbol has 16 possible values, only four distinct symbol values are used. During decoding, unused symbolic values, if detected, are treated as deletions. In order to maximize the likelihood of low-weight bit error patterns causing deletions rather than symbol errors, the symbol values are chosen to be spaced as uniformly as possible on the hypercube.

The minimum distance of the recursive location code is 4, so its error-correction capability is from one symbol to one deletion, and no two or more deletions of symbols.

The layout of the direction-indicating cyclic location codeword is shown in FIG. 11.

[Local codeword]

The tag at hand contains one complete codeword, which is used to encrypt information unique to that tag. The codeword is a perforated 24-ary (13, 7) Reed-Solomon code. Thus, the tag encrypts up to 28 bits of information unique to the tag.

The layout of the local codeword is shown in FIG.

[Distributed Codewords]

The tag also includes fragments of four codewords distributed across four adjacent tags in a tag group, which codewords are used to encrypt information common to a set of consecutive tags. Each codeword is a 24-ary (15, 11) Reed-Solomon code. Thus any four adjacent tags together encrypt up to 176 bits of information that is common to a set of consecutive tags.

The layout of four complete codewords, distributed over four adjacent tags in a tag group, is shown in FIG. The order of the four tags of the tag group of FIG. 13 is the order of the four tags of FIG. 9.

14 shows the layout of a complete tag group.

[Lead-solomon encryption]

[Local codeword]

The local codeword is encrypted using a perforated 24-ary (13, 7) Reed-Solomon code. The code encrypts 28 data bits (ie seven symbols) and 24 redundant bits (ie six symbols) in each codeword. Its error-detection is six symbols. Its error-correction is three symbols.

As shown in Fig. 15, the codeword coordinates are shown in counting order, and the data bit ordering follows the codeword bit ordering.

The code is a 24-ary (15, 7) Reed-Solomon code with two overlapping coordinates removed. Removed coordinates are the most important overlapping coordinates.

The code has the following raw polynomial:

(Equation 1)

The code has the following polynomial:

(Equation 2)

[Distributed Codewords]

Distributed codewords are encrypted using 24-ary (15, 11) Reed-Solomon codes. The code encrypts 44 data bits (ie 11 symbols) and 16 redundant bits (ie 4 symbols) in each codeword. Its error-detection is four symbols. Its error-correction is two symbols.

Codeword coordinates are indexed in counting order, and the data bit ordering follows the codeword bit ordering.

The code has the same basic polynomial as the local codeword code.

The code has the following generator polynomials:

(Equation 3)

[Tag coordinate space]

The tag coordinate space has two orthogonal axes labeled by x and y, respectively. When the positive x axis points to the right, the positive y points down.

Surface coding neither specifies the location of tag coordinate space origin on a particular tagged surface, nor does it specify the direction of the tag coordinate space relative to that surface. This information is application-specific. For example, if the tagged surface is a piece of paper, the application of printing the tags on that paper will record a substantial offset and orientation, which will be used to normalize any digital ink captured subsequently to the surface. Can be.

The encrypted location in the tag is defined in units of tags. By convention, the location is considered to be the center location of the target closest to its origin.

Tag Information Content

[Field Definition]

Table 1 defines the information fields inserted in surface coding. Table 2 defines how these fields map codewords.

Table 1. Field definitions

field Width (bits) Explanation Per tag X coordinate 9 or 13 The unsigned x coordinate of the tag allows maximum coordinate values of about 0.9 m and 14 m, respectively. Y coordinate 9 or 13 The unsigned y coordinate of the tag has a maximum of approximately 0.9 m and 14 m, respectively. Coordinate values  Allow. Active area Flag  ( flag ) One b'1 '  Indicates whether the region immediately surrounding the tag (the diameter of the region on the tag is nominally five times the diagonal size of the tag) crosses the active region. Data fragment Flag One The flag indicates the presence of a data fragment (see next field). b'1 ' indicates the presence of a data fragment. If there is a data fragment, the width is 9 in the x and y coordinates. In the absence, the width is 13. Data fragment 0 or 8 Fragment of inserted data flow. tag Per group (In other words, Per area ) Encryption format 8 Format of encryption 0: Current encryption. Other values are reserved. domain Flag 8 Flag that controls interpretation of region data 0: Region ID is EPC 1: Region has signature 2: Region has embedded data 3: Inserted data is signature Other bits are reserved and must be 0 Tag size ID 8 The size of the tag ID 0: 12 tags per the current size, 1600 dpi, macro nine dots per dot, and tags Macro dot the tags based on the nominal size is 1.7145 mm, other values are being retained. area ID 96 In the area containing the tags ID . signature 36 Signature of the zone. High order  Coordinate width ( w ) 4 The x and y coordinates of the tag High order  Width of the part. High order  x coordinate 0 to 15 The x coordinate of the tag High order  Part of the maximum coordinates is approximately 2.4 km  And 38 km To increase. High order  y coordinate 0 to 15 The y coordinate of the tag High order  Part of the maximum coordinates is approximately 2.4 km  And 38 km To increase. CRC 16 Of tag group data CRC .

The active area is in the area where any captured input must be immediately forwarded to the corresponding hyperlabel server for interpretation. It also allows the hyperlabel server to inform the user that the input has an immediate effect. Because the server has access to correct region definitions, any active region representation in surface coding can be inaccurate as long as it is included.

The width of the high order coordinate field, if zero, reduces the width of the signature field by the corresponding number of bits. Full coordinates are calculated by adding a high order coordinate field to its corresponding coordinate field.

Table 2. Codewords for Fields Mapping

Codeword Codeword bits field width Field bits A 12: 0 x coordinate 13 all 12: 9 Data fragment 4 3: 0 25:13 y coordinate 13 all 25:22 Data fragment 4 7: 4 26 Active area Flag One all 27 Data fragment Flag One all B 7: 0 Encryption format 8 all 15: 8 area Flags 8 all 23:16 Tag size ID 8 all 39:24 CRC 16 all 43:40 High order  Coordinate width (w) 4 3: 0 C 35: 0 signature 36 all (35-w): (36-2w) High order  x coordinate w all 35: (36-w) High order y coordinate w all 43:36 area ID 8 7: 0 D 43: 0 area ID 44 51: 8 E 43: 0 area ID 44 95:52

 [Embedded Data]

If the flag of "when the region has inserted data" is set in the region flag, the surface coding includes the inserted data. The data is encrypted within the data fragments of multiple consecutive tags and replicated many times during surface coding until fitted.

The inserted data is encrypted in such a way that an arbitrary and partial scan of the surface coding including the inserted data may be sufficient to recover the entire data. The scanning system rearranges the data from the recovered fragments and reports to the user when enough fragments have been recovered without error.

As shown in Table 3, a 200 bit data block encrypts 160 bits of data. Block data is encrypted in data fragments of a contiguous group of 25 tags arranged in a 5x5 square. One tag belongs to a block whose integer coordinates are the coordinates of the tag divided by five. Within each block, the data is arranged into tags with increasing x coordinates within increasing y coordinates.

The data fragment may be missing from the block where the active area map exists. However, missing data fragments are easy to recover from another copy of the block.

Data of any size is encrypted into a superblock consisting of a contiguous set of blocks arranged in a rectangle. The size of the superblock is encrypted in each block. A block belongs to a superblock whose integer coordinates are the coordinates of the block divided by the superblock size. Within each superblock, the data is arranged in blocks with increasing x coordinates within increasing y coordinates.

The superblock is replicated many times during surface coding until fitted, including portions along the edges of the surface coding.

Data encrypted within a superblock may include more accurate types of information, more accurate sized information, and wider error detection and / or correction data.

Table 3. Inserted data blocks

field width Explanation Data type 8 Type of data in the superblock. Values include the following: 0: The type is controlled by region flags . 1: MIME other values are TBA. Superblock width 8 In blocks, the width of the superblock Superblock height 8 In blocks, the height of the superblock. data 160 Block data. CRC 16 Of block data CRC . sum 200

It will be appreciated that any form of embedded data may be used, which includes, for example, text, image, audio and video data, such as product information, application data, contact data, business card data and directory.

[Zone signatures]

If the flag "Zone has signature" is set in the zone flags, the signature field contains a signature up to 36 bits wide. The signature is typically any number associated with the zone ID in the security database. The signature is ideally generated using a truly arbitrary process, such as a quantum process, or by extracting disorder from any cases.

In an online environment, the signature can be verified, along with the zone ID, by asking a server that can access the secure database.

If one of the region flags, "region has inserted data" and "inserted data is signature," is set, the surface coding includes a 160 bit cryptographic signature of the zone ID. The signature is encrypted within a one-block superblock.

In an online environment, any number of signature fragments can be used in conjunction with a zone ID and optionally any signature to verify the signature by asking a server that knows the full signature or corresponding private key.

In an offline (or online) environment, the entire signature can be recovered by reading multiple tags and then verified using the corresponding public key.

Signature verification is discussed in more detail below.

[MIME data]

If the inserted data type is "MIME", the superblock is RFC 2045 (Freed, N., and N. Borenstein, "Multipurpose Internet Mail Extensions (MIME) Part one: Format of Internet Message Bodies", RFC 2045, 1996, Multipurpose Internet electronics according to RFC 2046 (Freed, N., and N. Borenstein, "Multipurpose Internet Mail Extensions (MIME)-Part Two: Media Types", RFC 2046, 1996, November) and related RFCs. Contains mail (Multipurpose Internet Mail Extensions (MIME)). MIME data consists of a body followed by a header. The header is encrypted as a variable length string preceded by an 8 bit string length. The body is encoded as a variable length type-specific octet flow preceded by a 16 bit size in a big-endian manner.

The basic top-level media types described in RFC 2046 include text, pictures, audio, video, and applications.

RFC 2425 (Howes, T., M. Smith and F. Dawson, "A MIME Content-Type for Directory Information", RFC 2045, 1998, September) and RFC 2426 (Dawson, F., and T. Howes, " vCard MIME Directory Profile ", RFC 2046, 1998, September) describes character subtypes for directory information, which are suitable for encrypting contact information that may be represented, for example, on a business card.

[Considerations in Encoding and Printing]

Print engine controller (PEC) (09 / 575,108; 10 / 727,162 09 / 575,110; 09 / 607,985; 6,398,332; 6,394,573; 6,622,923) is a subject of many ongoing US patent applications, even though multiple codewords Encryption of two fixed (per page) 24-ary (15,7) Reed-Solomon codewords and four variability (per tag) of 24-ary (15,7) Reed-Solomon codewords It supports encryption.

In addition, PEC supports the rendering of tags through rectangular unit cells whose layout is constant (per page) but whose variable codeword data can vary from one unit cell to the next, and PEC pages It does not allow unit cells to overlap in the direction of movement.

A unit cell that can be used in a PEC includes a single tag group consisting of four tags. A tag group includes four unique B codewords and a unique A codeword that is unique to that tag group but is replicated four times within that tag group. They can be encrypted using five of the six supported variable codewords of the PEC. The tag group also includes eight fixed C and D codewords. One of these may be encoded using the remaining one of the variable codewords of the PEC, two or more may be encoded using the two fixed codewords of the PEC, and the remaining five are encrypted and provided to the PEC. Pre-rendered to Tag Format Structure (TFS).

PEC adds a limit of 32 unique bit addresses per TFS column. The contents of the unit cell are related to this limitation. PEC also imposes a 384 limit on the width of the TFS. The contents of the unit cell are related to this limitation.

Note that for a reasonable page size, if the number of variability coordinate bits in the A codeword is correct, encryption through a lookup table is facilitated. Encryption of B codewords via a lookup table may also be possible. Note that because Reed-Solomon code is systematic, only duplicate data needs to be represented in the lookup table.

Imaging and Decoding Considerations

The minimum imaging clock required to ensure acquisition of the full tag has a diameter of 39.6, i.e.

, Allowing any alignment between surface coding and field of view. If the macrodot spacing is 143m, this gives the required 5.7mm field of view.

Table 4 provides a pitch range that can achieve this surface coding for different sampling rates, with the image sensor assumed to be 128 pixels.

Table 4

Pitch range that can achieve current surface coding for different sampling rates, calculated using Optimize Hyperlabel Optics; Dot pitch = 1600 dpi, macrodot pitch = 9 dots, line of sight = 30mm, nib to FOV separation = 1mm, image sensor size = 128 pixels

 Sampling rate Pitch range 2 -40 to +49 2.5 -27 to +36 3 -10 to +18

For the surface coding, the decoding order is as follows:

● Sikkim location of the target of the complete tag

● reasoning from the perspective transformation targets

● sampling the circulating code location

● Decode cyclic location code

● determine the direction of circulation from the location code

● local Reed-Solomon codeword, and decoding the sampled

● determining the xy location of the tag

● infer the 3D deformation tag from the direction set targets

● determine the nip xy xy location from the location tag, and 3D transformations

● determine the active area status of the nip location by referring to the active area map

Generate local feedback based on the active region ● nip state

● Determine tag type

● The lead distribution-sampling Solomon code words (see the tag type and, modulo window alignment (modulo window alignment))

● distribution of the Reed-Solomon decoding of code words

● Check tag group data CRC

• Flag the bad zone ID sample in case of decryption error.

● Determine the type of luxury and wealth, the refusal of the encoded image

● Determine area flags

● Area ID, the nip xy-location, encoding the nip active area status in digital ink

Based on the area flag ● sending digital ink

Zone ID decoding need not occur at the same rate as location decoding, and if the codeword is found to be equal to a known good codeword, decoding of the codeword can be avoided.

If the higher order coordinate width is nonzero, special care is needed on the boundary between tags where the lower order x or y coordinates overlap, otherwise codeword errors can be introduced. If overlap is detected from a lower order x or y coordinate (ie, it contains only all zero bits or all one bit), the corresponding higher order coordinates may be adjusted before codeword decoding. When there is no true symbolic error in higher order coordinates, this will prevent the unintended introduction of codeword errors.

[Alternative tag array]

It will be appreciated that a range of different tag layouts and tag structures may be used.

For example, the tag group shown in FIG. 9 may be replaced with the tag group shown in FIG. 16, in which the tags do not rotate with respect to each other. Figure 17 shows an arrangement using six-fold rotational symmetry at the physical level, with each diamond shape representing a separate symbol. Figure 18 shows a version of a tag, where the tag expands by adding additional band symbols near its interface to increase its data capacity.

The use of these alternative tag structures, including the consideration of related encryption, is described and described in more detail in co-pending patent application numbers [HYG, list of numbers for HYT cases to be included herein]. Is incorporated herein by reference.

[Security discussion]

As described above, the authentication depends on confirming the match between the data and the signature of the data. The more difficult it is to forge a signature, the greater the trustworthiness of the signature-based certificate.

The item ID is unique, thus providing the basis for the signature. In the case of an online authentication access, the signature may be a simple random number associated with the item ID in the authentication database accessible to the trusted online authenticator. The random number can be generated by any suitable method, such as via a deterministic (pseudo-random) algorithm or through a speculative physical process. Keyed hashes or encrypted hashes may be desirable for random numbers because they do not require additional space in the authentication database. However, any signature of the same length as the locked signature is more secure than the locked signature because this method is not sensitive to key attacks. Similarly, shorter random signatures provide the same security as longer locked signatures.

In a limited case, since a simple presence of the item ID in the database indicates authenticity, substantially no signature is required. However, the use of the signature restricts the forger from forging the items he actually saw.

To prevent forgery of signatures for invisible IDs, signatures must be large enough to provide a thorough search through repeated access to unwieldy online authenticators.

If the signature is rather made using a key, the length of the signature must be large enough to prevent counterfeiters from extracting the key from known pairs of ID signatures.

Hundreds of bits of signatures are considered secure, whether created with private or secret keys.

It may be practical to include a reasonably secure random signature in a tag (or a local tag group), but including a secure ID derived signature in a label is particularly useful if the length of the ID is reduced to provide more space for the signature. It may not be feasible.

In order to maintain a signature derived from a secure ID, a fragment of the signature can be distributed across multiple labels. If each fragment can be identified as isolated against the ID, the goal of maintaining authentication can be achieved without increasing the sensor clock.

The security of the signature may be derived from the full length of the signature rather than from the length of the signature fragment. This is because the counterfeiter cannot predict which part of the signature the user will randomly choose to prove.

Trusted authenticators can always perform fragment verification because they have access to keys and / or fully stored signatures, so fragment verification is always possible when online access is available to trusted authenticators.

Fragment identification requires us to prevent brute force attacks against some individual fragments, or forgers can alternately attack each fragment to determine the complete signature.

Brute force attacks can be prevented by manipulating per-ID based authenticators. However, if the fragments are short, they require considerable control. As an alternative to authenticator control, the authenticator may enforce a restriction on the number of confirmation requests that are willing to answer a given number of fragments. Although the limit is very small, a normal user cannot consume it for a given number of fragments. Because there can be many fragments available, the actual fragments selected by the user are also variable. Moreover, one limitation may be substantial. More generally, the limit should be proportional to the size of the fragment, i.e. the fewer fragments, the smaller the limit should be. Thus, the user's experience may be somewhat variable in fragment size.

 Control and enforcement of fragment verification restrictions, both imply a continuum of requirements for authenticators. Enforcing fragment verification restrictions require more authenticators to maintain a per fragment count of satisfied verification requirements.

A brute force attack can also be prevented by concatenating fragments with random signatures encoded in a tag. Although random signatures can be thought of as protection of fragments, fragments can also be considered to be so by simply increasing the length of the random signature, thus increasing security.

Fragment identification can be further obtained by simultaneously requiring the confirmation of minimal fragments.

Fragment identification requires fragment identification. Fragments can be explicitly counted, or more economically identified by the module, which is a repetition of the signature across the successive tiling of the two-dimensional coordinate tag of their tag.

The limited length of the ID itself introduces another vulnerability. Ideally it should be at least a few hundred bits. 96-bit or less in a Netpage surface coding scheme. To overcome this, the ID may be padded. To do this effectively, the padding must be variable, ie it must change from one ID to the next. Ideally, padding is simply a random number and should be stored in the authentication database indicated by the ID. If padding is deterministic from the ID, it is useless.

Offline authentication of a secret key signature requires the use of a trusted offline authentication device. The QA chip (09 / 112,763; 09 / 112,762; 09 / 112,737; 09 / 112,761; 09 / 113,223, which is the subject of a number of pending US patent applications) is of limited capacity but provides the basis for such an apparatus. . The QA chip can be programmed to verify the signature using a secret key securely held in the chip's internal memory. However, in this scenario, maintaining per-ID-padding is not practical, and even maintaining more than a few secret keys is not practical. Moreover, QA chips programmed in this way are susceptible to selected message attacks. These limitations limit the applicability of QA-chip based reliable offline authenticators for niche applications.

In general, despite the patented security of any particular trusted offline authentication device, creators of secure items can reluctantly delegate their secret signing keys for such devices, which in turn can be used for niche applications. It is possible to limit the applicability of the devices.

In contrast, offline authentication of a public key signature is highly practical (ie, generated using corresponding private keys). An offline authentication device using public keys can obviously maintain some number of public keys and set the number of additional public keys required via a temporary online connection when encountering an identity that it knows does not have a corresponding public key. . Untrusted offline authentication can be attractive to most solid item creators because they can maintain exclusive control of their personal signature keys.

The disadvantage of off-line authentication of public key signatures is that a complete signature must be obtained from coding that interferes with our desire to maintain a certificate with minimal clock. The equivalent of offline authentication of public key signatures is that access to ID padding can be decrypted using a public key generated from both ID and ID padding, and padding can then be ignored. It is no longer necessary. Counterfeiters cannot take advantage of the fact that padding is ignored during offline authentication. This is because padding is not ignored during online authentication.

Obtaining a fully distributed signature is not particularly cumbersome. Enables to quickly obtain all of the pieces of any random or linear reinforcement signature of the portable sensor across the coded surface.

The sensing device is easily programmable to obtain a complete set of fragments and to signal the user upon completion of authentication. The scanning lazer can also easily get all the fragments of the signature. Both types of devices can be programmed to only perform authentication when the label indicates the presence of a signature.

It should be noted that the public key signature can be authenticated online through any of the fragments of the public key, either randomly or using a secret key or in the same way as any signature. Trusted online authenticators can use private keys and ID padding to generate signatures on demand or explicitly store the signatures in a database for authentication. The latter approach eliminates the need to store ID padding.

Signature-based certificates can be used in place of fragment-based certificates, even when online access is available for trusted certificates.

Table 5 provides a summary that the signature scheme is viable when considering the contents in the above table.

Table 5. Summary of Actionable Signature Plans

 Encoding in Tags  Acquisition from Tags  Generate signature  Online certification  Offline authentication local  all Random  ok Unrealistic to store per ID information Secret key  Signature too short to be safe  Undesirable for storing secret keys Private key Signature too short to be safe Allocation Fragment (s)  Random ok impractical ^b  Secret key ok impractical ^c  Private key ok impractical ^b all  Random ok impractical ^b  Secret key ok impractical ^c  Private key ok ok

[Security statement]

19 shows an example item signature target model. The item has an ID (X) and other details (not shown). Optionally has a secret signature (Z) It also optionally has a public key signature. The public key signature clearly records the signature (s) and / or the padding (P) used with the ID to create the signature.

The public key signature has a federated private key pair (K, L). The key pair is combined with one or more zones of item IDs.

Typically, issuers of security documents and constraints may use a zone of IDs to identify a range of documents and the like. Accordingly, the issuer will use these details to generate each IDs for each item or document to be specified.

The authentication of the product detects the label data encoded in the label and thus can be carried out online or offline, and depending on the situation, authentication is carried out using a number of different mechanisms.

Examples of the processes involved will now be described for the decryption key and private key encoding, respectively.

[Certification based on public key signature]

Equipment per ID Zone:

● Create a signature key pair (K.L), which is a key pair for decryption,

● Stores key pair (K.L) indicated by ID range

Settings per ID:

● Create ID padding (P),

Recover the private key (L) by ID (X),

`● Generate a signature by encoding ID (x) and create padding (p) using private key (L): S ← E _L (XP)

Storing the signature (S) in the database indicated by ID (X) (and / or storing padding (P))

Encoding ID (X) in all tag groups,

• Sign signature (s) across multiple labels in a repeated manner.

Authentication based on online fragments (users):

Get ID (x) from tags.

Get the location (x, y) _i and the signature fragment (T _i ) from the tag.

Generate fragment number (i) from location (x, y) _i :

i ← F [(x, y) _i ]

Examine a trusted authenticator by ID (x).

Send the ID (x), fragment (S _i ) and fragment number (i) to the trusted authenticator.

Authentication based on online fragments (trusted authenticators):

Receive the ID (x), fragment (S _i ) and fragment number (i) from the user.

Recovers the signature (S) from the database by ID (x) (or regenerates the signature);

● compared with the received fragment (S _i) corresponding to a fragment of the signature (S _i), and

● Report the authentication result to the user.

Authentication based on offline signature (user):

Get the ID from the tags (X).

Get the location (x, y) _i and the signature fragment (T _i ) from the tag.

Create fragments (i) from location (x, y) _i :

i ← F [(x, y) _i ]

S ← S ₀ | S ₁ | .... | S _{n -1}

Generate (n) signature (S) from fragments,

Retrieve the public signing key (K) by ID (X),

Decrypt the signature (S) using the public signature key (K) to obtain the ID (X ') and padding (P');

X '| P' ← D _K (S)

● Compare the obtained ID (X) with the decrypted ID (X ')

● Report the authentication result to the user.

Authentication based on secret key signature

Settings per ID:

● create a secret (Z),

Store the secret (Z) in the database indicated by the ID (X)

Encode ID (X) or secret (Z) in all tag groups.

Authentication based on online secret (user):

Get the ID (X) from the tags,

Get the secret (Z ') from the tags,

● examine the authenticators trusted by the identity,

● Send ID (X) and Secret (Z ') to trusted authenticators

Authentication based on online secret (trusted certifier):

● Receive ID (X) and Secret (Z ') from user

Retrieve the secret (Z) from the database by ID (x).

● Compare received secret (Z ') with secret (Z)

● Report the authentication result to the user

As described above, secret based authentication can be used with fragment based authentication.

[Cryptography Algorithms]

When the public key signature is authenticated offline, the user's authenticator typically does not have access to the padding used when the signature was originally created. Therefore, the signature verification step must decrypt the signature so that the authentication device can compare the ID obtained from the tags with the ID in the signature. It is a standard digital signature algorithm, US Department of Commerce / National Institute of Standards and Technology,

Decrypting signatures such as the Digital Signature Standard (DSS), FLPs 186-2, January 27, 2000, disables the use of algorithms that do not implement the signature verification step.

RSA coding is described below:

Rivert, R.L., A, shamir, and L, Adleman, "A Method for Obtaining Digital Signitures and Public-Key Cryptosystems", Communications of the ACM,

Vol. 21, No. 2, February 1978, pp. 120-126

Rivert, R.L., A, shamir, and L, Adleman, "Cryptographic communications system and method", U.S. Patent 4,405,829, issued 20 September 1983

RSA Laboratories, PKCS # 1 v2.0: RSA Encryption Standard, October 1, 1998

RSA provides a suitable public key digital signature algorithm to decrypt the signature. RSA is the National Institute of Standards and Technology, ANSI x9.31-1998 Digital signatures using reversible public key cryptograplry for the financial services industry (DSA)

Provides a basis for the ANSI x 9.31 digital signature standard for September 8, 1998. If no padding is used, any public key signing algorithm can be used.

In hyperlabel surface coding schemes, the ID is about 96 bits long or less. Padded to 160 bits before signing.

Padding is ideally generated using precisely randomized processes, such as quantum processes [14.15], or by extracting disorder from random events of Schneider, B., Applied Cryptography, Second Edition, John Wiley & sons 1996 ,.

In the hyperlabel surface coding scheme, the random signature, or secret, is 36 bits long or shorter. It is also ideally made using precisely randomized processes.

[Security Tagging and Tracking]

Money, checks and other monetary documents can be tagged to detect forgery and counter money laundering activities. Currency labeled with a hyperlabel can be identified and tracked through the monetary system. Hyperlabeled products, such as pharmaceuticals, can be tracked to items through distribution and retail systems.

Although numerous examples of hyperlabel security tagging and tracking concepts are specifically mentioned for banknotes and constraints, however, hyperlabel tagging secures other products, such as traveler's checks, deposits, passports, chemicals, etc., for example. It can be used evenly to attach and track the tracking device.

In conjunction with the Netpage system, hyperlabel tagging provides a mechanism for securely identifying and tracking objects. Hyperlabel tags on the object's surface uniquely identify the object. Each hyperlabel tag contains information that includes the subject's unique ID and the location of the label on the hyperlabeled surface. The hyperlabel tag also includes a signature fragment that can be used to authenticate the subject.

The scanning laser or image sensor may read the tag on any part of the object to identify the object, identify the object, and allow tracking of the object.

[Pharmata Tagging]

An example of the protection of constraints can now be described with reference to the specific protection of money, such as banknotes, but it will be understood that the techniques can be applied to any security document.

Hyperlabel tags may be printed over the entire surface of the pharmaceutical packaging or only on a smaller area of the packaging.

The hyperlabel pharmaceutical label includes the product ID of the item and a serial number to uniquely identify the individual item. The product ID identifies the National Drug Code (NDC) number of the item. The NDC number is assigned and controlled by the Food and Drug Administration (FDA) for drugs and drug-related items, and identifies the product and manufacturer.

Alternatively, the label may include an EAN code (European International Article Nunchering), or other product ID code such as EPC.

In this example, each hexagonal hyperlabel currency tag is about 2.5 mm in diameter and contains various data in the form of printed dots of infrared ink. Examples of labels included on pharmaceutical packaging are described in FIG. 20.

The label may include the following;

Alignment marks (there are larger dots in the image)

● Code indicating that this label is a pharmaceutical label as opposed to another commercial hyperlabel or hyperlabel tag.

A horizontal location code specifying that the tag is with packaging,

A vertical location code specifying that the tag is across packaging,

● signing the password notation,

Error detection and correction bits

Each tag is unique. That is, all tags must be printed on some packaging or other document, and no two tags are ever identical to each other. The tags are designed to be easily read by low cost scanners that can be assembled into various identification devices.

The constraint ID can be read by the scanner and used to examine the details of the lot number of the item and the expiration date. Alternatively, the lot number and expiration date may be included in the constraint label to allow offline retrieval of this information by some scanner. Pharmaceutical ID can also be used to access details such as dosage and administration information, drug interactions, precautions, contraindications, product warnings, recall information, and place of manufacture.

Hyperlabel call labels can be read by a hyperlabel scanner. These scanners can be incorporated into various devices to facilitate authentication and tracking, which will be described in more detail below.

[Tracking]

For tracking and item identification, the manufacturer, or other central authority, maintains a database that tracks the location and status of all items.

Each time a constraint is scanned, its location is recorded. This location information can be collected into a central database to enable analysis and identification of abnormal product movements and detection of counterfeit pharmaceuticals.

This allows real-time detection of the location of stolen or counterfeit constraints in numerous locations in the supply chain or distribution and real-time detection of the location of forged constraints for criminal activity and highly accurate intelligence of criminal activity. For example, in the case of a sophisticated counterfeit in which hyperlabel dot patterns are exactly duplicated, there may be multiple copies of constraints that are accurately forged (at least genuine and counterfeit). If multiple identical constraints appear in different places at the same time, all but one of the constraints must be counterfeit. After that, everything can be treated as suspicious.

Thus, when a business process contains constraints and implements them, the general process is as follows;

● The business is approved

● calls are provided in respect of business processes,

Constraints are scanned using a suitable sensing device,

● The sensing device detects at least one tag and produces predetermined data.

Predetermined data is moved to the central government database.

In this regard, the next predetermined data is automatically sent from the scanners to the central government currency database;

● Unique identifier for the constraint

● Nature of constraint item

● Confirmation data

● Serial number of the scanner

● Time and date of scan

The physical location of the scanner at the time of scanning (this is automatic for fixed scanners, and for mobile scanners the physical location is determined using the GPS tracker)

● Network location of the scanner

● The identity of the person who did the reportable business

Thus, hyperlabel technology enables the construction of a database containing a history of all the constraint items produced, and their tracking through distribution and use to consumers. The collected data can be used to construct a process based on the confirmation data received, the presence of which will provide a powerful means for law enforcement agencies to combat pharmaceutical counterfeiting.

This includes a large number of business processes, hundreds of millions per day. These are within the possibilities of conventional distributed business process systems. However, the hyperlabel communication system can be implemented at substantially low cost because it uses a new generation database system that performs business processing in the semiconductor memory instead of the disk drive. These processes can flow continuously to disk as background “back up” tasks. These systems will be mature enough when hyperlabel-based call tracking systems go online where they can be a viable option.

Like the basic tracking and identification functions, the database system can have the following additional features:

● Display of unusual constraint movement patterns within the system

● Preparation of Demand for Pharmaceutical Items

Data mining features that can be used to detect and prosecute counterfeiters

Neural networks based on fraud detection;

● Identify geographic trends

The central database maintains up-to-date information about the explicit subject IDs, the subject ID hotlist (all suspect subject IDs), and the list of public keys corresponding to the subject IDs. The central server also maintains a subject scanning history for tracking the movement of the subjects. Each time, the subject is scanned and the location where the subject's time stamp was taken is recorded. If known, details of the subject owner may also be recorded. This information may be known, especially for large business transactions. Such object scanning history data can be used to detect illegal product movement, such as illegal import of pharmaceuticals, for example. It can also be used to detect abnormal or suspicious product movements that may indicate product forgery.

If the subject is known to be stolen, it can be added directly to the subject's ID hotlist on a central server. This hotlist will be automatically distributed (or accessible) to all online scanners and downloaded to all offline scanners on their next up-to-date information. Theft stolen in this way is automatically and quickly spread to the majority of retailers. Similarly, if a subject wins in some other way, it can be added to a hotlist, so its situation inspires the person scanning the subject.

The on-line scanner instantaneously accesses the central server to allow checking of each target ID at the time of scanning. The object scanning history is also updated to the central server at the time the object is scanned.

The offline scanner internally stores the object state data so that the scanned object can be identified. Target status data includes the identified ID range list, target ID hotlist, public key list and target scanning history. Each time a subject is scanned, details are recorded in the subject scanning history. The object status data is downloaded from the central server, the object scanning history is uploaded to the central server, and the scanner is connected each time.

The location of the mobile scanner may be provided to the application by the scanner if it has become a GPS device. Alternatively the location of the scanner may be provided by the network through which it communicates.

For example, if the portable scanner uses a mobile telephone network, the location of the scanner may be provided by the mobile telephone network provider. There are a number of location technologies available. One is the Assisted Global Positioning System (A-GPS). This requires a GPS-equipped handset to receive location selection signals from GPS satellites. The telephone network can know the approximate location of the handset from the nearest cell site. Based on this, the network delivers to the handset, which is GPS satellites, for use within its location estimate.

Another technology that does not require a GPS-equipped device is uplink time difference of arrival (U-TDOA). It uses a form of triangulation to determine the location of the wireless handset by comparing the time it takes the signal from the wireless handset to reach some LMUs (Location Measurement units) installed on the network's websites. The handset location is then calculated based on the difference in time of arrival of the three (or more) signals.

[certification]

Each subject ID has a signature. Since the limited space within the hyperlabel tag structure is not practical to include a complete cryptographic signature within the label, the signature fragments are distributed across multiple labels.

Smaller random signatures, or secrets (signatures) may be included in the label.

To avoid any vulnerability due to the limited length of the target ID, the target ID is padded and ideally padded with a random number. The padding is stored in the authentication database indicated by the subject ID. The authentication database can be coordinated by the manufacturer or by a third party certifier.

Each hyperlabel tag contains a signature fragment, and each fragment (or subset of fragments can be authenticated at separation, relative to the object ID.) The security of the signature is still from the length of the fragment. Rather, it derives from the full length of the signature, because the forger cannot predict which fragment of the signature the user will randomly choose to prove.

Some fragment verification requires fragment identification. Fragments can be computed explicitly or can be identified by a two-dimensional coordinate of their label, a recursive module of signature across the continuous tiling of the label.

Note that trusted authenticators can always perform fragment identification, so fragment identification is always possible when online access is available to a trusted authenticator.

[Establishment of Authentication Database]

The new range of IDs requires some setup work to establish the authentication database before deploying.

For each range of IDs, a public key-private key pair is created, which is stored in the authentication database indicated by the ID range.

For each target ID in range, the following setup is required:

● Create an ID padding, store it in the authentication database indicated by the target ID,

● Retrieve the private key by subject ID,

● Use your private key to encrypt the destination ID and padding to create a signature,

Store the signature in the certificate database indicated by the subject ID and / or save the padding since the signature can be played back using ID padding and private key

Encode the signature across multiple labels in a repeated way.

Since this data is needed for hyperlabel tags, an authentication database must be established before or at the time of printing the hyperlabel.

Points to note about security are discussed in more detail above.

Figure 21 summarizes the printing and distribution of hyperlabel tags and pharmaceutical packaging.

Constraints are logged in the database each time they are scanned in circulation and even when they are broken. (I / O data is recorded.)

While techniques for printing commercial hyperlabel tags are commercially available, only authorized manufacturers can print codes corresponding to their products. These codes can be protected by 2048-bit RSA cipher text embedded in integrated circuits (chips) embedded in the Memjet ™ printer used to print hyperlabel tags. This is a highly secure form of asymmetric cryptography that uses private and public keys. Private keys associated with any particular call can only be kept by authorized National Sheriff's Offices.

[Authentication based on offline public key]

The offline authentication device uses a public key signature. The authentication device holds a plurality of public keys. The device may optionally retrieve additional public keys via a temporary online connection when encountering a subject ID that does not have a corresponding public key signature.

For offline authentication, full signature is required. The authenticator is swiped beyond the hyperlabeled surface and a number of labels are read. From this, the object ID is obtained with a number of signature fragments and their locations. The signature is then generated from these signature fragments. The public key is retrieved from the scanning device using the target ID. The signature is then decrypted using the public key to provide the destination ID and padding. If the object ID is obtained from signature partners, the object ID in the hyperlabel tag is considered true.

The offline authentication method can be used online with a trusted authenticator acting as an authenticator.

[Authentication Based on Online Public Key]

The online authentication device uses a trusted authenticator to confirm the subject's authentication. For online authentication, a single tag can be everything you need to perform authentication. The authentication device scans the subject and obtains one or more tags. From this, the subject ID is obtained with the location of at least one signature fragment and fragment. The number of fragments is made from the fragment location. The authenticator with proper trust is found by the subject ID. The destination ID, signature fragment, and fragment number are sent to the trusted authenticator.

The trusted authenticator receives the data and retrieves the signature from the authentication database by the subject ID. By comparing this signature with the supplied fragment, the authentication result is reported to the user.

[Authentication based on online secret]

Alternatively or additionally, if a random signature or secret is included in each tag (or in a tag group), this can be proved by reference to a copy of the secret that is accessible to the trusted authenticator. The database setup involves storing it in an authentication database, indicated by the secret ID and subject ID for each subject.

The authentication device scans the subject and obtains one or more tags. From this, the target ID is obtained similarly to the secret. The authenticator with proper trust is found by the subject ID. The subject ID and secret are sent to a trusted authenticator.

The trusted authenticator receives the data and retrieves the secret from the authentication database by the subject ID. This secret is compared with the one supplied and the authentication result is reported to the user.

Secret-based authentication can be used with online fragment-based authentication, which is discussed in more detail above.

[Product scanning interaction]

Product scanning at a retail store is illustrated in FIG. 22. When the store operator scans the product with the hyperlabel tag, the tag data is sent to the service terminal A. FIG. The service terminal sends the work processing data to the storage server (B). The storage server sends this data along with the retailer details to the manufacturer server (C). The hyperlabel server knows which manufacturer server to send the message from the target ID. Upon receiving input, the manufacturer server authenticates the subject if the manufacturer is a trusted authenticator. Alternatively, the manufacturer server passes the data to the authentication server to verify the object ID and signature (D).

The authentication server sends the authentication result back to the manufacturer server (E). The manufacturer server checks the status of the subject ID and sends a response back to the store server F, which in turn sends the results back to store service terminal G (for a list of the subject's authentic IDs and hotlist). The store server may communicate directly with the associated authentication server.

Interaction details for online product scanning at a retail store are described in FIG. 23. The store operator scans the hyperlabeled product.

The scanner sends the scanner ID and label data to the service terminal. The service terminal sends this data along with the terminal ID and scanner location to the store server. The store server then sends a request to the manufacturer server that performs the authentication (either on its own or through a third-party authentication server) and determines the target status. The response then returns to the store server and continues to be sent to the operational service terminal.

Interaction details for offline product scanning at a retail store are described in FIG. 24. The store operator scans the hyperlabeled product.

The scanner sends the scanner ID and tag data from multiple tags to the service terminal. The service terminal sends this data along with the terminal ID and scanner location to the store server. The store server then performs off-line authentication, as described in section 3.4.2, and determines the state of the subject through the subject's hidden hotlist, explicit subject ID list, and public key list.

The store server records the details of the scan in the internal target scanning history. The response is then sent back to the operator service terminal.

An alternative for off-line product scanners arises when the scanner is a portable, standalone scanner. In this case, the hidden authentication data is stored in the scanner itself and the scanner checks internally. The object scanning history is either hidden or in the scanner. Periodically, the scanner connects to the central database, uploads the target scanning history, and downloads the most recent public key list, target ID hotlist, and explicit ID range list.

This connection may be automatic (invisible to the user) or initiated by the user, for example when the scanner is placed in a docking station, charger.

Product scanning with the Netpage pen is illustrated in FIG. 25. When a user processes hyperlabeled items with their NetBeige pen, input is typically sent from the user's netpage pen to the netpage system in the usual (A) manner. To scan the product rather than interact with it, you can put the pen in a special mode. This is typically a one shot approach, which can be initiated by tapping the <Scan> button printed on the netpage. Alternatively, the pen may have a user-operable button when lightly knocked or restrained during a swipe, indicating that the pen is to process the interaction as a product scan rather than as normal interaction. Tell me. Tag data is sent from the pen to your netpage base station.

The netpage base station can be a user's mobile phone or PDA, or some other netpage device, such as a PC. The input is relayed to the hyperlabel server B, and then relayed to the manufacturer server C in the usual manner. Upon receipt of the input, the manufacturer server authenticates the subject if the manufacturer is a trusted authenticator. Alternatively, the manufacturer server passes the data to the authentication server to verify the object ID and signature (D).

The authentication server sends the authentication result back to the manufacturer server (E). The manufacturer server checks the status of the target ID (for valid ID list and hot list) and sends a response to the hyperlabel server (G).

As part of the netpage system, the hyperlabel server can be identified as the user's devices. The hyperlabel server can properly relay the response from the manufacturer server to the user's phone G or web browsing device H. If the user's netpage pen has LEDs, the hyperlabel server can send commands to the user's pen to find the appropriate LEDs (I, J).

Details of the interaction for scanning with the Netpage pen are described in FIG. 26. Click the Netpage pen on the hyperlabeled product. It sends the Netpage pen to PenID and sends the product's tag data and pen's location to the hyperlabel server.

If the pen ID is not already associated with the scanner, the hyperlabel server can create a new scanner record for the pen or use the pen ID as the scanner ID. The hyperlabel server sends the scanner ID, tag data, and scanner location (if known) to a manufacturer server that performs authentication (either itself or a third party authentication server) and determines the status of the subject. Thereafter, the response is sent back to the hyperlabel server and subsequently sent to the user's default web browsing device.

[Security Tagging and Tracking Target Model]

The security tagging and tracking target model contains almost hyperlabel tags, target IDs, and signatures. 37 illustrates the handling and configuration of these objects.

As can be seen from FIG. 27, the hyperlabel tag includes a tag type, an object ID, a two-dimensional location, and a signature fragment. The tag type indicates whether the label is on a conventional object or whether the label is on a particular type of object, such as currency or constraint.

The signature fragment has an optional fragment number that identifies the location of the fragment within the entire signature.

As mentioned above, the unique item ID of a product can be known as a special kind of unique object ID.

Electronic Product Code (EPC) is one of the latest standards for item ID. The item ID typically consists of a product ID and a serial number. The product ID identifies the class of product, while the serial number identifies a particular, e.g., individual product item of that class. The product ID, in turn, typically consists of a manufacturer number and a product classification number. The best known product IDs are EAN, UCC, Universal Product Code (UPC), and variants thereof.

The item ID classification chart is shown in FIG.

Constraints are identified by constraint ID. Typically the constraint ID may be an EPC. The pharmaceutical ID consists of a product ID and a serial number. The product ID, in turn, typically consists of a manufacturer number and a product classification number. The best known product ID for pharmaceuticals is the National Drug Code (NDC), which is assigned and managed by US.FDA.

The constraint ID classification diagram is shown in FIG. Object description ownership and collective classification diagrams are shown in FIG. This is explained in more detail above.

An object scanning history classification chart is shown in FIG.

The object has a history of object scanning and records each time the scanner scans the objects. Each object scanned result shows the scanner ID, the date and time of the scan, the status of the object at the time of the scan and when the object was scanned. Contains the location of the scanner. The state of the subject may be valid, stolen, suspected of forgery, or the like. If known, details of the subject owner can also be recorded.

The scanner has a unique scanner ID, network address, owner information and status (eg online or offline). The scanner may be a mobile scanner with a variable location, or a fixed, known scanner with a known location. It has the current location, including the scanner's location details and a time stamp. The scanner may be a netpage pen if combined with a netpage pen record. If the scanner is offline, the target scanning history can be archived, and the public key list, explicit ID range list, and target ID hotlist can be optionally stored. The scanner classification chart is shown in FIG.

The manufacturer, or other central authority, maintains a number of subject ID hotlists, each with a unique list ID, at which point the list is most recently updated. Each hotlist contains a list of suspect object IDs, including object ID, date, time, status (suspected or stolen, etc.) and other information. The target ID hotlist classification chart is shown in FIG.

The manufacturer or other central authority may note that the explicit object ID range of the explicit ID ranges includes the starting object ID and the endpoint object ID (obvious ID range) and the point in time when the entry was updated. A clear ID range list classification diagram is shown in FIG.

The manufacturer or other central authority maintains a list of public keys. The public key list consists of a number of entries that identify the public key over a range of target IDs. Each explicit object ID range entry includes an update time for the entry, a starting object ID for the range, an endpoint object ID for the range, and a public key applicable to each object ID within the given range. The public key list classification diagram is shown in FIG.

Subject authentication may be performed by the manufacturer or by a third party certifier. The trusted authenticator has the authenticator ID, name and details. Each trusted authenticator has a list of public keys associated with one or more ID ranges. This is a list of public / private key pairs corresponding to target ID ranges (identified by departure and endpoint IDs). The trusted authenticator maintains a list of secret signatures and a list of public key signatures. Each public key signature identifies the actual signature and / or padding used to make the signature. Each secret signature and public key signature is associated by a unique subject and subject ID. A trusted authenticator classification diagram is shown in FIG. 36.

[Scanners]

Hyperlabel scanners can be assembled into a variety of devices. Scanners can be stationary or mobile. The fixed scanner is a permanent and known location. The mobile scanner does not have a fixed location. The scanner may be either online or offline, with direct access to the central database.

The scanners may be specific product application scanners such as monetary calculations. Hyperlabel scanners may be inserted into other multifunction devices such as mobile phones or PDAs, for example.

Hyperlabel call labels can be read using many types, including:

● cash register

● POS inspection

● Mobile phone with built-in scanner

● Hyperlabel Pendle

● Vending machines

The hyperlabel technique used in these devices can be implemented in a wide range of applications. As a result, development and deployment costs can be allocated by key stakeholders. Therefore, it is feasible that they are carried out in a manner similar to those described above with regard to security documents. Hyperlabel scanners assembled with various products will include the following features, which are still under development at Silverbrook Laboratories.

Infrared image sensor for reading hyperlabel tags that uniquely identify each constraint.

• 32-bit RISC processor with 20 megabits of secure code space signed using 2048-bit RSA cryptography.

• Highly secure processor with cryptographic notation and physical security features to identify cryptographic signatures on hyperlabel tags. (Developed by Silverbrook Institute)

● Infrared optics including filter which matched wavelength to hyperlabel ink infrared spectrum

● Real time clock to verify each reported turnaround time

Software to decode hyperlabel tags, record the details of each scan, identify each scanned note, and promote automatic and secure communication with an online database

● Communication system to make secure network connection to central call identification database

Many of the hyperlabel scanners described below are set to include the following units.

• Built-in display and data entry mechanisms to show the operator details such as constraint items that are distributed, items that are suspected of counterfeiting, and the identity of the person requiring reporting transactions.

The hiding place of the serial numbers of all known counterfeit constraints;

● Different spectral filters with wavelengths tailored to safe currency ink (unlike commercially available hyperlabel inks).

GPS tracker to identify the location of the currency counter at the point of use.

[Mobile Phone with Built-in Scanner]

A mobile phone with a built-in hyperlabel infrared scanner to scan and identify each item can be used within a range of locations such as where drugs are stored for dispensing or dispensing. This is intended for the widespread use and distribution of a huge number of mobile subscribers. This can be used by consumers by identifying items, or by quickly finding additional information about prescription items. It can also be used for legally effective inspection applications and inventory control, such as trademark infringement detection or inventory checks.

[Hyperlabel Supermarket Checkout Scanner]

One of the other major applications of hyperlabels is in consumer packaged goods which have the potential to be next-generation barcodes and enable automatic tracking of individual items. The application of hyperlabel laser scanners makes it possible to automatically scan products at the supermarket checkout. These checkouts can make the pharmaceutical hyperlabels readable so that each item can be identified at point of sale. An example of a hyperlabel is shown in FIG. 38, in which the cross ref. any application describing Hyper label checkout].

[Cash register]

Cash registers can have a cumulative or built-in currency scanner for a small extra cost per unit.

Constraints are scanned at processing for sale. An example of a cash register is shown in FIG.

[Hyper Label Pen]

The hyperlabel pen can be used as a compact, low cost image sensor for consumers and small shops. It uses an infrared image sensor and is used to image the hyperlabel tag each time it is clicked against the surface. These pens are intended for high capacity consumer use, with an intended distribution exceeding 100 million units. The primary application of the pen is the use of a wide range of "interactive papers" and computer peripherals, which also allow consumers to identify constraints and other products by clicking on the hyperlabel.

Upon reading by the hyperlabel pen, the hyperlabel allows the pen to track its own nib movement relative to the label. The pen uses the location and orientation of each label within a 5mm field of view to determine a location that is significantly more precise than the exact location coded in the label. The pen sends interaction data to the hyperlabel server for interpretation. The interaction data consists of the kinetic data (or “digital ink”) defined for the product label identified by the EPC, thus allowing consumers to use the product label to interact directly with the manufacturer's website.

 The hyperlabel network can be managed by the provided hyperlabel servers, and any constraint scans from the hyperlabel pens can be sent to the pharmaceutical server through these servers.

 An example of a portable validity scanner is illustrated in FIGS. 2 or 25 and described in more detail in the crossing any application describing validity scanner.

 [Portable Validity Scanner]

Validity scanners of portable hyperlabels may also be used if a call counter is not needed or not suitable. These devices are expected to be more common than currency counters because they have many uses and are quite inexpensive.

Validity scanners have a number of uses, including pharmaceutical security, brand name security, inventory, legal investigation and enforcement. This is because it is not a provided communication device.

Since there is no communication directly with the government call server, the majority of non-call related messages need to be sent through that server. Instead, it communicates directly with commercial hyperlabel servers, so certain call-related valid requirements continue to pass to government servers.

To reduce the processing load on the government server, note related information can be hidden in the hyperlabel server as much as they are hidden in the currency counter.

Connections to databases can typically be relayed beyond radio connections to allow local movement.

 The radio connection, suitably, WiFi, GPRS. It may be 3G mobile, Bluetooth, or other IP.

 Internet operations are secured using encoded packets. An example of a handheld scanner is shown in FIG. 40 and an alternative example is shown in FIG. 22 and described in more detail in a crossing any application describing validity scanner.

 [Security Features]

 Hyperlabel call security features include:

Notes can be tracked at any time during the scanning process-in banks, supermarket checkouts, vending machines, cash registers and low cost home scanners.

● A unique range of currency tag numbers can only be printed by a government printing agency.

• Monetary IR inks with inherent spectral properties may only be available to government printing organizations.

● The bill serial number printed in the tag must match the printed serial number.

The tags are printed on both sides of the bill.

• Tags change across banknotes – a counterfeiter must match the thousands of tags printed on a bill.

• Additional proprietary security features are not disclosed in this document.

● Ability to determine both the validity and value of a currency.

[Benefit of Hyper Label]

Unlike 2D-optical barcodes that are often difficult to read due to direct line-of-sight needed for label damage and scanning, visually readable but invisible infrared hyperlabel tags are large cross-sections of product labels. Everything is printed on or over. Hyperlabel tags are printed all over or across a large section of the product label. Hyperlabel tags maintain omnidirectional eye reading. In practice, the hyperlabel reader is designed to scan the scanning field from at least two substantially perpendicular directions. This allows the reader to avoid occlusions that may occur when the hand grabs the item. Hyperlabel tags combine Reed-Solomon error correction to improve reliability.

Another advantage of hyperlabels over bar codes is that they do not use visible label space and do not overwhelm consumers because tag information is not limited to only one section of the label.

 Therefore, hyperlabel tags are easy to set up, easy to read, and enable accurate automatic scanning. Automatic checkout minimizes the likelihood of collusion between the operator and the consumer or shipping agent. In other words, the volume reduction due to the operator or shipbuilder's agency not intentionally scanning the selected items is significantly reduced. It also helps to prevent fraud based on substitution.

Hyperlabels are less mixed than RFID tags because they require a line-of sight for reading. This means that it will be difficult for consumers to scan their products for information without their knowledge.

 Hyperlabels provide consumers with the means to protect their privacy in the same way that they can now do when transporting pharmaceuticals.

 [Hyperlabels as Web pages working together]

 The clear and unique features of hyperlabel technology provide the opportunity for hyperlabels to design packaging labels as interacting "web pages"-thus a whole new range of product-linked products that can be introduced by the pharmaceutical industry. Consumer service may be possible.

Within a few years from now, when digital pens become widely used, product graphics may be added to labels to indicate areas of interaction and prompt consumers to write or click using a hyperlabel pen.

The digital hyperlabel pen can identify the x-y location on the label and can be linked to be established between the information on the label and the web page on the server. The hyperlabel pen connects consumers to the Internet-based hyperlabel server through the same counterpart of a mobile phone or computer.

By using the hyperlabel pen to interact with the label, consumers can be provided additional information about drug use, risks and advice regarding possible interactions between drugs. It also provides the opportunity for consumers to register to participate in sales promotions, participate in web discussions, or participate in drug trials where they can modify “free” samples. Web pages can be customized on-demand using a range of product supply chain data such as consumer profiles, local health data within the enterprise, or geographic locations.

Hyperlabels can thus enable the pharmaceutical industry to expand the use of product labels and packaging, increase brand strength, and establish closer links with consumers. Thus, with hyperlabels, a consumer can be an integral part of the product supply chain, and supply chain data can be integrated with a customer relationship management (CRM) or healthcare database to Improve efficiency and level.

  The following sections highlight how hyperlabel technology can be implemented to improve overall brand strength and increase security.

[Brand protection]

One of the most important challenges facing the pharmaceutical industry is brand protection. A strong brand protection strategy is just as important for the pharmaceutical industry as it is for consumers to protect profits and research and development investments. Illegal activities are used by modern criminals to destroy brand value, the most relevant being:

Parallel trade and illegal imports,

● Product replacement and forgery

● Tempering of the product.

[Parallel trade and illegal imports]

Parallel trade in pharmaceutical products often has significant price differences for the same product in different markets. Pharmaceutical manufacturers are adamant about parallel imports because parallel traders reduce their profits, and manufacturers claim that they will spend less money on research and development. Manufacturers also expressed their opinion that parallel imports do not meet international standards on safety, quality and efficacy and that they may create additional opportunities for counterfeiting.

  Expiration, contamination, weaker than normal potency, particularly potent or distributing by unregulated pharmaceutical channels of counterfeit constraints can also be a significant risk to consumers. Non-compliant pharmacists may provide patients with drugs that are inaccurate or contraindicated, inaccurate, or without appropriate instructions for use. State agencies governing the local pharmaceutical industry cannot meet appropriate standards and preventive measures to protect the public against the occurrence of these events.

 Another concern is that the recent outlook for international parallel trade is one of the controversies among governments. For example, the price of medicine for amoxicillin (amoxicillin) varies considerably around the world—the cheapest in US $ 8 in Pakistan, and the most expensive in Germany is US $ 60.

 Thus, it is now common for drugs such as parlors to be illegally imported across international borders to avoid high prices.

 The Food and Drug Administration (FDA) estimates that about 2 million parcels, including FDA-regulated products, enter the United States each year through international mail agencies for personal use. Other data estimate that nearly 70 pharmacies in Canada (40 in Manitoba) shipped nearly US $ 500 million in prescriptions in 2002 to the United States.

 This year, in the United States, the pharmaceutical industry's trading group, the Pharmaceutical Research and Manufacturers of America (PhRMA), spent $ 85 million in lobbying bills to allow imports of Canadian drugs. Therefore, more money is expected from the WTO. As a result, there will be further lobbying by the pharmaceutical industry against the WTO for the possibility of overcoming differences between national governments and regulations mandating the introduction of individual item identification.

Hyperlabels can be used to reduce the likelihood of parallel trade and illegal imports using EPC linked data to determine the origin and supply chain details for each item.

[Product Replacement and Forgery]

Counterfeit products may include products with wrong ingredients, no active ingredients, insufficient active ingredients or fake packaging. This type of illegal activity can result in economic losses and established reputation for patient safety for established pharmaceutical manufacturer.

Laws and regulations on counterfeiting have been around for twenty years, but evidence of counterfeiting is increasing. The FDA estimates that nearly 40 percent of pharmaceuticals shipped from countries such as Argentina, Colombia and Mexico will be counterfeit. There is no integrated global power agency to carry out the investigation and no global law to enforce it. In conclusion, pharmaceutical companies, and themselves, must augment legal approaches with alternatives to protect the pharmaceutical industry, stakeholders, and consumers.

Hyperlabels can help manufacturers by making it easier to recognize non-genuine goods and product tempering. Special “fingerprints” are made for each vial, drum, shipping container and label. Unique identifiers for all product items coming from the factory's shipping dock can be used for data collection such as manufacturing site, packaging date, storage location and time, distribution channel, repackaging details, inspection and other information available. Products may contain multiple tempered evidence.

 Thus, the hyperlabel item identification system can be used to assist the pharmaceutical industry in carrying out a cargo tracking system for an effective number of items.

[Tempering products]

Today, the pharmaceutical industry is at risk from the threat of pharmaceutical tempering. Some of today's biopharmacecuticals cost more than $ 2000-3000 per gram to produce, and some criminals (even pharmaceuticals) are tempering for profit. Because constraints are important for the social, economic and political stability of many countries, they are also vulnerable targets for terrorism. In each case, the lack of the ability to determine the actual origin is of greatest concern.

  To address these concerns, a series of safeguards are now implemented. These may include permanent criteria such as seals to be removed, features that are certain to break, or fragrance which is a fragment of color, taste and the product itself.

 Other tools include special-coded label words / symbols in which the color spectrum of the code is visible only under UV light or only as a special test device.

 The pharmaceutical industry is also implementing new technologies to secure supply chains to protect all stakeholders, patients and manufacturers alike. This also means that brand protection needs to be applied at several levels of packaging or containment, as all possible levels are provided for tempered products, which may involve the use of several different methods.

 Levels for tempered evidence start with the largest unit (the wholesaler building) and need to be applied to each package arrangement level, down to the item label and contents.

 Hyperlabels, when used in conjunction with other product brand protection methods, may offer the possibility to improve brand protection at each of these points within the supply chain.

[Adding Consumers to the Pharmaceutical Supply Chain]

One of the key benefits that hyperlabels can provide to the pharmaceutical industry is the ability to extend the use of labeling to enable them to be web-interactive, so consumers can be an integral part of the supply chain. There are a number of ways Web-interactive hyperlabels can benefit the pharmaceutical industry. Some of these are:

● enabling consumers to identify and authenticate the product itself,

● protect brand strength through improved market segmentation and ordering;

• To be more consumer-centric by introducing new consumer-led marketing models.

● Improving marketing mix by introducing web-based directed to customer (DTC) marketing campaigns,

• Differentiate your product by using an expanded label marketing model.

[Consumer Certification of Products]

Changes in anti-counterfeiting approaches help manufacturers and regulators distinguish real products from false positives, while rapid changes can embarrass the public.

This makes it difficult for consumers to check the certification of the product itself. By using hyperlabel pens, consumers can identify items for themselves as well as access to additional product information and consumer-centric services.

[Market Segmentation and Customization]

The pharmaceutical market can be divided into three broad product divisions.

Prescription only pharmaceuticals (including about 80% of the market by value and 50% by volume)

Generic brand drugs, and

Counter medicines (TCCs), available over-the-counter and may be generic or branded.

Each of these market segments requires a different strategic approach. Suppliers of branded prescription drugs need to protect their research and development efforts.

 In general, companies focus on supply chains and manufacturing costs. OTCs (counter medications) are rarely prescribed, and they require a direct-to-customer marketing method. In each case, labeling of hyperlabel web-interactions allows the pharmaceutical industry to establish direct marketing relationships with consumers in each segment, while at the same time providing an opportunity to improve market segmentation.

[Consumer-led marketing]

Most pharmaceutical companies are led by most products rather than by consumers. This was probably the unpredictable result of the research and development process because the product was not easy to develop to meet particular consumer needs. Web-interactive hyperlinks provide consumers with an 'opt in' way to engage in marketing activities led by new consumers. For example, they can make an allusion to the web depicting a sticker, so they want to show on the packaging to make a child “feel better”.

[Web DTC (direct to customer) marketing]

Other emerging trends develop around the importance of growth beyond direct-to-customer advertising. As a medium, DTC TV advertising was one of the factors responsible for increased sales in the US pharmaceutical market during the 1990s. Although the EU still does not allow DTC advertising of pharmaceuticals, consumers can access product information on the web.

In 2000, health was one of the two top reasons for people doing web research. Many consumers are still using the Internet as a source of health-related information, and more pharmaceutical suppliers are using the Web as a DTC advertising medium.

[Expanded label marketing model]

70% of purchase options are made from sales information at the point of sale, and marketers sell with packaging that can give brand recognition and directly impact consumers. Because of this, pharmaceutical companies are still spending more on packaging than they spend on advertising. As the market matures and competitive discrimination narrows, packaging has become an important component of the marketing strategy.

The package of the product is the most obvious marketing effort of the product, which performs a number of essential functions: the package provides the means of communication with the consumer. However, because the regulations require more information that can be placed on labels, the packaging also tends to 'shrink', while the use of available space becomes more important. Barcodes take up some of this space. By using invisible web-interactive hyperlabels, the pharmaceutical industry can imagine an extended range of label marketing models. For example, they may include hyperlinks in a web page to take medications, to get a recorder item, or to request SMS reminders to access support services.

Thus, there are numerous ways in which web-interactive hyperlabels benefit manufacturers and improve market acceptance of pharmaceutical products.

Hyperlabel Profit Analysis Matrix

From the conclusions drawn from the section above, it is clear that the hyperlabels offer a unique opportunity for the pharmaceutical industry to introduce alternative long term, low cost, unique item identification solutions that have significant advantages.

 A summary of the relative advantages of hyperlabels over 2D optical barcodes and RFID tags are provided in Table 12 below.

  These benefits, which are a range of benefits, are transferable to the pharmaceutical industry and include:

 • meet current and anticipated legal requirements,

 ● protects expensive research and development investment,

 ● limiting business and consumer-risk through criminal and terrorist activities,

 ● reduce parallel trade and illegal income,

 ● reduce substitution and forgery,

 ● to prevent tempering of the product,

 • establish web links (via hyperlabels) between the pharmaceutical industry and consumers,

 • Improve pharmaceutical supply chain planning and efficiency.

 It is also evident that unique product identification and cargo tracking possibilities are the cornerstone for achieving these goals.

Table 12

Requirements 2D barcodes RFID / EPC Hyperlabel regulation Meets current FDA labeling standards for food, drugs, and cosmetics. √ √ √  Meet WHO / FDA Cargo Tracking Guidelines Prohibiting and Detecting Counterfeit Drugs √ √ √ Packaging producer Provide new revenue streams for existing packaging substrates. × × √ consumer It provides a consumer-centric 'opt-in' web interaction for the provision of specific product items and specialty products. × × √ It provides an acceptable solution for privacy advocates concerned about the ability to read tags without consumer knowledge. √ × √ TICAL INDUSTRY  Produced at low cost. √ × √  Read out omnidirectionally. × √ √  Be cautious to the consumer. × √ √  Identify personal product items. √ √ √  Introduce new consumer-centric marketing models based on web-label interaction × × √  Can be used with radiopaque materials. √ × √

Claims (290)

As a terminal for business processing to perform business on pharmaceuticals, The pharmaceutical formulation is associated with a packaging in which coded data comprising a plurality of coded data portions is placed on or in a package, each coded data portion representing an identifier of the pharmaceutical formulation, and the terminal for business processing , A radiation source for exposing at least one coded data portion, A sensor for detecting at least one exposed coded data portion, and Determine the detected identifier using at least one sensed coded data portion, and And a processor for performing business processing using the sensed identifier. The method of claim 1, The processor, Certification of pharmaceuticals, Approval of work processes, Determination of business details; A business terminal, wherein the identifier is used to perform at least one of the updating of the tracking information related to the pharmaceutical agent. The method of claim 1, The terminal for business processing, Cash Register, vending machine, Supermarket checkup, and And at least one of the scanners placed on the palm of the computer system. The method of claim 1, The identifier is The serial number of the pharmaceutical product, The identifier of the pharmaceutical, EPC, The identifier of the packaging, and And at least partly formed from at least one of the identifiers of the packaging areas. The method of claim 1, The coded data portion represents at least a portion of the signature, the signature is a digital signature of at least a portion of the identifier, and the processor is configured to: Determine using at least one sensed coded data portion, at least one sensed signature portion, A terminal for processing using the detected identifier and at least one detected signature portion to cause authentication of the pharmaceutical formulation The method of claim 5, The processor, Generate data indicative of at least partially indicated sensed identifier and at least one sensed signature portion, and Transfer the indicated data to the computer system, The computer system, Using the sensed identifier, determine the sensed identifier and at least one sensed signature portion, and Responsive to the indication data to authenticate the pharmaceutical formulation using the detected identifier and at least one detected signature portion. The method of claim 5, The pharmaceutical formulation, Using the detected identifier, determine the key, Using the detected identifier and key, determine the determined signature, and And at least one of a processor and a computer system comparing the determined signature with the at least one detected signature portion for authenticating the pharmaceutical by them. The method of claim 5, The full signature is encoded within the plurality of coded data portions, The processor determines, from the plurality of sensed coded data portions, the sensed signature and wherein the pharmaceutical formulation is Using the detected identifier, determine the key, Using the detected signature and key, to determine the determined identifier, and A terminal for business processing, characterized in that it is authenticated by at least one of a processor and a computer system for comparing the sensed identifier with the identifier determined for authenticating the pharmaceutical formulation by them; The method of claim 5, The coded data includes a number of layouts, each layout defining a location of a plurality of first symbols encoding an identifier, the plurality of second symbols defining at least a portion of the signature. Terminal for business processing, characterized in that. The method of claim 1, The terminal for business processing includes a communication system for communicating with a database, the database stored data relating to the pharmaceutical formulation, Authentication data including at least one key associated with the signature; The signature is a digital signature that is at least part of an identifier, Tracking data; The tracking data, Owners of pharmaceuticals, One or more processes performed using pharmaceuticals, Location of pharmaceuticals, Location of the sensing device; At least partially indicate tracking information including at least one of the product data, The product data, Product cost, Patient identifier, User identifier, Owner identifier, Date of Manufacture, Batch number, Manufacturer, Product Distributor, Product Provider, Issuing Country, Ingredients, Storage condition, Disposal Conditions, Serial Number, Expiry Date, Effects, Side effects, Conditions of use, Use Content, Links to further information, Contraindications, A terminal for processing a business, characterized in that at least partially representing product information including at least one of the dosage. The method of claim 1, The terminal for business processing, Certification result, Tracking information, and And a display for showing at least one of the product information. The method of claim 1, And said coded data is substantially invisible to the human eye. The method of claim 1, The coded data is, Invisible ink, and A terminal for processing, characterized in that printed on the surface using at least one of the infrared absorption ink. The method of claim 1, And said coded data is provided in substantially coincident with human visible and readable information. The method of claim 5, The coded data includes a plurality of coded data portions, and the at least some coded data portions are: The location of each coded piece of data, The location of each coded data portion on the surface, The size of the coded data parts, Signature, The size of the signature, The identifier of the signature part, Units of indicated locations, and At least one of at least some of the data objects, wherein the entire data object is encoded at least once by a plurality of coded data portions. The method of claim 14, The data target, Multipose Internet Mail Extensions data, Text Data, Image Data, Audio data, Video data, Application data, Contact data, Information, Business card data, and And at least one of the directory data. The method of claim 1, The coded data is, Surplus data, Data to enable error correction, Reed-Solomon (Reed-Solomon) data, alc A cyclic redundancy check (CRC) terminal for processing a business comprising at least one of the data. The method of claim 5, The digital signature is, Random number associated with the identifier, At least the lock hash of the identifier, Keyed hash of the minimum identifier that is generated using the private key and can be proved using the public key, Cipher-text generated by encoding at least the identifier, Cipher-text generated by encoding at least an identifier and a random number, and A terminal for processing a business, characterized in that it comprises at least one of a ciphertext that is generated using a private key and can be authenticated using a corresponding public key. The method of claim 1, The coded data is arranged according to at least one layout having a plane of symmetry that rotates n times, n is at least 2, a layout containing n identical auxiliary layouts rotates 1 / n away from the center of rotation, At least one auxiliary layout includes rotation indication data that separates the auxiliary layout from each other auxiliary layout. The method of claim 1, Wherein the coded data is arranged according to at least one layout having a symmetric plane that is rotated n times, n is at least 2, and the layout encoding the direction indication data includes an order of m, which is an integer multiple of n symbols, m is 1 or more, and each coded symbol is each of the perimeter of the rotating symmetry plane of the layout such that decoding the symbols in each of the n directions of the layout produces n representatives of direction data. Distributed to n locations of each of the representatives includes different periodic movements of the direction indicating data and indicates a degree of rotation of the layout. The method of claim 1, The processing terminal includes a printer for printing the packaging, The printer, Determine the visibility information to be provided with respect to packaging, Determine the identifier associated with the pharmaceutical, Generate coded data using identifiers, A terminal for processing a business, characterized in that for printing packaging by printing coded data and visible information. The method of claim 1, The business terminal further performs a method for the user to interact with the pharmaceutical, The method in a computer system, Receiving display data from a sensing device; The sensing device is responsive to the sensing of the data coded to produce display data at least partially representing an identifier, Using the indication data, determining at least one operation; Performing an operation associated with the pharmaceutical formulation; The operation is Providing information to the user; Updating tracking information related to the pharmaceutical preparation; Performing business processes related to pharmaceuticals; Authenticating the pharmaceutical formulation; And And at least one of receiving a feedback from a user. The method of claim 1, The processing terminal further performs pharmaceutical formulation authentication, each coded data portion further representing a signature, the signature being at least a digital signature of a partial identifier, encoded within a plurality of coded data portions, The method in the sensing device, Detecting at least one coded data portion; Using the sensed coded data portions, Identifier; And generating display data indicative of at least one signature portion, Within the processor, An identifier determined from the indication data; And determining at least one determined signature portion; Authenticating the pharmaceutical formulation using the determined identifier and the at least one determined signature portion. The method of claim 1, The processing terminal further performs pharmaceutical formulation authentication, each coded data portion further represents a signature, the signature is at least a digital signature of a partial identifier, The method in a computer system, Receiving display data from a sensing device; The sensing device may comprise an identifier of a pharmaceutical formulation; And in response to detecting the coded data to produce display data at least partially representing the signature portion, An identifier determined from the indication data; And determining at least one determined signature portion; Authenticating the pharmaceutical formulation using the determined identifier and the at least one determined signature portion. The method of claim 1, The business terminal further performs a method of determining possible cloning of pharmaceutical packaging, The method in a computer system, Receiving display data from a sensing device; The sensing device is responsive to sensing of coded data to produce display data indicative of an identifier, Determining an identifier determined from the display data; Accessing tracking data relating to the pharmaceutical formulation using the determined identifier; And The tracking data is at least partially an indication of the location of the pharmaceutical formulation, Using the tracking data to determine if the pharmaceutical preparation is a replica possible business process terminal. The method of claim 1, The terminal for business processing further performs a method of tracking the pharmaceutical system, The method in a computer system, Receiving display data from a sensing device; And The sensing device is responsive to the detection of data coded to produce display data indicative of an identifier of a product item, and Updating the tracking data indicative of the tracking information, at least in part, using the received indication data. The method of claim 1, The terminal for processing the pharmaceutical further performs a pharmaceutical packaging manufacturing method, Within a computer system, the method Determining a serial number associated with the pharmaceutical formulation; Generating an identifier using the serial number; Generating a signature using the identifier; Causing generation of coded data using the identifier; The coded data comprises a plurality of coded data portions, Each coded data portion comprises the identifier; And encode the signature, The signature is a digital signature of at least a partial identifier, On pharmaceutical packaging, at least some coded data, identifiers and Causing the printing of at least one of the serial numbers. The method of claim 1, The business processing terminal further performs a pharmaceutical formulation distribution method, The method in a computer system, Receiving display data from a sensing device; The sensing device is responsive to the detection of the coded data to at least partially produce display data indicative of the identifier, Determining from the distribution database at least one criterion for pharmaceutical formulation distribution using the indication data; And Causing the pharmaceutical formulation to be dispensed if at least one criterion is met. The method of claim 1, The terminal for business processing further includes a sensing device for use with pharmaceutical preparations, The sensing device, A housing adapted to be held by the user in use; A radiation source for exposing at least one coded data portion; A sensor for sensing at least one exposed coded data portion; And And a processor for determining a sensed identifier using at least one sensed coded data portion. A printer for printing packaging related to pharmaceuticals, The printer, Determine the visible information to be provided on the packaging, Determine the identifier associated with the pharmaceutical, Generate coded data using identifiers, To print the packaging by printing coded data and visible information, Wherein the coded data comprises a plurality of coded data portions, each coded data portion representing at least an identifier of a pharmaceutical formulation. The method of claim 30, Each coded data portion represents at least a portion of a signature, The signature is a digital signature that is at least part of an identifier, The printer, Determine the signature, and And generate coded data using the signature. The method of claim 31, wherein The printer, Secure data for storing data; And And a processor for generating a signature using the data stored in the data store. The method of claim 31, wherein And the printer encodes the entire signature within the plurality of coded data portions. The method of claim 30, The printer, Determine the layout, The layout is, Coded data layout; And At least one of the document contents, The layout represents the location of each coded data portion on the packaging, The document content indicates the location of the visible information on packaging; And print at least one of the coded data and the visible information using the layout. The method of claim 30, The printer, A communication system for communicating with a database, said database stored data being associated with a pharmaceutical system, Authentication data comprising at least one key associated with the signature; Tracking data; And At least one of the product data, The signature is a digital signature representing at least a portion of an identifier, The tracking data may include tracking information including at least one of an owner of the pharmaceutical formulation, one or more transactions performed using the pharmaceutical formulation, a location of the pharmaceutical formulation, and a location of the sensing device. At least partially, The product data includes product cost, patient identifier, user identifier, owner identifier, date of manufacture, batch number, product manufacturer, product distributor, product supplier, issuing country, ingredients, storage conditions, disposal conditions, serial number. And at least partly presenting product information, including at least one of an expiration date, effects, side effects, conditions of use, usage details, linking to further information, contraindications, and dosages. 36. The method of claim 35 wherein The printer, Update at least some of the data related to the pharmaceutical formulation, and At least one of generating coded data using at least some of the data related to the pharmaceutical formulation. The method of claim 30, The identifier is Serial number of the pharmaceutical formulation, An identifier of the pharmaceutical formulation, EPC, The identifier of the packaging, and And at least partly formed from at least one of the identifiers of the packaging areas. The method of claim 30, The packaging is Blister pack, bottle, Bottle Cap, label, Box, and And at least one of a leaflet. The method of claim 30, The printer, Receive the packaging, Scan the packaging to determine information indicated by at least one of the source of the pharmaceutical formulation, the pharmaceutical formulation type, the identifier of the pharmaceutical formulation, and the serial number of the pharmaceutical formulation, And generate using the determined information and at least a portion of the coded data. The method of claim 30, The coded data is a detection of at least one coded data portion by a sensing device, Identifier, At least one signature portion, The location of the sensing device relative to the packaging, and And an indication of a plurality of reference points to permit determination of at least one of the transmission of the locator associated with the packaging. The method of claim 30, And the coded data is substantially invisible to the human eye. The method of claim 30, The coded data is Invisible ink, and And a printer printed on the surface using at least one of the infrared-absorbing inks. The method of claim 30, And the coded data is provided to substantially match the human-readable and readable information. The method of claim 30, The coded data comprises a plurality of coded data portions, At least some of the coded data portions, The location of each coded data portion, The location of each coded data portion on the surface, The size of the coded data parts, Signature, The size of the signature, The identifier of the signature part, Units of indicated locations, and Encoding at least one of at least some data objects, Wherein the entire data object is encoded at least once by a plurality of coded data portions. The method of claim 44, The data target, Multipose Internet Mail Extensions data, Text Data, Image Data, Audio data, Video data, Application data, Contact data, Information, Business card data, and And at least one of the directory data. The method of claim 30, The coded data is Redundant data; Data to enable error correction; Reed-Solomon data; And, And at least one of cyclic redundancy check (CRC) data. The method of claim 31, wherein The digital signature is, Random number associated with the identifier; At least an identifier lock hash; A lock hash of the minimum identifier generated using the private key and provable using the public key; A cipher-text generated by encoding at least the identifier; Cipher-text generated by encoding at least an identifier and a random number; And, And at least one of cipher-text generated using the private key and authenticating using the public key. The method of claim 30, The coded data is arranged according to at least one layout having a plane of symmetry that rotates n times, n is at least 2, a layout containing n identical auxiliary layouts rotates 1 / n away from the center of rotation, And at least one secondary layout includes rotation indication data that separates the secondary layout from each other secondary layout. The method of claim 30, Wherein the coded data is arranged according to at least one layout having a symmetric plane that is rotated n times, n is at least 2, and the layout encoding the direction indication data includes an order of m, which is an integer multiple of n symbols, m is 1 or more, and each coded symbol is a symbol of each of the perimeters of the rotating symmetry plane of the layout such that decoding symbols in each n directions of the layout produces n representatives of direction data. a printer distributed to n locations, each representative comprising a different periodic movement of direction indication data, said indicative of the degree of rotation of said layout. The method of claim 30, The printer includes a business processing terminal for performing business processing related to the pharmaceutical formulation, The terminal for business processing, A radiation source for exposing at least one coded data portion; A sensor for sensing at least one exposed coded data portion; And And a processor for determining a sensed identifier using at least one sensed coded data portion and for performing business processing using the sensed identifier. The method of claim 30, The printer further performs a method by which the user can interact with the pharmaceutical formulation, The method in a computer system, Receiving display data from a sensing device; The sensing device is responsive to the sensing of the coded data to produce at least partially indication data representing the identifier, Using the indication data, determining at least one operation; And Performing an operation associated with the pharmaceutical formulation, The operation is Providing information to the user; Updating tracking information related to the pharmaceutical preparation; Performing a business process related to the pharmaceutical preparation; Authenticating the pharmaceutical formulation; And A printer comprising at least one of receiving feedback from a user. The method of claim 30, The printer further performs pharmaceutical authentication, each coded data portion further representing a signature, the signature being at least a digital signature of a partial identifier, encoded within a plurality of coded data portions, The method in the sensing device, Detecting at least one coded data portion; An identifier using the sensed coded data portion; And generating display data indicative of at least one signature portion; Within the processor, An identifier determined from the display data; And determining at least one determined signature portion; And authenticating the pharmaceutical formulation using the determined identifier and the at least one determined signature portion. The method of claim 30, The printer further performs pharmaceutical authentication, each coded data portion further representing a signature, the signature being at least a digital signature of a partial identifier, The method in a computer system, Receiving display data from a sensing device; The sensing device may comprise an identifier of a pharmaceutical formulation; And in response to detection of the coded data to produce display data at least partially representing the signature portion, An identifier determined from the indication data; And determining at least one determined signature portion; Authenticating the pharmaceutical formulation using the determined identifier and the at least one determined signature portion. The method of claim 30, The printer further performs a method of determining possible duplication of packaging, The method in a computer system, Receiving display data from a sensing device; The sensing device is responsive to the sensing of the coded data to produce display data indicative of the identifier, Determining an identifier determined from the display data; Using the determined identifier to access tracking data relating to the pharmaceutical formulation, The tracking data at least partially represents the location of the pharmaceutical formulation, Using tracking data to determine if the pharmaceutical formulation is a replica capable. The method of claim 30, The printer further performs a method of tracking the pharmaceutical system, The method in a computer system, Receiving display data from a sensing device; And The sensing device is responsive to the detection of data coded to produce display data indicative of an identifier of a product item Updating the tracking data indicative of the tracking information, at least in part, using the received display data. The method of claim 30, The printer further performs a packaging recipe, In a computer system the method is Determining a serial number associated with the pharmaceutical formulation; Generating an identifier using the serial number; Using the identifier, generating a signature: Causing generation of coded data using the identifier; The coded data includes a plurality of coded data portions, each coded data portion comprising an identifier; And encode the signature, The signature is at least a digital signature of the partial identifier, Causing printing on the pharmaceutical packaging, at least some of the coded data and at least one of the identifier and the serial number. The method of claim 30, The printer further performs a pharmaceutical dispensing method, The method in a computer system, Receiving display data from a sensing device; The sensing device is responsive to the sensing of the data coded to produce display data at least partially representing an identifier, Determining at least one criterion for pharmaceutical system distribution from the distribution database using the indication data; And Causing the pharmaceutical to be dispensed if at least one criterion is met. The method of claim 30, The printer further includes a sensing device for use with pharmaceuticals, The sensing device A housing adapted to be held by the user in use; A radiation source for exposing at least one coded data portion; A sensor for sensing at least one exposed coded data portion; And And a processor for determining a detected identifier using at least one sensed coded data portion. In a way that allows a user to interact with a pharmaceutical, The pharmaceutical formulation is associated with a packaging placed in or on the coded data, At least some coded data indicates at least an identifier, The method in a computer system, Receiving display data from a sensing device; The sensing device is responsive to the sensing of the data coded to produce display data at least partially representing an identifier, Determining at least one operation using the indication data; And Performing an operation associated with said pharmaceutical formulation, The above operation Providing information to the user; Updating tracking information related to the pharmaceutical preparation; Performing a business process related to the pharmaceutical preparation; Authenticating the pharmaceutical formulation; And At least one of receiving feedback from the user; Method comprising a. The method of claim 59, The identifier is Coded data part identifier; An identifier of the pharmaceutical formulation; EPC; An identifier of the packaging; And At least partially formed from at least one of the identifiers of the packaging regions, Wherein said region is associated with each operation. The method of claim 59, The method in a computer system, Determining contents using the display data; And Using said content, determining said operation. The method of claim 59, The coded data represents a plurality of reference points, The display data, Location of the sensing device relative to the packaging; And At least partially represent at least one of the movements of the sensing device relative to the packaging, The method in a computer system, Using the indication data, determining at least one of a determined position and a determined transmission; And And performing the at least partial operation based on at least one of the determined location and the determined transmission. The method of claim 59, The coded data comprises a plurality of coded data portions, each coded data portion representing at least a portion of a signature, the signature being at least a digital signature of a portion of the identifier, the coded data portion of the at least one coded data portion In response to the sensing, the sensing device generates display data at least partially representing the at least one signature portion, The method in a computer system, Determining, from the indication data, a determined identifier and at least one determined signature portion; And Authenticating the pharmaceutical formulation using the determined identifier and the at least one determined signature portion. The method of claim 63, wherein The full signature is encoded within a plurality of coded data portions, The method in the sensing device comprises sensing a plurality of coded data portions for which a full signature is to be determined. The method of claim 63, wherein The coded data comprises a plurality of layouts, each layout defining the position of a plurality of first symbols encoding the identifier, the plurality of second symbols defining at least part of the signature How to The method of claim 59, The information is, Product cost, Patient Identifier, User Identifier, Ownership Identifier, Date of Manufacture, Batch number, Manufacturer, Product Distributor, Product Provider, Issuing Country, Ingredients, Storage condition, Disposal Conditions, Serial Number, Expiry Date, effect, Side Effect, Conditions of use, Use Content, Linking to a layer of information, Contraindications, and A method comprising at least one of the dosages The method of claim 59, The feedback is An indication of the effects of the pharmaceutical formulation; Marketing feedback; Questions about the pharmaceutical formulation; And And at least one of the answers to the customer survey. The method of claim 59, The tracking information, The current owner of the pharmaceutical formulation; One or more business processes performed using the pharmaceutical formulation; Location of the pharmaceutical formulation; And Displaying at least one of the locations of the sensing device. The method of claim 59, The coded data is substantially invisible to the human eye. The method of claim 59, The coded data is, Invisible ink; And Printing on said surface using at least one of an infrared absorbing ink. The method of claim 59, And wherein said coded data is provided substantially in accordance with human readable and readable information. The method of claim 63, wherein The coded data includes a plurality of coded data portions, and the at least some coded data portions, Location of each coded data portion; The location of each coded data portion on the surface; The size of the coded data portions; Signature part; The size of the signature; An identifier of the signature portion; Units of the indicated location; And Encoding at least one of at least a portion of the data objects, wherein the entire data object is encoded at least once by a plurality of coded data portions. The method of claim 72, The data object, Multipose Internet Mail Extensions data; Text data; Image data; Audio data; Video data; Application data; Contact data; Information; Business card data; And And at least one of the directory data. The method of claim 59, The coded data is, Redundant data; Data to enable error correction; Reed-Solomon data; And At least one of cyclic redundancy check (CRC) data. The method of claim 63, wherein The digital signature is A random number associated with the identifier; At least a lock hash of the identifier; A lock hash of the minimum identifier that can be generated using a private key and proved using that public key; A cipher-text generated by encoding at least the identifier; Cipher-text generated by encoding at least an identifier and a random number; And And at least one of cipher-text generated using the private key and provable using the public key. The method of claim 59, The coded data is arranged according to at least one layout having a plane of symmetry that rotates n times, n is at least 2, a layout containing n identical auxiliary layouts rotates 1 / n away from the center of rotation, At least one sub-layout comprises rotation indication data that separates the sub-layout from each other sub-layout. The method of claim 59, Wherein the coded data is arranged according to at least one layout having a symmetric plane that is rotated n times, n is at least 2, and the layout encoding the direction indication data includes an order of m, which is an integer multiple of n symbols, m is 1 or more, and each coded symbol is a symbol of each of the perimeters of the rotating symmetry plane of the layout such that decoding symbols in each n directions of the layout produces n representatives of direction data. distributed to n locations, each representative comprising a different periodic movement of the direction indication data and indicating a degree of rotation of the layout. As a way for users to interact with pharmaceuticals, The pharmaceutical formulation is associated with a packaging placed on or in the coded data, at least some of the coded data representing at least an identifier, The method in the sensing device, Sensing at least some of the coded data; Using the sensed coded data, determining indication data at least partially indicating the identifier; And Transmitting the display data to a computer system, The computer system, Using the indication data, determine at least one operation, and Respond to indication data for performing the operation associated with the pharmaceutical formulation, The operation is Providing information to the user; Updating tracking information related to the pharmaceutical preparation; Performing a business process related to the pharmaceutical preparation; Authenticating the pharmaceutical formulation; And At least one of receiving feedback from the user. The method of claim 59, The method comprises the use of a processing terminal for performing the processing related to the pharmaceutical formulation, The terminal for business processing, A radiation source for exposing at least one coded data portion; A sensor for sensing at least one exposed coded data portion; And And a processor for determining a sensed identifier using the at least one sensed coded data portion, and for performing the business process using the sensed identifier. The method of claim 59, The method includes the use of a printer for packaging printing, The printer, Determine visible information provided on the packaging, Determine an identifier associated with the pharmaceutical formulation, Generate coded data using the identifier, and For printing the packaging by printing the coded data and the visible information, The coded data comprises a plurality of coded data portions, each coded data portion at least indicating an identifier of the pharmaceutical formulation. The method of claim 59, The method is further used for authenticating the pharmaceutical agent, each coded data portion further representing at least a portion of a signature, the signature at least partially being a digital signature of the identifier and encoding within multiple coded data portions. , The method in the sensing device, Detecting at least one coded data portion; And Using the sensed coded data portion, the identifier; Generating indication data indicative of the at least one determined signature portion; Within the processor, An identifier determined from the indication data; And determining at least one determined signature portion; Authenticating the pharmaceutical formulation using the determined identifier and the at least one determined signature portion. The method of claim 59, The method is further used to authenticate the pharmaceutical formulation, each coded data portion further representing at least a portion of a signature, the signature being a digital signature of at least some identifiers, The method in a computer system, Receiving display data from the sensing device; The sensing device may include an identifier of the pharmaceutical formulation; And responsive to the detection of the coded data to generate display data at least partially representing the signature portion, The determined identifier; And determining at least one determined signature portion from the indication data; Authenticating the pharmaceutical formulation using the determined identifier and the at least one determined signature portion. The method of claim 59, The method is further used to determine possible replication of pharmaceutical packaging, The method in a computer system, Receiving display data from a sensing device; The sensing device is responsive to sensing of coded data to produce display data indicative of the identifier, Determining, from the indication data, the determined identifier; Accessing the tracking data related to the pharmaceutical formulation using the determined identifier; And If the pharmaceutical formulation is a replica possible, determining using the tracking data, Wherein said tracking data comprises at least partially an indication of a location of said pharmaceutical formulation. The method of claim 59, The method is further used for tracking the pharmaceutical formulation, The method in a computer system, Receiving display data from the sensing device; The sensing device is responsive to the sensing of the coded data to produce display data indicative of an identifier of a product item, Updating the tracking data indicative of the tracking information at least in part using the received indication data. The method of claim 59, The method is further used to produce pharmaceutical packaging, The method in a computer system, Determining a serial number associated with the pharmaceutical formulation; Generating an identifier using the serial number; Using the identifier, generating a signature; Causing generation of coded data using the identifier; The coded data comprises a plurality of coded data portions, Each piece of coded data Identifier; And encode the signature, The signature is at least partially a digital signature of an identifier, At least some coded data and said identifier on said pharmaceutical packaging; And Causing printing of at least one of the serial numbers. The method of claim 59, The method is further used for dispensing the pharmaceutical formulation, The method in a computer system, Receiving display data from the sensing device; The sensing device is responsive to sensing of the coded data to at least partially produce display data indicative of the identifier, Using the indication data from a distribution database, determining at least one criterion for dispensing the pharmaceutical formulation; And Causing the pharmaceutical to be dispensed if at least one criterion is satisfied. The method of claim 59, The sensing device is for use with pharmaceuticals, The sensing device, A housing adapted to be held by the user in use; A radiation source for exposing at least one coded data portion; A sensor for sensing the at least one exposed coded data portion; And And a processor for determining a sensed identifier using the at least one sensed coded data portion. As a method for authenticating pharmaceuticals, The pharmaceutical formulation is associated with a packaging in which coded data comprising a plurality of coded data portions is placed on or in the packaging, Each coded data portion represents an identifier and at least part of a signature of the pharmaceutical formulation, The signature is a digital signature that is at least part of an identifier and is encoded within a plurality of coded data portions, The method in the sensing device, Detecting at least one coded data portion; And An identifier using the sensed coded data portion; Generating display data indicative of at least one signature portion; Within the processor, An identifier determined from the indication data; And determining at least one determined signature portion; Authenticating the pharmaceutical formulation using the determined identifier and the at least one determined signature portion. 89. The method of claim 88 wherein The method in the processor, Obtaining a key from a secure data store using the identifier; The secure store stores at least one secret key, Generating a generated signature using the determined identifier and the key; And Comparing them with the generated signature to the at least one determined signature portion for authenticating the pharmaceutical formulation. 91. The method of claim 89 wherein And said secure data store forms internal memory of said processor. 89. The method of claim 88 wherein The method in the processor, Within the sensing device, Sensing a plurality of coded data portions; And Using the sensed coded data portions, generating indication data indicative of the signature; Within the processor, Determining, from the indication data, the determined signature; Using the identifier, determining a key; Generating a generated identifier using the determined signature and the key; And Comparing them with said generated identifier to authenticate said pharmaceutical formulation by them. 92. The method of claim 91 wherein The method in the processor, Obtaining a key from a local data store using the identifier; And If a key cannot be obtained from the local data store, using the identifier to obtain a key from a remote data store. 89. The method of claim 88 wherein The method among at least one of the sensing device and the processor, Determining when sufficient; Within the sensing device, Detecting at least one coded data portion; And Using the sensed coded data portion, the identifier; And generating display data indicative of the at least one signature portion; Within the processor, An identifier determined from the indication data; And determining at least one determined signature portion; Authenticating the pharmaceutical formulation using the determined identifier and the at least one determined signature portion. 89. The method of claim 88 wherein The identifier is Coded data portion identifier; An identifier of the pharmaceutical formulation; EPC; An identifier of the packaging; And And at least partially formed from at least one of the identifiers of the packaging area. 89. The method of claim 88 wherein The coded data includes a plurality of layouts, each layout defining the location of the plurality of first symbols encoding the identifier, And the plurality of second symbols define at least some signatures. 89. The method of claim 88 wherein The method in the processor, A database comprising communicating with a local database, the database storing data related to pharmaceuticals, Authentication data including at least a key associated with the signature; Tracking data; And At least one of the product data, The signature is a digital signature that is at least part of an identifier, The tracking data, The owner of the pharmaceutical formulation, One or more business processes performed using the pharmaceutical formulation, Location of the pharmaceutical formulation, and At least partially indicate tracking information including at least one of a location of the sensing device, The product data, Product cost, Patient identifier, User identifier, Owner identifier, Batch number, Manufacturer, Product Distributor, Product Provider, Issuing Country, Ingredients, Storage condition, Disposal Conditions, Serial Number, Expiry Date, effect, Side Effect, Conditions of use, Use Content, To more information, Contraindications, and And at least partially indicating product information comprising at least one of the dosages. 89. The method of claim 88 wherein The method, Authentication results; Tracking information; And Displaying at least one of the product information. 89. The method of claim 88 wherein The packaging is Blister packs; bottle; Bottle cap; label; Box; And At least one of a sheet printed matter. 89. The method of claim 88 wherein The coded data is substantially invisible to the human eye. 89. The method of claim 88 wherein The coded data is, Invisible ink; And Printing on said surface using at least one of an infrared absorbing ink. 89. The method of claim 88 wherein Wherein said coded data is provided substantially consistent with human readable and readable information. 89. The method of claim 88 wherein The coded data comprises a plurality of coded data portions, The at least some of the coded data portions, Location of each coded data portion; The location of each coded data portion on the surface; The size of the coded data portions; Signature portion; The size of the signature; An identifier of the signature portion; Units of indicated locations; And Encoding at least one of at least portions of the data object, And wherein the entire data object is encoded at least once by a plurality of coded data portions. 102. The method of claim 101, wherein The data target, Multipurpose Internet Mail Extensions (MINE) data; Text data; Image data; Audio data; Video data; Application data; Contact data; Information; Business card data; And And at least one of the directory data. 89. The method of claim 88 wherein The coded data is, Redundant data; Data to enable error correction; Reed-Solomon data; And And at least one of cyclic redundancy check (CRC) data. 89. The method of claim 88 wherein The digital signature is A random number associated with the identifier; A lock hash of at least the identifier; A minimum lock hash of said identifier, generated using a private key and proving using that public key; Cipher-text generated by encoding at least the identifier; Cipher-text generated by encoding at least the identifier and the random number; And And at least one of the ciphertexts generated using the private key and certifiable using the public key. 89. The method of claim 88 wherein The coded data is arranged according to at least one layout having a plane of symmetry that rotates n times, n is at least 2, a layout containing n identical auxiliary layouts rotates 1 / n away from the center of rotation, At least one sub-layout comprises rotation indication data that separates the sub-layout from each other sub-layout. 89. The method of claim 88 wherein Wherein the coded data is arranged according to at least one layout having a symmetric plane that is rotated n times, n is at least 2, and the layout encoding the direction indication data includes an order of m, which is an integer multiple of n symbols, m is 1 or more, and each coded symbol is a symbol of each of the perimeters of the rotating symmetry plane of the layout such that decoding symbols in each n directions of the layout produces n representatives of direction data. distributed to n locations, each representative comprising a different periodic movement of the direction indication data and indicating a degree of rotation of the layout. 89. The method of claim 88 wherein The method includes the use of a business process terminal for performing business processes related to the pharmaceutical formulation, The business processing terminal, A radiation source for exposing at least one coded data portion; A sensor for sensing at least one exposed coded data portion; And And a processor for determining a detected identifier using at least one sensed coded data portion and for performing the business process using the sensed identifier. 89. The method of claim 88 wherein The method includes the use of a printer to print the packaging, The printer, Determine visible information provided on the package, Determine an identifier associated with the pharmaceutical formulation, Generate coded data using the identifier, and For printing the packaging by printing the coded data and the visible information, The coded data comprises a plurality of coded data portions, Wherein each coded data portion represents at least an identifier of the pharmaceutical formulation. 89. The method of claim 88 wherein The method is further used to allow the user to interact with the pharmaceutical formulation, The method in a computer system, Receiving display data from the sensing device; The sensing device is responsive to sensing of the coded data to produce at least partially indicating data indicative of an identifier, Using the indication data, determining at least one operation; And Performing the operation associated with the pharmaceutical formulation, The operation is Providing information to the user; Updating tracking information related to the pharmaceutical preparation; Performing a business process related to the pharmaceutical preparation; Authenticating the pharmaceutical formulation; And At least one of receiving feedback from the user. 89. The method of claim 88 wherein The method is further used to authenticate pharmaceutical formulations, The method in a computer system, Receiving display data from the sensing device; The sensing device may include an identifier of the pharmaceutical formulation; And responsive to sensing of the coded data to generate display data at least partially representing the signature portion; An identifier determined from the indication data; And determining at least one determined signature portion; And Authenticating the pharmaceutical formulation using the determined identifier and the at least one determined signature portion. 89. The method of claim 88 wherein The method is further used to determine possible replication of the pharmaceutical packaging, The method in a computer system, Receiving display data from the sensing device; Determining, from the indication data, the determined identifier; Accessing the tracking data related to the pharmaceutical formulation using the determined identifier; And Using the tracking data, determining whether the pharmaceutical formulation is a possible duplicate, The sensing device is responsive to the sensing of the coded data to generate display data indicative of the identifier, The tracking data comprises at least partially an indication of a location of the pharmaceutical formulation. 89. The method of claim 88 wherein The method is further used to track the pharmaceutical formulation, The method in a computer system, Receiving display data from the sensing device; And The sensing device is responsive to the sensing of the coded data to generate display data indicative of an identifier of the product item, Updating the tracking data indicative of the tracking information, at least in part, using the received indication data. 89. The method of claim 88 wherein The method is further used to produce pharmaceutical packaging, The method in a computer system, Determining a serial number associated with the pharmaceutical formulation; Generating an identifier using the serial number; Using the identifier, generating a signature; Causing generation of coded data using the identifier; And Causing on said pharmaceutical packaging, printing at least some coded data and at least one of said identifier and said serial number, The coded data includes a plurality of coded data portions, each coded data portion comprising an identifier; And encode the signature, The signature is at least partly a digital signature of the identifier. 89. The method of claim 88 wherein The method is further used for dispensing the pharmaceutical, The method in a computer system, Receiving display data from the sensing device; The sensing device is responsive to sensing of the coded data to generate display data at least partially indicating an identifier, Using the indication data, determining, from a distribution database, at least one criterion for dispensing the pharmaceutical formulation; And Causing said pharmaceutical formulation to be dispensed if at least one criterion is met. 89. The method of claim 88 wherein The sensing device is for use with the pharmaceutical formulation, The sensing device, A housing adapted to be held by the user in use; A radiation source for exposing at least one coded data portion; A sensor for sensing at least one exposed coded data portion; And And a processor for determining a sensed identifier using at least one sensed coded data portion. As a method for authenticating pharmaceuticals, Wherein the pharmaceutical formulation is associated with a packaging disposed on or in a coded data packaging comprising a plurality of coded data portions, each coded data portion representing an identifier of the pharmaceutical formulation and at least part of a signature, wherein The signature is a digital signature that is at least part of an identifier, The method in a computer system, Receiving display data from a sensing device; The sensing device, An identifier of the pharmaceutical formulation; And responsive to sensing of the coded data to generate display data at least partially representing the signature portion; An identifier determined from the indication data; And determining at least one determined signature portion; Authenticating the pharmaceutical formulation using the determined identifier and the at least one determined signature portion. 118. The method of claim 117 wherein The method in a computer system, Using the determined identifier, determining a key; Generating a generated signature using the determined identifier and the key; And Comparing the generated signature with the at least one determined list of books to authenticate the pharmaceutical agent by them. 118. The method of claim 117 wherein The full signature is encoded within a plurality of coded data portions, and the sensing device is responsive to sensing of the plurality of coded data portions to produce indication data representing the full signature, The method in the computer system, Determining the determined signature using the indication data; Using the determined identifier, determining a key; Generating a generated identifier using the determined signature and the key; And Comparing the generated identifier with the identifier determined for authenticating the pharmaceutical formulation by them. 118. The method of claim 117 wherein The method in the computer system, Using the determined identifier, determining tracking data at least partially indicating a location of the pharmaceutical formulation; And Using tracking data, determining whether the pharmaceutical formulation is a replica capable. 118. The method of claim 117 wherein In the computer system and in response to a successful authentication, the method includes: Authorizing processing related to the pharmaceutical formulation; And Updating tracking data related to the pharmaceutical formulation, The tracking data at least partially indicating a location of the pharmaceutical formulation. 118. The method of claim 117 wherein The method in the computer system, Communicating with a database, The database for storing data related to the pharmaceutical formulation, Authentication data including at least one key associated with the signature; Tracking data; And Including product data, The signature is a digital signature that is at least part of an identifier, The tracking data, At least partially display tracking information including at least one of an owner of the pharmaceutical formulation, one or more business processes performed using the pharmaceutical formulation, a location of the pharmaceutical formulation, and a location of the sensing device, The product data, Product Cost, Patient Identifier, User Identifier, Owner Identifier, Date of Manufacture, Batch Number, Product Manufacturer, Product Distributor, Product Supplier, Country of Origin, Ingredients, Storage Conditions, Disposal Conditions, Serial Number, Expiration Date, Effect At least partly presenting product information comprising at least one of: side effects, conditions of use, usage, linking to further layers of information, contraindications, and dosages 123. The method of claim 122 wherein The method in the computer system, Results of authentication; Tracking information; And Causing at least one display of product information. 118. The method of claim 117 wherein The identifier is Coded data portion identifier; An identifier of the pharmaceutical formulation; EPC; An identifier of the packaging; And And at least partially formed from at least one of the identifiers of the packaging regions. 118. The method of claim 117 wherein The coded data comprises a plurality of layouts, each layout defining a location of a plurality of first symbols encoding the identifier, and a plurality of second symbols defining at least some signatures. . 118. The method of claim 117 wherein The packaging, Blister packs; bottle; Bottle cap; label; Box; And At least one of a sheet printed matter. 118. The method of claim 117 wherein The coded data is substantially invisible to the human eye. 118. The method of claim 117 wherein The coded data is Invisible ink; And Printing on said surface using at least one of an infrared absorbing ink. 118. The method of claim 117 wherein Wherein said coded data is provided in substantially coincident with human-readable and readable information. 121. The method of claim 121, wherein The coded data comprises a plurality of coded data portions, The at least some coded data portions, Location of each coded data portion; The location of each coded data portion on the surface; The size of the coded data portions; Signature part; The size of the signature; An identifier of the signature portion; Units of indicated locations; And Encoding at least one of at least portions of the data object, And wherein the entire data object is encoded at least once by a plurality of coded data portions. 131. The method of claim 130, The data target, Multipose Internet Mail Extensions data; Text data; Image data; Audio data; Video data; Application data; Contact data; Information; Business card data; And And at least one of the directory data. 118. The method of claim 117 wherein The coded data is, Redundant data; Data to enable error correction; Reed-Solomon data; And And at least one of cyclic redundancy check (CRC) data. 121. The method of claim 121, wherein The digital signature is, A random number associated with the identifier; At least a lock hash of the identifier; A lock hash generated using a private key and provable using that public key; A cipher-text generated by encoding at least the identifier; A cipher-text generated by encoding at least said identifier and a random number; And And at least one of cipher-text generated using the private key and provable using the public key. 118. The method of claim 117 wherein The coded data is aligned according to at least one layout having a plane of symmetry that rotates n times, n is at least 2, and a layout containing n identical auxiliary layouts rotates 1 / n away from the center of the rotation. And the at least one auxiliary layout includes rotation indication data that separates the auxiliary layout from each other auxiliary layout. 118. The method of claim 117 wherein Wherein the coded data is arranged according to at least one layout having a symmetric plane that is rotated n times, n is at least 2, and the layout encoding the direction indication data includes an order of m, which is an integer multiple of n symbols, m is 1 or more, and each coded symbol is a symbol of each of the perimeters of the rotating symmetry plane of the layout such that decoding symbols in each n directions of the layout produces n representatives of direction data. distributed to n locations, each representative comprising a different periodic movement of the direction indication data and indicating a degree of rotation of the layout. As a method for authenticating pharmaceuticals, Wherein said pharmaceutical formulation is associated with a packaging in which coded data is placed on or in a packaging comprising a plurality of coded data portions, each coded data portion representing an identifier and at least part of a signature of said pharmaceutical formulation, said The signature is a digital signature of at least some identifiers, The method in the sensing device, Detecting at least one coded data portion; Using the sensed coded data portion, the identifier; Generating display data at least partially representing at least one signature portion; And Transmitting the display data to a computer system, The computer system, Determining, from the indication data, a determined identifier: and at least one determined signature portion, Using the determined identifier and the at least one determined signature portion, responsive to the indication data to authenticate the pharmaceutical formulation. 118. The method of claim 117 wherein The method comprises the use of a business terminal for performing business processes related to the pharmaceutical formulation, The terminal for business processing, A radiation source for exposing at least one coded data portion; A sensor for sensing at least one exposed coded data portion; And And a processor for using the at least one sensed coded data portion to determine a sensed identifier, and to perform the business process using the sensed identifier. 118. The method of claim 117 wherein The method includes the use of a printer to print the packaging, The printer, Determine visible information provided on the packaging, Determine an identifier associated with the pharmaceutical formulation, Generate coded data using the identifier, For printing the packaging by printing the coded data and the visible information, The coded data comprises a plurality of coded data portions, each coded data portion representing at least an identifier of the pharmaceutical formulation. 118. The method of claim 117 wherein The method is further used to allow the user to interact with the pharmaceutical formulation, The method in a computer system, Receiving display data from the sensing device; The sensing device is responsive to the sensing of the coded data to generate display data that at least partially represents an identifier, Using the indication data, determining at least one operation; And Performing the operation associated with the pharmaceutical formulation, The operation is Providing information to the user; Updating tracking information related to the pharmaceutical preparation; Performing a business process related to the pharmaceutical preparation; Authenticating the pharmaceutical formulation; And At least one of receiving feedback from the user. 118. The method of claim 117 wherein The method is further used for the pharmaceutical certification, The method in the sensing device, Detecting at least one coded data portion; And Using the sensed coded data portion, the identifier; And generating display data representing the at least one signature portion. Within the processor, An identifier determined from the indication data; And determining at least one determined signature portion; Authenticating the pharmaceutical formulation using the determined identifier and the at least one determined signature portion. 118. The method of claim 117 wherein The method is further used to determine possible replication of pharmaceutical packaging, The method in a computer system, Receiving display data from a sensing device; The sensing device is responsive to the sensing of the coded data to generate display data indicative of the identifier, Determining, from the indication data, the determined identifier; Using the determined identifier, accessing tracking data related to the pharmaceutical formulation: The tracking data at least partially represents a location of the pharmaceutical formulation, Using the tracking data, determining if the pharmaceutical formulation is a possible duplicate. 118. The method of claim 117 wherein The method is further used to track the pharmaceutical formulation, The method in a computer system, Receiving display data from the sensing device; And The sensing device is responsive to sensing of the coded data to generate display data indicative of an identifier of the product item, and Updating the tracking data indicative of the tracking information, at least in part, using the received indication data. 118. The method of claim 117 wherein The method is further used to produce pharmaceutical packaging, The method in a computer system, Determining a serial number associated with the pharmaceutical formulation; Generating an identifier using the serial number; Using the identifier, generating a signature; Causing generation of coded data using the identifier; The coded data comprises a plurality of coded data portions, Each coded data portion comprises: the identifier; And encode the signature, The signature is at least a partial digital signature of the identifier, At least some coded data and said identifier on said pharmaceutical packaging; And causing printing of at least one of the serial numbers. 118. The method of claim 117 wherein The method is further used for dispensing the pharmaceutical, The method in a computer system, Receiving display data from the sensing device: The sensing device is responsive to sensing of the coded data to generate display data at least partially indicating an identifier, Using the indication data and determining at least one criterion for dispensing the pharmaceutical from a distribution database; And Causing said pharmaceutical formulation to be dispensed if said at least one criterion is met. 118. The method of claim 117 wherein The sensing device is for use with the pharmaceutical formulation, The sensing device, A housing adapted to be held by the user in use; A radiation source for exposing at least one coded data portion; A sensor for sensing the at least one exposed coded data portion; And And a processor for determining a sensed identifier using at least one sensed coded data portion. As a method of determining possible replication of pharmaceutical packaging, The packaging places coded data comprising or a plurality of coded data portions on or within the packaging, each coded data portion representing at least an identifier of the pharmaceutical formulation, The method in a computer system, Receiving display data from a sensing device; The sensing device is responsive to the sensing of the coded data to generate display data indicative of the identifier, Determining, from the indication data, the determined identifier; Accessing the tracking data related to the pharmaceutical formulation using the determined identifier; And The tracking data is at least in part an indication of a location of the pharmaceutical formulation, Using the tracking data, determining if the pharmaceutical formulation is a possible duplicate. 146. The method of claim 146 wherein The tracking data represents tracking information for each of a plurality of existing pharmaceutical agents, The method in a computer system, Determining whether the pharmaceutical formulation is a replica of one of the existing pharmaceutical formulations. 146. The method of claim 146 wherein The method in a computer system, Determining the current location of the pharmaceutical formulation using the indication data; Comparing the current location with the tracking information; And Determining that the pharmaceutical formulation is a possible duplicate if the current location is inconsistent with the tracking information. 146. The method of claim 146 wherein The method in a computer system, Determining whether the current location is inconsistent with the tracking information using predetermined rules. 146. The method of claim 146 wherein Each said coded data portion is at least a partial representation of a signature, said signature is at least partially a digital signature of said identifier, said presentation data at least partially representing at least one signature portion, The method in a computer system, Determining, from the indication data, at least one determined signature portion; And Authenticating the pharmaceutical formulation using the determined identifier and the at least one determined signature portion. 151. The method of claim 150, The method in a computer system and in response to successful authentication, Authorizing processing related to the pharmaceutical formulation; Updating the tracking data related to the pharmaceutical formulation. 146. The method of claim 146 wherein The method in a computer system, Communicating with a database, The database for storing data related to the pharmaceutical formulation, Authentication data including at least one key associated with the signature; Tracking data; And Including product data, The signature is a digital signature of at least some identifiers, The tracking data, the owner of the pharmaceutical formulation; One or more business processes performed using the pharmaceutical formulation; Location of the pharmaceutical formulation; And at least partially display tracking information including at least one of a location of the sensing device, and The product data, Product cost, patient identifier, user identifier, owner identifier, date of manufacture, batch number, product manufacturer, product distributor, product supplier, country of origin, ingredients, storage conditions, disposal conditions, serial number, expiration date, effect, At least partially presenting product information, including at least one of side effects, conditions of use, usage, further information, contraindications, and dosages. 152. The method of claim 152, The method in a computer system, Results of authentication; Tracking information; And Causing a display of at least one of the product information, 146. The method of claim 146 wherein The identifier is An identifier of the coded data portion, An identifier of the pharmaceutical formulation; EPC; An identifier of the packaging; And And at least partially formed from at least one of the identifiers of the packaging regions. 146. The method of claim 146 wherein The packaging, Blister packs; bottle; Bottle cap; label; Box; And And at least one of the sheet prints. 146. The method of claim 146 wherein The coded data is substantially invisible to the human eye. 146. The method of claim 146 wherein The coded data is, Invisible ink; And Printing on said surface using at least one of an infrared absorbing ink. 146. The method of claim 146 wherein And wherein said coded data is provided substantially in accordance with human readable and readable information. 152. The method of claim 152, The coded data comprises a plurality of coded data portions, The at least some coded data portions, Location of each coded data portion; Location of each coded data portion on the surface; The size of the coded data portions; Signature portion; The size of the signature; An identifier of the signature portion; Units of indicated locations; And Encoding at least one of at least portions of the data object, And wherein the entire data object is encoded at least once by a plurality of coded data portions. 161. The method of claim 159, The data target Multipose Internet Mail Extensions data; Text data; Image data; Audio data; Video data; Application data; Contact data; Information; Business card data; And And at least one of the directory data. 146. The method of claim 146 wherein The coded data is, Redundant data; Data to enable error correction; Reed-Solomon data; And At least one of cyclic redundancy check (CRC) data. 151. The method of claim 150, The digital signature is, A random number associated with the identifier; At least a lock hash of the identifier; A lock hash of at least an identifier generated using the private key and provable using the public key; A cipher-text generated by encoding at least the identifier; A cipher-text generated by encoding at least said identifier and a random number; And And at least one of cipher-text generated using a private key and provable using the public key. 146. The method of claim 146 wherein The coded data is arranged according to at least one layout having a plane of symmetry that rotates n times, n is at least 2, a layout containing n identical auxiliary layouts rotates 1 / n away from the center of rotation, At least one sub-layout comprises rotation indication data that separates the sub-layout from each other sub-layout. 146. The method of claim 146 wherein Wherein the coded data is arranged according to at least one layout having a symmetric plane that is rotated n times, n is at least 2, and the layout encoding the direction indication data includes an order of m, which is an integer multiple of n symbols, m is 1 or more, and each coded symbol is a symbol of each of the perimeters of the rotating symmetry plane of the layout such that decoding symbols in each n directions of the layout produces n representatives of direction data. distributed to n locations, each representative comprising a different periodic movement of the direction indication data and indicating a degree of rotation of the layout. As a method of determining possible replication of pharmaceutical packaging, Said packaging places coded data on or within said plurality of coded data portions, each coded data portion representing at least an identifier of said pharmaceutical formulation, The method in the sensing device, Sensing at least some of the coded data; Using the sensed coded data, determining indication data indicative of the identifier at least partially; And Transmitting the display data to a computer system; The computer system, From the indication data, the determined identifier is determined, Using the determined identifier to access tracking data related to the pharmaceutical formulation, Using the tracking data, in response to the indication data to determine if the pharmaceutical agent is replicable, Said tracking data comprising at least partially indicating a location of said pharmaceutical formulation. 146. The method of claim 146 wherein The method comprises the use of a processing terminal for performing the processing related to the pharmaceutical formulation, The terminal for business processing, A radiation source for exposing at least one coded data portion; A sensor for sensing at least one exposed coded data portion; And A processor for determining a sensed identifier using at least one sensed coded data portion and for performing the business process using the sensed identifier. 146. The method of claim 146 wherein The method includes the use of a printer to print the packaging, The printer, Determine visible information provided on the packaging, Determine an identifier associated with the pharmaceutical formulation, Generate coded data using the identifier, and For printing the packaging by printing the coded data and the visible information, The coded data comprises a plurality of coded data portions, each coded data portion representing at least an identifier of the pharmaceutical formulation. 146. The method of claim 146 wherein The method is further used to allow the user to interact with the pharmaceutical formulation, The method in a computer system, Receiving display data from the sensing device; The sensing device is responsive to the sensing of the coded data to generate display data that at least partially represents an identifier, Using the indication data, determining at least one operation; And Performing the operation associated with the pharmaceutical formulation, The operation is Providing information to the user; Updating tracking information related to the pharmaceutical preparation; Performing a business process related to the pharmaceutical preparation; And At least one of authenticating the pharmaceutical formulation, Receiving feedback from the user. 146. The method of claim 146 wherein The method is further used for authenticating a pharmaceutical formulation, each coded data portion further representing at least a portion of a signature, the signature being at least part of an identifier, a digital signature, encoded within multiple coded data portions, The method in the sensing device, Detecting at least one coded data portion; And Using the sensed coded data portion, the identifier; Generating display data indicative of the at least one signature portion; Within the processor, An identifier determined from the indication data; And determining at least one determined signature portion; And Authenticating the pharmaceutical formulation using the determined identifier and the at least one determined signature portion. 146. The method of claim 146 wherein The method is further used to authenticate the pharmaceutical formulation, each coded data portion further representing at least a portion of a signature, the signature being a digital signature of at least some identifiers, The method in a computer system, Receiving display data from the sensing device; The sensing device may include an identifier of the pharmaceutical formulation; And responsive to sensing of the coded data to generate display data at least partially representing the signature portion, An identifier determined from the indication data; And determining at least one determined signature portion; And Authenticating the pharmaceutical formulation using the determined identifier and the at least one determined signature portion. 146. The method of claim 146 wherein The method is further used to track the pharmaceutical formulation, The method in a computer system, Receiving display data from the sensing device; And The sensing device is responsive to the sensing of the coded data to generate display data representing an identifier of the product item, Updating the tracking data indicative of the tracking information, at least in part, using the received indication data. 146. The method of claim 146 wherein The method is further used to produce pharmaceutical packaging, The method in a computer system, Determining a serial number associated with the pharmaceutical formulation; Generating an identifier using the serial number; Using the identifier, generating a signature; Using the identifier, causing generation of coded data; The coded data comprises a plurality of coded data portions, Each coded data portion comprises: the identifier; And encode the signature, The signature is at least a partial digital signature of the identifier, Causing, on the pharmaceutical package, causing printing of at least some coded data and at least one of the identifier and the serial number. 146. The method of claim 146 wherein The method is further used for dispensing the pharmaceutical formulation, The method in a computer system, Receiving display data from the sensing device; The sensing device is responsive to sensing of the coded data to generate display data at least partially indicating an identifier, Using the indication data, determining at least one criterion for dispensing the pharmaceutical formulation from a distribution database; And Causing the pharmaceutical formulation to be dispensed if the at least one criterion is met. 146. The method of claim 146 wherein The sensing device is for use with the pharmaceutical formulation, The sensing device, A housing adapted to be held by the user in use; A radiation source for exposing at least one coded data portion; A sensor for sensing at least one exposed coded data portion; And And a processor for determining a sensed identifier using at least one sensed coded data portion. As a way to track pharmaceuticals, Wherein the pharmaceutical agent is associated with a packaging in which coded data is placed on or within the plurality of coded data portions, each coded data portion representing an identifier of the pharmaceutical agent, The method in a computer system, Receiving display data from a sensing device; And The sensing device is responsive to the sensing of the coded data to generate display data indicative of an identifier of the product item, Updating the tracking data indicative of the tracking information at least partially using the received indication data. 175. The method of claim 175, At least one of the tracking information and the display data, An identifier of the sensing device; The identifier of the patient; An identifier of the current owner of the pharmaceutical formulation; One or more business processes performed using the pharmaceutical formulation; Location of the pharmaceutical formulation; And And at least one of the locations of the sensing devices. 175. The method of claim 175, Each of the coded data portions represents at least a portion of a signature, the signature is a digital signature of at least some identifiers, the presentation data at least partially represents at least one signature portion, The method in a computer system, Determining at least one determined signature portion from the indication data; And Authenticating the pharmaceutical formulation using the determined identifier and the at least one determined signature portion. 178. The method of claim 177, The method in a computer system and in response to successful authentication, Recognizing a business process related to the pharmaceutical formulation; And Updating the tracking data. 178. The method of claim 177, The full signature is encoded within a plurality of coded data portions, And the system comprises the sensing device designed to sense a plurality of coded data portions to thereby determine the full signature. 175. The method of claim 175, The method in a computer system, Communicating with a database, The database for storing data related to the pharmaceutical formulation, Authentication data comprising at least one key associated with the signature; And At least one of the product data, The signature is a digital signature of at least some identifiers, and The product data, Product cost, patient identifier, user identifier, owner identifier, date of manufacture, batch number, product manufacturer, product distributor, product supplier, country of origin, ingredients, storage conditions, disposal conditions, serial number, expiration date, effect, At least partly presenting product information, including at least one of side effects, conditions of use, usage, further information, contraindications, and dosages, 175. The method of claim 175, The method in a computer system, Results of authentication; Tracking information; And Causing the display of at least one of the product information. 178. The method of claim 177, The coded data comprises a plurality of layouts, each layout defining the position of the plurality of first symbols encoding the identifier, and the plurality of second symbols define at least some signatures Way. 175. The method of claim 175, The identifier is Coded data portion identifier; An identifier of the pharmaceutical formulation; EPC; An identifier of the packaging; And And at least partially formed from at least one of the identifiers of the packaging regions. 175. The method of claim 175, The packaging, Blister packs; bottle; Bottle cap; label; Box; And A method comprising at least one of cut sheets. 175. The method of claim 175, The coded data is substantially invisible to the human eye. 175. The method of claim 175, The coded data is, Invisible ink; And Printing on said surface using at least one of an infrared absorbing ink. 175. The method of claim 175, Wherein said coded data is provided in substantially coincident with human-readable and readable information. 178. The method of claim 179, The coded data comprises a plurality of coded data portions, The at least some of the coded data portions, Location of each coded data portion; The location of each coded data portion on the surface; The size of the coded data portions; Signature portion; The size of the signature; An identifier of the signature portion; Units of indicated locations; And Encoding at least one of at least portions of the data object, And wherein the entire data object is encoded at least once by a plurality of coded data portions. 185. The method of claim 188, The data target, Multipose Internet Mail Extensions data; Text data; Image data; Audio data; Video data; Application data; Contact data; Information; Business card data; And And at least one of the directory data. 175. The method of claim 175, The coded data is, Redundant data; Data to enable error correction; Reed-Solomon data; And And at least one of cyclic redundancy check (CRC) data. 178. The method of claim 179, The digital signature is, A random number associated with the identifier; A lock hash of at least the identifier; A lock hash of at least the identifier generated using the private key and provable using the public key; A cipher-text generated by encoding at least the identifier, A cipher-text generated by encoding at least the identifier and the random number, And at least one of cipher-text generated using a private key and provable using the public key. 175. The method of claim 175, The coded data is arranged according to at least one layout having a plane of symmetry that rotates n times, n is at least 2, a layout containing n identical auxiliary layouts rotates 1 / n away from the center of rotation, At least one sub-layout comprises rotation indication data that separates the sub-layout from each other sub-layout. 175. The method of claim 175, Wherein the coded data is arranged according to at least one layout having a symmetric plane that is rotated n times, n is at least 2, and the layout encoding the direction indication data includes an order of m, which is an integer multiple of n symbols, m is 1 or more, and each coded symbol is each of the perimeter of the rotating symmetry plane of the layout such that decoding the symbols in each of the n directions of the layout produces n representatives of direction data. Wherein each representative includes a different periodic movement of the direction indication data and indicates the degree of rotation of the layout. As a way to track pharmaceuticals, The pharmaceutical formulation is associated with a packaging in which the coded data is placed on or within the plurality of coded data portions, Each coded data portion represents an identifier of the pharmaceutical formulation, The method in the sensing device, Sensing at least some of the coded data; Using the sensed coded data, determining indication data indicative of the identifier at least partially; And Transmitting the display data to a computer system, And the computer system uses the received indication data to react to the indication data to cause the tracking data to be updated. 175. The method of claim 175, The method comprises the use of a business terminal to perform business processes related to the pharmaceutical formulation, The terminal for business processing, A radiation source for exposing at least one coded data portion; A sensor for sensing at least one exposed coded data portion; And A processor for determining a sensed identifier using at least one sensed coded data portion and for performing the business process using the sensed identifier. 175. The method of claim 175, The method includes the use of a printer to print the packaging, The printer, Determine visible information provided on the packaging, Determine an identifier associated with the pharmaceutical formulation, Generate coded data using the identifier, For printing the packaging by printing the coded data and the visible information, The coded data comprises a plurality of coded data portions, each coded data portion representing at least an identifier of the pharmaceutical formulation. 175. The method of claim 175, The method is further used to allow the user to interact with the pharmaceutical formulation, The method in a computer system, Receiving display data from the sensing device; The sensing device is responsive to sensing of the coded data at least in part to generate display data indicative of the identifier, Using the indication data, determining at least one operation; And Performing the operation associated with the pharmaceutical formulation, The operation is Providing information to the user; Updating tracking information related to the pharmaceutical preparation; Performing a business process related to the pharmaceutical preparation; Authenticating the pharmaceutical formulation; And At least one of receiving feedback from the user, Method comprising a. 175. The method of claim 175, The method is further used for authenticating the pharmaceutical formulation, each coded data portion further representing at least a portion of a signature, the signature being a digital signature of at least some identifiers, encoded within a plurality of coded data portions and , The method in the sensing device, Detecting at least one coded data portion; And Using the sensed coded data portion, the identifier; Generating display data indicative of the at least one signature portion; Within the processor, An identifier determined from the indication data; And determining at least one determined signature portion; Authenticating the pharmaceutical formulation using the determined identifier and the at least one determined signature portion. 175. The method of claim 175, The method is further used to authenticate the pharmaceutical formulation, each coded data portion further representing at least a portion of a signature, the signature being a digital signature of at least some identifiers, The method in a computer system, Receiving display data from the sensing device; The sensing device may include an identifier of the pharmaceutical formulation; And responsive to sensing of the coded data to generate display data at least partially representing the signature portion, An identifier determined from the indication data; And determining at least one determined signature portion; Authenticating the pharmaceutical formulation using the determined identifier and the at least one determined signature portion. 175. The method of claim 175, The method is further used to determine possible replication of pharmaceutical packaging, The method in a computer system, Receiving display data from a sensing device; The sensing device is responsive to the sensing of the coded data to generate display data indicative of the identifier, Determining, from the indication data, the determined identifier; Accessing the tracking data related to the pharmaceutical formulation using the determined identifier; And The tracking data is at least partially an indication of a location of the pharmaceutical formulation, Using the tracking data, determining if the pharmaceutical formulation is a possible duplicate. 175. The method of claim 175, The method is further used to produce pharmaceutical packaging, The method in a computer system, Determining a serial number associated with the pharmaceutical formulation; Generating an identifier using the serial number; Using the identifier, generating a signature; Using the identifier, causing generation of coded data; And The coded data includes a plurality of coded data portions, each coded data portion comprising: the identifier; And encode the signature, The signature is a digital signature of at least some identifiers, On the pharmaceutical package, at least some coded data and the identifier; And causing printing of at least one of the serial numbers. 175. The method of claim 175, The method is further used for dispensing the pharmaceutical formulation, The method in a computer system, Receiving display data from the sensing device; The sensing device is responsive to sensing of the coded data at least in part to generate display data indicative of the identifier, Using the indication data, determining at least one criterion for dispensing the pharmaceutical formulation from a distribution database; And Causing the dispensing to the pharmaceutical formulation if the at least one criterion is met. 175. The method of claim 175, The sensing device is for use with the pharmaceutical formulation, The sensing device, A housing adapted to be held by the user in use; A radiation source for exposing at least one coded data portion; A sensor for sensing at least one exposed coded data portion; And And a processor for determining a sensed identifier using at least one sensed coded data portion. As a method of producing pharmaceutical packaging, The method in a computer system, Determining a serial number associated with the pharmaceutical formulation; Generating an identifier using the serial number; Generate a signature using the identifier, the signature is a digital signature that is at least part of the identifier, Using the identifier, causing generation of coded data; And On the pharmaceutical package, the identifier; And causing printing of at least one of the serial numbers, The coded data includes a plurality of coded data portions, each coded data portion comprising: the identifier; And encoding at least some signatures. 204. The method of claim 204, The identifier is Serial number of the pharmaceutical formulation; An identifier of the pharmaceutical formulation; EPC; An identifier of the packaging; And And at least partially formed from at least one of the identifiers of the packaging regions. 204. The method of claim 204, And the method comprises encoding the entire signature within the plurality of coded data portions. 204. The method of claim 204, The method, Determining visible information related to the pharmaceutical formulation; Determining content; Recording an association between the identifier and the layout; And Using the layout, causing printing of the packaging, And said content is a layout of said visible information. 213. The method of claim 207, The foregoing indicates at least one operation associated with a pharmaceutical formulation, The operation is Providing information to the user; Updating tracking information related to the pharmaceutical preparation; Performing a business process related to the pharmaceutical preparation; Authenticating the pharmaceutical formulation; And At least one of receiving feedback from the user. 204. The method of claim 204, The method in the computer system, Communicating with a database, The database for storing data related to the pharmaceutical formulation, Authentication data including at least one key associated with the signature; Tracking data; And Including product data, The signature is a digital signature of at least some identifiers, The tracking data, Owner of the pharmaceutical formulation; One or more business processes performed using the pharmaceutical formulation; Location of the pharmaceutical formulation; And At least partially indicate tracking information including at least one of a location of the sensing device, The product data, Product cost, patient identifier, user identifier, owner identifier, date of manufacture, batch number, product manufacturer, product distributor, product supplier, country of origin, ingredient, storage condition, disposal condition, serial number, expiration date, effect, At least partly presenting product information comprising at least one of side effects, conditions of use, usage, further information, contraindications and dosages. 208. The method of claim 209 wherein The method in the computer system, Updating at least some of said data relating to said pharmaceutical formulation; And Generating said coded data using at least some of said data relating to said pharmaceutical formulation. 204. The method of claim 204, The method in the computer system, Receiving from a scanning system in response to the scanning of the packaging; Information is, A source of the pharmaceutical formulation; The type of pharmaceutical preparation; An identifier of the pharmaceutical formulation; And At least one of a serial number of the pharmaceutical formulation. 204. The method of claim 204, The coded data may include at least one coded data portion by a sensing device. The identifier; At least one signature portion; Location of the sensing device relative to the packaging; And And a plurality of reference points to allow determination of at least one of the movements of the sensing device in relation to the packaging. 204. The method of claim 204, The identifier is Coded data portion identifier; An identifier of the pharmaceutical formulation; EPC; An identifier of the packaging; And And at least partially formed from at least one of the identifiers of the packaging regions. 204. The method of claim 204, The packaging, Blister packs; bottle; Bottle cap; label; Box; And At least one of a sheet printed matter. 204. The method of claim 204, The coded data is substantially invisible to the human eye. 204. The method of claim 204, The coded data is Invisible ink; And Printing on said surface using at least one of an infrared absorbing ink. 204. The method of claim 204, Wherein said coded data is provided in substantially coincident with human-readable and readable information. 204. The method of claim 204, The coded data comprises a plurality of coded data portions, At least some of the coded data portions, Location of each coded data portion; The location of each coded data portion on the surface; The size of the coded data portions; Signature portion; The size of the signature; An identifier of the signature portion; Units of indicated locations; And Encoding at least one of at least portions of the data object, And wherein the entire data object is encoded at least once by a plurality of coded data portions. 218. The method of claim 218, The data target Multipose Internet Mail Extensions data; Text data; Image data; Audio data; Video data; Application data; Contact data; Information; Business card data; And And at least one of the directory data. 204. The method of claim 204, The coded data is Redundant data; Data to enable error correction; Reed-Solomon data; And And at least one of cyclic redundancy check (CRC) data. 204. The method of claim 204, The digital signature is, A random number associated with the identifier; A lock hash of at least the identifier; A lock hash of at least the identifier generated using the private key and provable using the public key; A cipher-text generated by encoding at least the identifier, A cipher-text generated by encoding at least said identifier and a random number, and And at least one of cipher-text generated using a private key and provable using the public key. 204. The method of claim 204, The coded data is arranged according to at least one layout having a plane of symmetry that rotates n times, n is at least 2, a layout containing n identical auxiliary layouts rotates 1 / n away from the center of rotation, At least one sub-layout comprises rotation indication data that separates the sub-layout from each other sub-layout. 204. The method of claim 204, Wherein the coded data is arranged according to at least one layout having a symmetric plane that is rotated n times, n is at least 2, and the layout encoding the direction indication data includes an order of m, which is an integer multiple of n symbols, m is 1 or more, and each coded symbol is a symbol of each of the perimeters of the rotating symmetry plane of the layout such that decoding symbols in each n directions of the layout produces n representatives of direction data. distributed to n locations, each representative comprising a different periodic movement of the direction indication data and indicating a degree of rotation of the layout. 204. The method of claim 204, The method comprises the use of a processing terminal for performing the processing related to the pharmaceutical formulation, The terminal for business processing, A radiation source for exposing at least one coded data portion; A sensor for sensing at least one exposed coded data portion; And A processor for determining a sensed identifier using at least one sensed coded data portion and for performing the business process using the sensed identifier. 204. The method of claim 204, The method includes the use of a printer to print the packaging, The printer, Determine visible information provided on the packaging, Determine an identifier associated with the pharmaceutical formulation, Generate coded data using the identifier, The coded data comprises a plurality of coded data portions, and For printing the packaging by printing the coded data and the visible information, Wherein each coded data portion represents at least an identifier of the pharmaceutical formulation. 204. The method of claim 204, The method is further used to allow the user to interact with the pharmaceutical formulation, The method in a computer system, Receiving display data from the sensing device; The sensing device is responsive to sensing of the coded data at least in part to generate display data indicative of the identifier, Using the indication data, determining at least one operation; Performing the operation associated with the pharmaceutical formulation, The operation is Providing information to the user; Updating tracking information related to the pharmaceutical preparation; Performing a business process related to the pharmaceutical preparation; Authenticating the pharmaceutical formulation; And At least one of receiving feedback from the user. 204. The method of claim 204, The method is further used to authenticate the pharmaceutical agent, each coded data portion further representing at least a portion of a signature, the signature being a digital signature of at least some identifier, encoded within a plurality of coded data portions , The method in the sensing device, Detecting at least one coded data portion; And Using the sensed coded data portion, the identifier; Generating display data indicative of the at least one signature portion; Within the processor, An identifier determined from the indication data; And determining at least one determined signature portion; Authenticating the pharmaceutical formulation using the determined identifier and the at least one determined signature portion. 204. The method of claim 204, The method is further used for authenticating a pharmaceutical formulation, each coded data portion further representing at least a portion of a signature, the signature being a digital signature of at least some identifiers, The method in a computer system, Receiving display data from the sensing device; The sensing device may include an identifier of the pharmaceutical formulation; And responsive to sensing of the coded data to generate display data at least partially representing the signature portion, An identifier determined from the indication data; And determining at least one determined signature portion; And Authenticating the pharmaceutical formulation using the determined identifier and the at least one determined signature portion. 204. The method of claim 204, The method is further used to determine possible replication of the pharmaceutical packaging, The method in a computer system, Receiving display data from a sensing device; The sensing device is responsive to the sensing of the coded data to generate display data indicative of the identifier, Determining, from the indication data, the determined identifier; Accessing the tracking data related to the pharmaceutical formulation using the determined identifier; And The tracking data at least partially indicates the location of the pharmaceutical formulation, Using the tracking data to determine if the pharmaceutical formulation is a possible duplicate. 204. The method of claim 204, The method is further used to track the pharmaceutical formulation, The method in a computer system, Receiving display data from the sensing device; The sensing device is responsive to the sensing of the coded data to generate indication data indicative of an identifier of the product item, Updating the tracking data indicative of the tracking information at least partially using the received indication data. 204. The method of claim 204, The method is further used for dispensing the pharmaceutical formulation, The method in a computer system, Receiving display data from the sensing device; The sensing device is responsive to sensing of the coded data at least in part to generate display data indicative of the identifier, Using the indication data, determining at least one criterion for dispensing the pharmaceutical formulation from a distribution database; And Causing the pharmaceutical formulation to be dispensed if the at least one criterion is met. 204. The method of claim 204, The sensing device is for use with the pharmaceutical formulation, The sensing device, A housing adapted to be held by the user in use; A radiation source for exposing at least one coded data portion; A sensor for sensing at least one exposed coded data portion; And And a processor for determining a sensed identifier using at least one sensed coded data portion. As a method for dispensing pharmaceuticals, The pharmaceutical formulation is associated with a packaging in which coded data is placed thereon or within, at least some coded data representing at least an identifier of the pharmaceutical formulation, The method in a computer system, Receiving display data from a sensing device; The sensing device is responsive to sensing of the coded data at least in part to generate display data indicative of the identifier, Using the indication data, determining at least one criterion for dispensing the pharmaceutical formulation from a distribution database; And Causing the pharmaceutical formulation to be dispensed if the at least one criterion is met. 233. The method of claim 233 wherein The at least one criterion indicates an intended recipient of the pharmaceutical formulation, The method in a computer system, Determining identifier data indicative of an identifier of the entity requesting the pharmaceutical formulation; Comparing the identifier data with the at least one criterion; And Determining that the at least one criterion is satisfied if the identifier of the entity is the same as the identifier of the intended recipient. 234. The method of claim 234 wherein The sensing device includes a data store for storing the identifier data, And the method comprises determining the identifier data from the data store. 233. The method of claim 233 wherein The at least one criterion is, An intended time for dispensing the pharmaceutical formulation; An intended date for dispensing the pharmaceutical formulation; And At least one of the intended locations for dispensing the pharmaceutical. 233. The method of claim 233 wherein The coded data includes a plurality of coded data portions, each coded data portion representing at least a portion of a signature, the signature being a digital signature of at least some identifiers, and for sensing at least one coded data portion. In response, the sensing device generates display data at least partially representing at least one signature portion, The method in a computer system, Determining, from the indication data, a determined identifier and at least one determined signature portion; Authenticating the pharmaceutical formulation using the determined identifier and the at least one determined signature portion; And Dispensing the pharmaceutical formulation for successful authentication. 237. The method of claim 237, The full signature is encoded within a plurality of coded data portions, The method in the sensing device comprises sensing a plurality of coded data portions to determine the full signature. 233. The method of claim 233 wherein The method in a computer system, Communicating with a database, The database for storing data related to the pharmaceutical formulation, Authentication data comprising at least one key associated with the signature; Tracking data; And At least one of the product data, The signature is a digital signature of at least some identifiers, The tracking data, The owner of the pharmaceutical formulation, One or more business processes performed using the pharmaceutical agent, Location of the pharmaceutical formulation, and At least partially display tracking information including at least one of a location of the sensing device; The product data, Product cost, patient identifier, user identifier, owner identifier, date of manufacture, batch number, product manufacturer, product distributor, product supplier, country of origin, ingredients, storage conditions, disposal conditions, serial number, expiration date, effect, A method comprising at least partially indicating product information including at least one of side effects, conditions of use, usage, further information, contraindications, and dosages, 233. The method of claim 233 wherein The method in a computer system, Results of authentication; Tracking information; And Causing an indication of at least one of the product information. 233. The method of claim 233 wherein The identifier is Coded data portion identifier; An identifier of the pharmaceutical formulation; EPC; An identifier of the packaging; And And at least partially formed from at least one of the identifiers of the packaging regions. 233. The method of claim 233 wherein The packaging, Blister packs; bottle; Bottle cap; label; Box; And A method comprising at least one of cut sheets. 233. The method of claim 233 wherein The coded data is substantially invisible to the human eye. 233. The method of claim 233 wherein The coded data is, Invisible ink; And Printing on said surface using at least one of an infrared absorbing ink. 233. The method of claim 233 wherein And wherein said coded data is provided substantially in accordance with human readable and readable information. 237. The method of claim 237, The coded data comprises a plurality of coded data portions, The at least some of the coded data portions, Location of each coded data portion; The location of each coded data portion on the surface; The size of the coded data portions; Signature portion; The size of the signature; An identifier of the signature portion; Units of indicated locations; And Encoding at least one of at least portions of the data object, And wherein the entire data object is encoded at least once by a plurality of coded data portions. 246. The method of claim 246 The data target Multipose Internet Mail Extensions data; Text data; Image data; Audio data; Video data; Application data; Contact data; Information; Business card data; And And at least one of the directory data. 233. The method of claim 233 wherein The coded data is Surplus data Data that enables error correction Reed-Solomon data; And And at least one of cyclic redundancy check (CRC) data. 237. The method of claim 237, The digital signature is, A random number associated with the identifier; A lock hash of at least the identifier; A lock hash of at least the identifier generated using the private key and provable using the public key; A cipher-text generated by encoding at least the identifier; Encrypted text generated by encoding at least said identifier and a random number; And And at least one of cipher-text generated using a private key and provable using the public key. 233. The method of claim 233 wherein The coded data is arranged according to at least one layout having a plane of symmetry that rotates n times, n is at least 2, a layout containing n identical auxiliary layouts rotates 1 / n away from the center of rotation, At least one sub-layout comprises rotation indication data that separates the sub-layout from each other sub-layout. 233. The method of claim 233 wherein Wherein the coded data is arranged according to at least one layout having a symmetric plane that is rotated n times, n is at least 2, and the layout encoding the direction indication data includes an order of m, which is an integer multiple of n symbols, m is 1 or more, and each coded symbol is a symbol of each of the perimeters of the rotating symmetry plane of the layout such that decoding symbols in each n directions of the layout produces n representatives of direction data. distributed to n locations, each representative comprising a different periodic movement of the direction indication data and indicating a degree of rotation of the layout. As a method of dispensing pharmaceuticals, The pharmaceutical formulation is associated with a packaging in which coded data is placed thereon or within, at least some of the coded data representing at least an identifier of the pharmaceutical formulation, The method in the sensing device, Sensing at least some of the coded data; Using the sensed coded data, determining indication data indicative of the identifier at least partially; Transmitting the display data to a computer system, The computer system, The indication data is used to determine at least one criterion for dispensing the pharmaceutical from a distribution database and to respond to the indication data to cause the pharmaceutical to be dispensed if the at least one criterion is satisfied. Characterized in that. 233. The method of claim 233 wherein The method comprises the use of a processing terminal for performing the processing related to the pharmaceutical formulation, The terminal for business processing, A radiation source for exposing at least one coded data portion; A sensor for sensing at least one exposed coded data portion; And A processor for determining a sensed identifier using at least one sensed coded data portion and for performing the business process using the sensed identifier. 233. The method of claim 233 wherein The method, The use of a printer to print the packaging, The printer, Determine visible information provided on the packaging, Determine an identifier associated with the pharmaceutical formulation, Using the identifier, generate coded data, The coded data comprises a plurality of coded data portions, each coded data portion representing at least an identifier of the pharmaceutical formulation, and for printing the packaging by printing the coded data and the visible information. How to. 233. The method of claim 233 wherein The method is further used to allow the user to interact with the pharmaceutical formulation, The method in a computer system, Receiving display data from the sensing device; The sensing device is responsive to sensing of the coded data at least in part to generate display data indicative of the identifier, Using the indication data, determining at least one operation; And Performing the operation associated with the pharmaceutical formulation, The operation is Providing information to the user; Updating tracking information related to the pharmaceutical preparation; Performing a business process related to the pharmaceutical preparation; Authenticating the pharmaceutical formulation; And At least one of receiving feedback from the user. 233. The method of claim 233 wherein The method is further used to authenticate the pharmaceutical agent, each coded data portion further representing at least a portion of a signature, the signature being a digital signature of at least some identifier, encoded within a plurality of coded data portions , The method in the sensing device, Detecting at least one coded data portion; And Using the sensed coded data portion, the identifier; Generating display data indicative of the at least one signature portion; Within the processor, An identifier determined from the indication data; And determining at least one determined signature portion; Authenticating the pharmaceutical formulation using the determined identifier and the at least one determined signature portion. 233. The method of claim 233 wherein The method is further used to authenticate the pharmaceutical formulation, each coded data portion further representing at least a portion of a signature, the signature being a digital signature of at least some identifiers, The method in a computer system, Receiving display data from the sensing device; The sensing device may include an identifier of the pharmaceutical formulation; And responsive to sensing of the coded data to generate display data at least partially representing the signature portion, An identifier determined from the indication data; And determining at least one determined signature portion; And Authenticating the pharmaceutical formulation using the determined identifier and the at least one determined signature portion. 233. The method of claim 233 wherein The method is further used to determine possible replication of the pharmaceutical packaging, The method in a computer system, Receiving display data from a sensing device; The sensing device is responsive to the sensing of the coded data to generate display data indicative of the identifier, Determining, from the indication data, the determined identifier; Accessing the tracking data related to the pharmaceutical formulation using the determined identifier; And The tracking data at least partially represents a location of the pharmaceutical formulation, Using the tracking data, determining if the pharmaceutical formulation is a possible duplicate. 233. The method of claim 233 wherein The method is further used to track pharmaceuticals, The method in a computer system, Receiving display data from the sensing device; And The sensing device is responsive to sensing of the coded data to generate display data indicative of an identifier of the product item, Using the received indication data, updating the tracking data at least partially indicative of the tracking information. 233. The method of claim 233 wherein The method is further used to produce pharmaceutical packaging, The method in a computer system, Determining a serial number associated with the pharmaceutical formulation; Generating an identifier using the serial number; Using the identifier, generating a signature; Using the identifier, causing generation of coded data; The coded data includes a plurality of coded data portions, each coded data portion comprising: the identifier; And encode a signature, the signature being a digital signature of at least some identifiers, At least some coded data and said identifier on said pharmaceutical packaging; And causing printing of at least one of the serial numbers. 233. The method of claim 233 wherein The sensing device is for use with the pharmaceutical formulation, The sensing device, A housing adapted to be held by the user in use; A radiation source for exposing at least one coded data portion; A sensor for sensing at least one exposed coded data portion; And And a processor for determining a sensed identifier using at least one sensed coded data portion. Sensing device for use with pharmaceuticals, The pharmaceutical formulation is associated with a packaging in which coded data is placed on or in the plurality of coded data portions, each coded data couple representing an identifier of the pharmaceutical formulation, The sensing device, A housing adapted to be held by the user in use; A radiation source for exposing at least one coded data portion; A sensor for sensing at least one exposed coded data portion; And And a processor for determining a sensed identifier, using at least one sensed coded data portion. 262. The method of claim 262, The sensing device includes a communication system, The processor, Generate display data at least partially indicative of the detected identifier, and Transmit the display data to a computer system, The computer system, Authentication of the pharmaceutical formulation; Approving the transaction; Determination of business details; And And responsive to the indication data to perform an operation that includes at least one of updating tracking information related to the pharmaceutical formulation. 262. The method of claim 262, The processor, Authentication of the pharmaceutical formulation; Approving the transaction; Determining the business details; And And use the sensed identifier to perform at least one of updating tracking information related to the pharmaceutical formulation. 262. The method of claim 262, The identifier is Serial number of the pharmaceutical formulation; An identifier of the pharmaceutical formulation; EPC; An identifier of the packaging; And And at least partially formed from at least one of the identifiers of the packaging regions. 262. The method of claim 262, The coded data portion represents at least part of a signature, the signature is a digital signature of at least some identifier, The processor, Using the at least one sensed coded data portion, determining at least one sensed signature portion, And use the detected identifier and the at least one detected signature portion to cause authentication of the pharmaceutical formulation. 266. The method of claim 266, The pharmaceutical formulation, Using the detected identifier, determine a key, Using the detected identifier and the key, determine a determined signature, and And at least one of a processor and a computer system for comparing the at least one detected signature portion with the determined signature to authenticate the pharmaceutical formulation. 266. The method of claim 266, The full signature is encoded in a plurality of coded data portions, The processor determines a sensed signature from the plurality of sensed coded data portions, The pharmaceutical formulation, Determine a key using the detected identifier, Using the detected signature and the key, determine a determined identifier, and And at least one of the processor and the computer system for comparing the determined identifier with the sensed identifier to thereby authenticate the pharmaceutical formulation. 266. The method of claim 266, The coded data comprises a plurality of layouts, each layout defining the position of the plurality of first symbols encoding the identifier, and the plurality of second symbols define at least some signatures Sensing device. 262. The method of claim 262, The packaging, Blister packs; bottle; Bottle cap; label; Box; And Sensing device comprising at least one of a single sheet. 262. The method of claim 262, The sensing device includes a communication system in communication with a database, the database storing data relating to the pharmaceutical formulation, Authentication data comprising at least one key associated with the signature; Tracking data; And Include at least one of the product data, The signature is a digital signature of at least some identifiers, The tracking data, Owner of the pharmaceutical formulation; One or more business processes performed using the pharmaceutical formulation; Location of the pharmaceutical formulation; And At least partially indicate tracking information including at least one of a location of the sensing device, The product data, Product Cost, Patient Identifier, User Identifier, Owner Identifier, Date of Manufacture, Batch Number, Product Manufacturer, Product Distributor, Product Supplier, Country of Origin, Ingredient, Storage Conditions, Processing Conditions, Serial Number, Expiry Date, Effect Detecting, at least in part, product information, including at least one of side effects, conditions of use, usage, further information, contraindications, and dosages; 262. The method of claim 262, The sensing device, Results of authentication; Tracking information; And And a display for showing at least one of the product information. 262. The method of claim 262, The coded data is substantially invisible to the human eye. 262. The method of claim 262, The coded data is, Invisible ink; And And a sensing device printed on the surface using at least one of infrared absorption ink. 262. The method of claim 262, And the coded data is provided in substantially coincident with human visible and readable information. 266. The method of claim 266, The coded data comprises a plurality of coded data portions, The at least some coded data portions Location of each coded data portion; The location of each coded data portion on the surface; The size of the coded data portions; Signature part; The size of the signature; An identifier of the signature portion; Units of indicated locations; And Encoding at least one of at least portions of the data object, And the entire data object is encoded at least once by a plurality of coded data portions. 277. The method of claim 275, wherein The data target, Multipose Internet Mail Extensions data; Text data; Image data; Audio data; Video data; Application data; Contact data; Information; Business card data; And And at least one of the directory data. 262. The method of claim 262, The coded data is, Redundant data; Data to enable error correction; Reed-Solomon data; And And at least one of cyclic redundancy check (CRC) data. 266. The method of claim 266, The digital signature is, A random number associated with the identifier; A lock hash of at least the identifier; A lock hash of at least the identifier generated using the private key and provable using the public key; A cipher-text generated by encoding at least the identifier; A cipher-text generated by encoding at least said identifier and a random number; And And at least one of cipher-text that is generated using a private key and can be authenticated using a corresponding public key. 262. The method of claim 262, The coded data is arranged according to at least one layout having a plane of symmetry that rotates n times, n is at least 2, a layout containing n identical auxiliary layouts rotates 1 / n away from the center of rotation, And at least one auxiliary layout includes rotation indication data that separates the auxiliary layout from each other auxiliary layout. 262. The method of claim 262, Wherein the coded data is arranged according to at least one layout having a symmetric plane that is rotated n times, n is at least 2, and the layout encoding the direction indication data includes an order of m, which is an integer multiple of n symbols, m is 1 or more, and each coded symbol is a symbol of each of the perimeters of the rotating symmetry plane of the layout such that decoding symbols in each n directions of the layout produces n representatives of direction data. and is distributed to n locations, each representative including a different periodic movement of the direction indication data and indicating the degree of rotation of the layout. 262. The method of claim 262, The sensing device is connected to a business processing terminal for performing business processes related to the pharmaceutical agent, The business processing terminal, A radiation source for exposing at least one coded data portion; A sensor for sensing at least one exposed coded data portion; And And a processor for determining a sensed identifier using at least one sensed coded data portion and for performing the business process using the sensed identifier. 262. The method of claim 262, The sensing device is connected to a printer to print a packaging associated with the pharmaceutical agent, The printer, Determine visible information provided on the packaging, Determine an identifier associated with the pharmaceutical formulation, Generate coded data using the identifier, the coded data comprising a plurality of coded data portions, each coded data portion representing at least an identifier of the pharmaceutical agent, and And to print the packaging by printing the coded data and the visible information. 262. The method of claim 262, The sensing device is further used to perform a method to allow a user to interact with the pharmaceutical agent, The method in a computer system, Receiving display data from the sensing device; The sensing device is responsive to sensing of the coded data at least in part to generate display data indicative of the identifier, Using the indication data, determining at least one operation; And Performing the operation associated with the pharmaceutical formulation, The operation is Providing information to the user; Updating tracking information related to the pharmaceutical preparation; Performing a business process related to the pharmaceutical preparation; Authenticating the pharmaceutical formulation; And And at least one of receiving feedback from the user. 262. The method of claim 262, The sensing device is further used to perform a method for authenticating the pharmaceutical formulation, each coded data portion further representing at least a portion of a signature, the signature being a digital signature of at least some identifiers, a plurality of coded data Coded within the parts, The method in the sensing device, Detecting at least one coded data portion; And Using the sensed coded data portion, the identifier; Generating display data indicative of the at least one signature portion; Within the processor, An identifier determined from the indication data; And determining at least one determined signature portion; And authenticating the pharmaceutical formulation using the determined identifier and the at least one determined signature portion. 262. The method of claim 262, The sensing device is further used to perform a method for authenticating the pharmaceutical formulation, each coded data portion further representing at least a portion of a signature, the signature being a digital signature of at least some identifiers, The method in a computer system, Receiving display data from the sensing device; The sensing device may include an identifier of the pharmaceutical formulation; And responsive to sensing of the coded data to generate display data at least partially representing the signature portion, An identifier determined from the indication data; And determining at least one determined signature portion; And And authenticating the pharmaceutical formulation using the determined identifier and the at least one determined signature portion. 262. The method of claim 262, The sensing device is further used to carry out a method of determining possible replication of pharmaceutical packaging, The method in a computer system, Receiving display data from the sensing device; The sensing device is responsive to the sensing of the coded data to generate display data indicative of the identifier, Determining, from the indication data, the determined identifier; Accessing the tracking data related to the pharmaceutical formulation using the determined identifier; And The tracking data at least partially represents a location of the pharmaceutical formulation, and And using the tracking data to determine if the pharmaceutical is a replica possible. 262. The method of claim 262, The sensing device is further used to carry out a method for tracking the pharmaceutical formulation, The method in a computer system, Receiving display data from a sensing device; And The sensing device is responsive to the sensing of the coded data to generate display data indicative of an identifier of the product item, And updating the tracking data indicative of the tracking information at least in part by using the received display data. 262. The method of claim 262, The sensing device is further used to carry out a method for producing pharmaceutical packaging, The method in a computer system, Determining a serial number associated with the pharmaceutical formulation; Generating an identifier using the serial number; Using the identifier, generating a signature; Using the identifier, causing generation of coded data; And The coded data comprises a plurality of coded data portions, Each coded data portion comprises: the identifier; And encode the signature, The signature is a digital signature of at least some identifiers, At least some coded data and said identifier on said pharmaceutical packaging; And causing printing of at least one of the serial numbers. 262. The method of claim 262, The sensing device is further used to carry out a method of dispensing the pharmaceutical agent, The method in a computer system, Receiving display data from the sensing device; The sensing device is responsive to sensing of the coded data at least in part to generate display data indicative of the identifier, Using the indication data and determining, from a distribution database, at least one criterion for dispensing the pharmaceutical formulation; And And if the at least one criterion is met, causing the pharmaceutical product to be dispensed.

Images